{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:39:48Z","timestamp":1792723188501,"version":"4.5.0"},"reference-count":485,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08661-6","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T09:15:52Z","timestamp":1785143752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanisms and functions of the TRIM protein family in digestive system cancers"],"prefix":"10.1186","volume":"24","author":[{"given":"Yujie","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengchen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangliu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6380-1919","authenticated-orcid":false,"given":"Pengfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"13","key":"8661_CR1","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.7150\/thno.113356","volume":"15","author":"X Yang","year":"2025","unstructured":"Yang X, Zhu J, Tao X, Gao F, Cai Y, Lv Y, et al. Challenges and opportunities for the diverse substrates of SPOP E3 ubiquitin ligase in cancer. Theranostics. 2025;15(13):6111\u201345. https:\/\/doi.org\/10.7150\/thno.113356.","journal-title":"Theranostics"},{"key":"8661_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.metabol.2025.156394","volume":"174","author":"J Wang","year":"2026","unstructured":"Wang J, Wang Q, Li X, Cai Q, Bi Y, Xu C, et al. Emerging roles of TRIM in metabolic regulation. Metabolism. 2026;174:174. https:\/\/doi.org\/10.1016\/j.metabol.2025.156394.","journal-title":"Metabolism"},{"issue":"1","key":"8661_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40164-022-00322-w","volume":"11","author":"N Huang","year":"2022","unstructured":"Huang N, Sun X, Li P, Liu X, Zhang X, Chen Q, et al. TRIM family contribute to tumorigenesis, cancer development, and drug resistance. Exp Hematol Oncol. 2022;11(1):75. https:\/\/doi.org\/10.1186\/s40164-022-00322-w.","journal-title":"Exp Hematol Oncol"},{"key":"8661_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jare.2023.01.011","volume":"54","author":"J Gu","year":"2023","unstructured":"Gu J, Chen J, Xiang S, Zhou X, Li J. Intricate confrontation: research progress and application potential of TRIM family proteins in tumor immune escape. J Adv Res. 2023;54:147\u201379. https:\/\/doi.org\/10.1016\/j.jare.2023.01.011.","journal-title":"J Adv Res"},{"issue":"16","key":"8661_CR5","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1097\/CM9.0000000000003225","volume":"137","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Song K, Chen Y, Zhang Y, Dai M, Wu D, et al. Burden of six major types of digestive system cancers globally and in China. Chin Med J. 2024;137(16):1957\u201364. https:\/\/doi.org\/10.1097\/CM9.0000000000003225.","journal-title":"Chin Med J"},{"issue":"1","key":"8661_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","volume":"78","author":"RJ Deshaies","year":"2009","unstructured":"Deshaies RJ, Joazeiro CAP. RING domain E3 ubiquitin ligases. Annu Rev Biochem. 2009;78(1):399\u2013434. https:\/\/doi.org\/10.1146\/annurev.biochem.78.101807.093809.","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"8661_CR7","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1042\/BST20200383","volume":"48","author":"F Fiorentini","year":"2020","unstructured":"Fiorentini F, Esposito D, Rittinger K. Does it take two to tango? RING domain self-association and activity in TRIM E3 ubiquitin ligases. Biochem Soc Trans. 2020;48(6):2615\u201324. https:\/\/doi.org\/10.1042\/BST20200383.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"8661_CR8","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1038\/s41467-025-58807-1","volume":"16","author":"J Dudley-Fraser","year":"2025","unstructured":"Dudley-Fraser J, Esposito D, McPhie KA, Morley-Williams C, Auchynnikava T, Rittinger K. Identification of RING E3 pseudoligases in the TRIM protein family. Nat Commun. 2025;16(1):3456. https:\/\/doi.org\/10.1038\/s41467-025-58807-1.","journal-title":"Nat Commun"},{"issue":"4","key":"8661_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jmb.2011.01.048","volume":"407","author":"X Han","year":"2011","unstructured":"Han X, Du H, Massiah MA. Detection and characterization of the in vitro e3 ligase activity of the human MID1 protein. J Mol Biol. 2011;407(4):505\u201320. https:\/\/doi.org\/10.1016\/j.jmb.2011.01.048.","journal-title":"J Mol Biol"},{"issue":"9","key":"8661_CR10","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.7150\/ijbs.97091","volume":"20","author":"C Gu","year":"2024","unstructured":"Gu C, Xia Y, Lu C, Qiu S, Wang J, Zhang L, et al. TRIM50 inhibits glycolysis and the malignant progression of gastric cancer by ubiquitinating PGK1. Int J Biol Sci. 2024;20(9):3656\u201374. https:\/\/doi.org\/10.7150\/ijbs.97091.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"8661_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/iub.580","volume":"64","author":"LM Napolitano","year":"2012","unstructured":"Napolitano LM, Meroni G. TRIM family: pleiotropy and diversification through homomultimer and heteromultimer formation. IUBMB Life. 2012;64(1):64\u201371. https:\/\/doi.org\/10.1002\/iub.580.","journal-title":"IUBMB Life"},{"issue":"24","key":"8661_CR12","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3390\/cells13242107","volume":"13","author":"W Wu","year":"2024","unstructured":"Wu W, Yang J, Yu T, Zou Z, Huang X. The role and mechanism of TRIM proteins in gastric cancer. Cells. 2024;13(24):2107. https:\/\/doi.org\/10.3390\/cells13242107.","journal-title":"Cells"},{"issue":"1","key":"8661_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12929-022-00854-7","volume":"29","author":"K Lu","year":"2022","unstructured":"Lu K, Pan Y, Huang Z, Liang H, Ding Z-Y, Zhang B. TRIM proteins in hepatocellular carcinoma. J Biomed Sci. 2022;29(1):69. https:\/\/doi.org\/10.1186\/s12929-022-00854-7.","journal-title":"J Biomed Sci"},{"issue":"1","key":"8661_CR14","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.1038\/s41467-024-52918-x","volume":"15","author":"L \u00c1lvarez","year":"2024","unstructured":"\u00c1lvarez L, Haubrich K, Iselin L, Gillioz L, Ruscica V, Lapouge K, et al. The molecular dissection of TRIM25\u2019s RNA-binding mechanism provides key insights into its antiviral activity. Nat Commun. 2024;15(1):8485. https:\/\/doi.org\/10.1038\/s41467-024-52918-x.","journal-title":"Nat Commun"},{"key":"8661_CR15","doi-asserted-by":"publisher","unstructured":"Wen P, Wang H, Li Y, Sui X, Hou Z, Guo X, et al. MICALL2 as a substrate of ubiquitinase TRIM21 regulates tumorigenesis of colorectal cancer. Cell Commun Signal. 2022;20(1). https:\/\/doi.org\/10.1186\/s12964-022-00984-3.","DOI":"10.1186\/s12964-022-00984-3"},{"issue":"1","key":"8661_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/cells12010201","volume":"12","author":"U Nasrullah","year":"2023","unstructured":"Nasrullah U, Stanke K, Recknagel V, Bozkurt S, Wurzel P, Gauer S, et al. The E3 ligase TRIM25 impairs apoptotic cell death in Colon carcinoma cells via destabilization of caspase-7 mRNA: a possible role of hnRNPH1. Cells. 2023;12(1):201. https:\/\/doi.org\/10.3390\/cells12010201.","journal-title":"Cells"},{"key":"8661_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ijbiomac.2025.144236","volume":"314","author":"X Wu","year":"2025","unstructured":"Wu X, Li Z, Cao C, Ge J, Shen X, Sun W, et al. A novel DNA binding protein encoded by circZNF131 inhibits the growth of gastric cancer by suppressing CTBP2 transcription. Int J Biol Macromolecules. 2025;314:314. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144236.","journal-title":"Int J Biol Macromolecules"},{"issue":"14","key":"8661_CR18","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.scib.2019.05.024","volume":"64","author":"J Cui","year":"2019","unstructured":"Cui J, Hu J, Ye Z, Fan Y, Li Y, Wang G, et al. TRIM28 protects CARM1 from proteasome-mediated degradation to prevent colorectal cancer metastasis. Sci Bull. 2019;64(14):986\u201397. https:\/\/doi.org\/10.1016\/j.scib.2019.05.024.","journal-title":"Sci Bull"},{"issue":"1","key":"8661_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","volume":"81","author":"D Komander","year":"2012","unstructured":"Komander D, Rape M. The ubiquitin code. Annu Rev Biochem. 2012;81(1):203\u201329. https:\/\/doi.org\/10.1146\/annurev-biochem-060310-170328.","journal-title":"Annu Rev Biochem"},{"key":"8661_CR20","doi-asserted-by":"publisher","unstructured":"Zang X, Jiang J, Gu J, Chen Y, Wang M, Zhang Y, et al. Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of \u03b2-catenin by promoting \u03b4-catenin ubiquitin degradation and upregulating SIK1. Mol Cancer. 2022;21(1). https:\/\/doi.org\/10.1186\/s12943-022-01606-9.","DOI":"10.1186\/s12943-022-01606-9"},{"key":"8661_CR21","doi-asserted-by":"publisher","unstructured":"Zhou L, Wang Z, Huang Y, Zhang X, Jiang H, Guo Z, et al. NLRP12 decreases TRIM25-mediated HK2 degradation to promote glycolysis and H3K18la in gastric cancer. Cell Death Dis. 2025;16(1). https:\/\/doi.org\/10.1038\/s41419-025-07923-3.","DOI":"10.1038\/s41419-025-07923-3"},{"key":"8661_CR22","doi-asserted-by":"publisher","unstructured":"Niu Y, Ding C, Wang Q, Yin J, Li L, Liu W, et al. TRIM6 ablation reverses ICB resistance in MSS gastric cancer by unleashing cGAS-STING-dependent antitumor immunity. J Exp Clin Cancer Res. 2025;44(1). https:\/\/doi.org\/10.1186\/s13046-025-03513-5.","DOI":"10.1186\/s13046-025-03513-5"},{"key":"8661_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.drup.2024.101096","volume":"76","author":"H Zhang","year":"2024","unstructured":"Zhang H, Zheng Y, Wang Z, Dong L, Xue L, Tian X, et al. KLF12 interacts with TRIM27 to affect cisplatin resistance and cancer metastasis in esophageal squamous cell carcinoma by regulating L1CAM expression. Drug Resist Updates. 2024;76:76. https:\/\/doi.org\/10.1016\/j.drup.2024.101096.","journal-title":"Drug Resist Updates"},{"key":"8661_CR24","doi-asserted-by":"publisher","unstructured":"Wang S, Zhu L, Wang Y, Han Y, Wang Q, Yang W, et al. ILF3 promotes colorectal cancer cell resistance to ferroptosis by enhancing cysteine uptake and GSH synthesis via stabilizing SLC3A2 mRNA. Cell Death Dis. 2025;16(1). https:\/\/doi.org\/10.1038\/s41419-025-07872-x.","DOI":"10.1038\/s41419-025-07872-x"},{"issue":"2","key":"8661_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/cas.15618","volume":"114","author":"T Wang","year":"2023","unstructured":"Wang T, Min L, Gao Y, Zhao M, Feng S, Wang H, et al. Sumoylation of TUFT1 is essential for gastric cancer progression through AKT\/mTOR signaling pathway activation. Cancer Sci. 2023;114(2):533\u201345. https:\/\/doi.org\/10.1111\/cas.15618.","journal-title":"Cancer Sci"},{"issue":"44","key":"8661_CR26","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41388-024-03167-1","volume":"43","author":"Z Liu","year":"2024","unstructured":"Liu Z, Hu Q, Luo Q, Zhang G, Yang W, Cao K, et al. NUP37 accumulation mediated by TRIM28 enhances lipid synthesis to accelerate HCC progression. Oncogene. 2024;43(44):3255\u201367. https:\/\/doi.org\/10.1038\/s41388-024-03167-1.","journal-title":"Oncogene"},{"issue":"5","key":"8661_CR27","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/hep.31530","volume":"73","author":"Z Li","year":"2021","unstructured":"Li Z, Lu X, Liu Y, Zhao J, Ma S, Yin H, et al. Gain of LINC00624 enhances liver cancer progression by disrupting the histone deacetylase 6\/Tripartite motif containing 28\/Zinc finger protein 354C corepressor complex. Hepatology. 2021;73(5):1764\u201382. https:\/\/doi.org\/10.1002\/hep.31530.","journal-title":"Hepatology"},{"issue":"12","key":"8661_CR28","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3390\/cells8121622","volume":"8","author":"U Nasrullah","year":"2019","unstructured":"Nasrullah U, Haeussler K, Biyanee A, Wittig I, Pfeilschifter J, Eberhardt W. Identification of TRIM25 as a negative regulator of Caspase-2 expression reveals a novel target for sensitizing colon carcinoma cells to intrinsic Apoptosis. Cells. 2019;8(12):1622. https:\/\/doi.org\/10.3390\/cells8121622.","journal-title":"Cells"},{"key":"8661_CR29","doi-asserted-by":"publisher","unstructured":"Tang Y, Meng X, Luo X, Yao W, Tian L, Zhang Z, et al. Arginine methylation-dependent TRIM47 stability mediated by CARM1 promotes the metastasis of hepatocellular carcinoma. Cell Death Discov. 2024;10(1). https:\/\/doi.org\/10.1038\/s41420-024-02244-4.","DOI":"10.1038\/s41420-024-02244-4"},{"key":"8661_CR30","doi-asserted-by":"publisher","unstructured":"Han Y, Lu S, Song C, Xuan Y, Zhang M, Cai H. Dual roles of TRIM3 in colorectal cancer by retaining p53 in the cytoplasm to decrease its nuclear expression. Cell Death Discov. 2023;9(1). https:\/\/doi.org\/10.1038\/s41420-023-01386-1.","DOI":"10.1038\/s41420-023-01386-1"},{"issue":"2","key":"8661_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10863-021-09872-w","volume":"53","author":"L Zhang","year":"2021","unstructured":"Zhang L, Qin B, Zou B, Wang S, Quan X, Wang J, et al. Knockdown of TRIM15 inhibits the proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inactivation of the Wnt\/\u03b2-catenin signaling pathway. J Bioenerg Biomembr. 2021;53(2):213\u201322. https:\/\/doi.org\/10.1007\/s10863-021-09872-w.","journal-title":"J Bioenerg Biomembr"},{"issue":"5","key":"8661_CR32","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3390\/cancers17050718","volume":"17","author":"J Liu","year":"2025","unstructured":"Liu J, Qiu L, Chen J, Zeng T. Lycorine hydrochloride suppresses the proliferation and invasion of esophageal cancer by targeting TRIM22 and inhibiting the JAK2\/STAT3 and erk pathways. Cancers. 2025;17(5):718. https:\/\/doi.org\/10.3390\/cancers17050718.","journal-title":"Cancers"},{"key":"8661_CR33","doi-asserted-by":"publisher","unstructured":"George SA, Kotapalli V, Ramaswamy P, Kumar R, Gowrishankar S, Uppin SG, et al. Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma. J Cellular Biochem. 2024;125(4). https:\/\/doi.org\/10.1002\/jcb.30534.","DOI":"10.1002\/jcb.30534"},{"issue":"4","key":"8661_CR34","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s12253-018-0558-6","volume":"25","author":"B Liu","year":"2019","unstructured":"Liu B, Li X, Liu F, Li F, Wei S, Liu J, et al. Expression and significance of TRIM 28 in squamous carcinoma of esophagus. Pathol Oncol Res. 2019;25(4):1645\u201352. https:\/\/doi.org\/10.1007\/s12253-018-0558-6.","journal-title":"Pathol Oncol Res"},{"key":"8661_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cellsig.2025.111975","volume":"135","author":"L Ge","year":"2025","unstructured":"Ge L, Sun M, Xu D, Sun G. The E3 ubiquitin ligase TRIM31 enhances the progression of esophageal cancer through the ubiquitination of BBOX1. Cellular Signalling. 2025;135:135. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111975.","journal-title":"Cellular Signalling"},{"key":"8661_CR36","doi-asserted-by":"publisher","unstructured":"Xia T, Meng L, Xu G, Sun H, Chen H. TRIM33 promotes glycolysis through regulating P53 K48-linked ubiquitination to promote esophageal squamous cell carcinoma growth. Cell Death Dis. 2024;15(10). https:\/\/doi.org\/10.1038\/s41419-024-07137-z.","DOI":"10.1038\/s41419-024-07137-z"},{"issue":"8","key":"8661_CR37","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1245\/s10434-025-17238-4","volume":"32","author":"A Yamaguchi","year":"2025","unstructured":"Yamaguchi A, Yokobori T, Sohda M, Watanabe T, Nakazawa N, Sano A, et al. Low TIF1\u03b3 expression is associated with cancer aggressiveness and shorter recurrence-free survival in patients with esophageal squamous cell carcinoma. Ann Surg Oncol. 2025;32(8):6023\u201330. https:\/\/doi.org\/10.1245\/s10434-025-17238-4.","journal-title":"Ann Surg Oncol"},{"key":"8661_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.intimp.2024.112362","volume":"137","author":"Y Ji","year":"2024","unstructured":"Ji Y, Li F, Zhang H, Yang L, Yi Y, Wang L, et al. Targeting TRIM40 signaling reduces esophagus cancer development: a mechanism involving in protection of oroxylin a. Int Immunopharmacol. 2024;137:137. https:\/\/doi.org\/10.1016\/j.intimp.2024.112362.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"8661_CR39","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1111\/cas.13762","volume":"109","author":"D Xiong","year":"2018","unstructured":"Xiong D, Jin C, Ye X, Qiu B, Jianjun X, Zhu S, et al. TRIM44 promotes human esophageal cancer progression via the AKT\/mTOR pathway. Cancer Sci. 2018;109(10):3080\u201392. https:\/\/doi.org\/10.1111\/cas.13762.","journal-title":"Cancer Sci"},{"issue":"1","key":"8661_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2020.12267","volume":"21","author":"R Liu","year":"2020","unstructured":"Liu R, Li H, Xu Y, Li X, Guo X, Shi J, et al. Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53. Oncol Lett. 2020;21(1):1\u20131. https:\/\/doi.org\/10.3892\/ol.2020.12267.","journal-title":"Oncol Lett"},{"issue":"15","key":"8661_CR41","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1038\/s41388-018-0621-5","volume":"38","author":"J Zhu","year":"2019","unstructured":"Zhu J, Wu G, Ke Z, Cao L, Tang M, Li Z, et al. Targeting TRIM3 deletion-induced tumor-associated lymphangiogenesis prohibits lymphatic metastasis in esophageal squamous cell carcinoma. Oncogene. 2019;38(15):2736\u201349. https:\/\/doi.org\/10.1038\/s41388-018-0621-5.","journal-title":"Oncogene"},{"key":"8661_CR42","doi-asserted-by":"publisher","unstructured":"Lin Z, Huang J, Zhu L, Lin X, Huang Y, Chen C, et al. TRIM9 interacts with ZEB1 to suppress esophageal cancer by promoting ZEB1 protein degradation via the UPP pathway. Biomed Res Int. 2023;2023(1). https:\/\/doi.org\/10.1155\/2023\/2942402.","DOI":"10.1155\/2023\/2942402"},{"issue":"10","key":"8661_CR43","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jgg.2019.10.004","volume":"46","author":"L Zheng","year":"2019","unstructured":"Zheng L, Zhao Z, Rong L, Xue L, Song Y. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma. J Genet Genomics. 2019;46(10):477\u201388. https:\/\/doi.org\/10.1016\/j.jgg.2019.10.004.","journal-title":"J Genet Genomics"},{"issue":"8","key":"8661_CR44","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/jso.21855","volume":"103","author":"CC Yen","year":"2011","unstructured":"Yen CC, Tsao YP, Chen PCH, Wu YC, Liu JH, Pan CC, et al. PML protein as a prognostic molecular marker for patients with esophageal squamous cell carcinomas receiving primary surgery. J Surg Oncol. 2011;103(8):761\u201367. https:\/\/doi.org\/10.1002\/jso.21855.","journal-title":"J Surg Oncol"},{"key":"8661_CR45","doi-asserted-by":"publisher","unstructured":"Li L, Wang Y, Tian R, Yang T, Liu Y, Shan B, et al. TRIM21-mediated K11-linked Ubiquitination of ID1 suppresses Tumorigenesis and promotes cuproptosis in esophageal squamous cell carcinoma. Adv Sci. 2025;12(35). https:\/\/doi.org\/10.1002\/advs.202502501.","DOI":"10.1002\/advs.202502501"},{"key":"8661_CR46","doi-asserted-by":"publisher","unstructured":"Yi Q, Zhao Y, Xia R, Wei Q, Chao F, Zhang R, et al. TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750. Cell Death Discov. 2023;9(1). https:\/\/doi.org\/10.1038\/s41420-023-01491-1.","DOI":"10.1038\/s41420-023-01491-1"},{"issue":"5","key":"8661_CR47","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s13577-022-00737-x","volume":"35","author":"B Zhao","year":"2022","unstructured":"Zhao B, Qiao G, Li J, Wang Y, Li X, Zhang H, et al. TRIM36 suppresses cell growth and promotes apoptosis in human esophageal squamous cell carcinoma cells by inhibiting Wnt\/\u03b2-catenin signaling pathway. Hum Cell. 2022;35(5):1487\u201398. https:\/\/doi.org\/10.1007\/s13577-022-00737-x.","journal-title":"Hum Cell"},{"issue":"1","key":"8661_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12029-020-00563-0","volume":"53","author":"J Farhadi","year":"2022","unstructured":"Farhadi J, Goshayeshi L, Motavalizadehkakhky A, Mehrzad J, Mehrad-Majd H. Decreased expression of TRIM3 gene predicts a poor prognosis in gastric cancer. J Gastrointest Canc. 2022;53(1):179\u201386. https:\/\/doi.org\/10.1007\/s12029-020-00563-0.","journal-title":"J Gastrointest Canc"},{"key":"8661_CR49","doi-asserted-by":"publisher","unstructured":"Fu H, Yang H, Zhang X, Wang B, Mao J, Li X, et al. Exosomal TRIM3 is a novel marker and therapy target for gastric cancer. J Exp Clin Cancer Res. 2018;37(1). https:\/\/doi.org\/10.1186\/s13046-018-0825-0.","DOI":"10.1186\/s13046-018-0825-0"},{"key":"8661_CR50","doi-asserted-by":"publisher","unstructured":"Wang F, Ruan L, Yang J, Zhao Q, Wei W. TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial\u2011to\u2011mesenchymal transition via activation of AKT signaling regulated by miR\u2011195\u20115p. Oncol Rep. 2018. https:\/\/doi.org\/10.3892\/or.2018.6750.","DOI":"10.3892\/or.2018.6750"},{"issue":"8","key":"8661_CR51","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/08941939.2019.1705443","volume":"34","author":"W Zhou","year":"2021","unstructured":"Zhou W, Chen H, Ruan Y, Zeng X, Liu F. High expression of TRIM15 is associated with tumor invasion and predicts poor prognosis in patients with gastric cancer. J Invest Surg. 2021;34(8):853\u201361. https:\/\/doi.org\/10.1080\/08941939.2019.1705443.","journal-title":"J Invest Surg"},{"key":"8661_CR52","doi-asserted-by":"publisher","first-page":"8033","DOI":"10.12659\/MSM.911142","volume":"24","author":"W Chen","year":"2018","unstructured":"Chen W, Lu C, Hong J. TRIM15 exerts anti-tumor effects through suppressing cancer cell invasion in gastric adenocarcinoma. Med Sci Monit. 2018;24:8033\u201341. https:\/\/doi.org\/10.12659\/MSM.911142.","journal-title":"Med Sci Monit"},{"issue":"9","key":"8661_CR53","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1111\/jgh.12976","volume":"30","author":"Y Yan","year":"2015","unstructured":"Yan Y, Shen Z, Gao Z, Cao J, Yang Y, Wang B, et al. Long noncoding ribonucleic acid specific for distant metastasis of gastric cancer is associated with TRIM16 expression and facilitates tumor cell invasion in vitro. J Gastro Hepatol. 2015;30(9):1367\u201375. https:\/\/doi.org\/10.1111\/jgh.12976.","journal-title":"J Gastro Hepatol"},{"issue":"1","key":"8661_CR54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12029-021-00791-y","volume":"54","author":"M Seifi Inallou","year":"2023","unstructured":"Seifi Inallou M, Safaralizadeh R, Rajabi A, Hosseinpourfeizi M, Haghi M. Changes in the expression of long non-coding RNA SDMGC and its target gene, TRIM16, in patients with gastric cancer. J Gastrointest Canc. 2023;54(1):44\u201350. https:\/\/doi.org\/10.1007\/s12029-021-00791-y.","journal-title":"J Gastrointest Canc"},{"issue":"10","key":"8661_CR55","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1038\/s41418-023-01221-1","volume":"30","author":"J Shen","year":"2023","unstructured":"Shen J, Yang H, Qiao X, Chen Y, Zheng L, Lin J, et al. The E3 ubiquitin ligase TRIM17 promotes gastric cancer survival and progression via controlling BAX stability and antagonizing apoptosis. Cell Death Differ. 2023;30(10):2322\u201335. https:\/\/doi.org\/10.1038\/s41418-023-01221-1.","journal-title":"Cell Death Differ"},{"issue":"12","key":"8661_CR56","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.prp.2018.10.010","volume":"214","author":"Y Yao","year":"2018","unstructured":"Yao Y, Liu Z, Guo H, Huang S, Zhong M, Deng J, et al. Elevated TRIM23 expression predicts poor prognosis in Chinese gastric cancer. Pathol - Res Pract. 2018;214(12):2062\u201368. https:\/\/doi.org\/10.1016\/j.prp.2018.10.010.","journal-title":"Pathol - Res Pract"},{"issue":"5","key":"8661_CR57","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00428-015-1737-4","volume":"466","author":"Z-F Miao","year":"2015","unstructured":"Miao Z-F, Wang Z-N, Zhao T-T, Xu Y-Y, Wu J-H, Liu X-Y, et al. TRIM24 is upregulated in human gastric cancer and promotes gastric cancer cell growth and chemoresistance. Virchows Arch. 2015;466(5):525\u201332. https:\/\/doi.org\/10.1007\/s00428-015-1737-4.","journal-title":"Virchows Arch"},{"key":"8661_CR58","doi-asserted-by":"crossref","unstructured":"Song S, Fan Y, Zou G, Huo L, Kumar J, Li Y, et al. KAP1 promotes gastric adenocarcinoma progression by activating Hippo\/YAP1 signaling via binding to HNRNPAB. Cancer letters. 2025;621.","DOI":"10.1016\/j.canlet.2025.217695"},{"key":"8661_CR59","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.canlet.2023.216510","volume":"581","author":"T Jiang","year":"2024","unstructured":"Jiang T, Xia Y, Li Y, Lu C, Lin J, Shen Y, et al. TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer. Cancer Lett. 2024;581:581. https:\/\/doi.org\/10.1016\/j.canlet.2023.216510.","journal-title":"Cancer Lett"},{"key":"8661_CR60","doi-asserted-by":"publisher","unstructured":"Wang C, Zhou Y, Chen B, Yuan W, Huang J. Prognostic value of tripartite motif containing 29 expression in patients with gastric cancer following surgical resection. Oncol Lett. 2018. https:\/\/doi.org\/10.3892\/ol.2018.8059.","DOI":"10.3892\/ol.2018.8059"},{"key":"8661_CR61","doi-asserted-by":"publisher","unstructured":"Feng Q, Nie F, Gan L, Wei X, Liu P, Liu H, et al. Tripartite motif 31 drives gastric cancer cell proliferation and invasion through activating the Wnt\/\u03b2-catenin pathway by regulating Axin1 protein stability. Sci Rep. 2023;13(1). https:\/\/doi.org\/10.1038\/s41598-023-47139-z.","DOI":"10.1038\/s41598-023-47139-z"},{"issue":"5","key":"8661_CR62","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.3892\/ol.2017.5806","volume":"13","author":"M Ito","year":"2017","unstructured":"Ito M, Migita K, Matsumoto S, Wakatsuki K, Tanaka T, Kunishige T, et al. Overexpression of E3 ubiquitin ligase tripartite motif 32 correlates with a poor prognosis in patients with gastric cancer. Oncol Lett. 2017;13(5):3131\u201338. https:\/\/doi.org\/10.3892\/ol.2017.5806.","journal-title":"Oncol Lett"},{"issue":"2","key":"8661_CR63","doi-asserted-by":"publisher","first-page":"316","DOI":"10.7150\/jca.47577","volume":"12","author":"K Nishibeppu","year":"2021","unstructured":"Nishibeppu K, Komatsu S, Kiuchi J, Kishimoto T, Takashima Y, Shoda K, et al. TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer. J Cancer. 2021;12(2):316\u201325. https:\/\/doi.org\/10.7150\/jca.47577.","journal-title":"J Cancer"},{"issue":"5","key":"8661_CR64","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.gendis.2021.10.008","volume":"9","author":"H Zhu","year":"2022","unstructured":"Zhu H, Wang G, Sun Q, Zhu H, Xu A. Elevation of TRIM44 potentiates propagation of gastric cancer stem cells. Genes & Dis. 2022;9(5):1156\u201359. https:\/\/doi.org\/10.1016\/j.gendis.2021.10.008.","journal-title":"Genes & Dis"},{"issue":"2","key":"8661_CR65","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4149\/neo_2020_200708N706","volume":"68","author":"Y Xia","year":"2021","unstructured":"Xia Y, Wei Z, Huang W, Wei X, He Y. Trim47 overexpression correlates with poor prognosis in gastric cancer. Neoplasma. 2021;68(2):307\u201316. https:\/\/doi.org\/10.4149\/neo_2020_200708N706.","journal-title":"Neoplasma"},{"issue":"6","key":"8661_CR66","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/ajco.13747","volume":"18","author":"H Cao","year":"2022","unstructured":"Cao H, Li Y, Chen L, Lu Z, You T, Wang X, et al. Tripartite motif-containing 54 promotes gastric cancer progression by upregulating K63-linked ubiquitination of filamin C. Asia-Pac J Clncl Oncol. 2022;18(6):669\u201377. https:\/\/doi.org\/10.1111\/ajco.13747.","journal-title":"Asia-Pac J Clncl Oncol"},{"issue":"11","key":"8661_CR67","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.4251\/wjgo.v14.i11.2183","volume":"14","author":"W-W Li","year":"2022","unstructured":"Li W-W, Yuan H, Kong S, Tian S-B. E3 ubiquitin ligase TRIM55 promotes metastasis of gastric cancer cells by mediating epithelial-mesenchymal transition. World J Gastrointest Oncol. 2022;14(11):2183\u201394. https:\/\/doi.org\/10.4251\/wjgo.v14.i11.2183.","journal-title":"World J Gastrointest Oncol"},{"key":"8661_CR68","doi-asserted-by":"publisher","unstructured":"Yang W, Cui X, Sun D, Sun G, Yan Z, Wei M, et al. POU5F1 promotes the proliferation, migration, and invasion of gastric cancer cells by reducing the ubiquitination level of TRAF6. Cell Death Dis. 2023;14(12). https:\/\/doi.org\/10.1038\/s41419-023-06332-8.","DOI":"10.1038\/s41419-023-06332-8"},{"key":"8661_CR69","doi-asserted-by":"publisher","unstructured":"Gong L-P, Chen J-N, Dong M, Xiao Z-D, Feng Z-Y, Pan Y-H, et al. Epstein\u2013barr virus-derived circular RNA LMP2A induces stemness in EBV-associated gastric cancer. EMBO Rep. 2020;21(10). https:\/\/doi.org\/10.15252\/embr.201949689.","DOI":"10.15252\/embr.201949689"},{"issue":"2","key":"8661_CR70","doi-asserted-by":"publisher","first-page":"113154","DOI":"10.1016\/j.yexcr.2022.113154","volume":"416","author":"C Liu","year":"2022","unstructured":"Liu C, Sun W, Yang K, Xia B. Knockdown of TRIM65 suppressed the proliferation and invasiveness of gastric cancer cells by restricting the ubiquitin degradation of PPM1A. Exp Cell Res. 2022;416(2):113154. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113154.","journal-title":"Exp Cell Res"},{"key":"8661_CR71","doi-asserted-by":"publisher","unstructured":"Chen Q, Zhang T, Zeng R, Zhang K, Li B, Zhu Z, et al. The E3 ligase TRIM7 suppresses the tumorigenesis of gastric cancer by targeting SLC7A11. Sci Rep. 2024;14(1). https:\/\/doi.org\/10.1038\/s41598-024-56746-3.","DOI":"10.1038\/s41598-024-56746-3"},{"issue":"1","key":"8661_CR72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.canlet.2006.03.034","volume":"247","author":"HE Lee","year":"2007","unstructured":"Lee HE, Jee CD, Kim MA, Lee HS, Lee YM, Lee BL, et al. Loss of promyelocytic leukemia protein in human gastric cancers. Cancer Lett. 2007;247(1):103\u201309. https:\/\/doi.org\/10.1016\/j.canlet.2006.03.034.","journal-title":"Cancer Lett"},{"key":"8661_CR73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbrc.2021.07.040","volume":"586","author":"M Ping","year":"2022","unstructured":"Ping M, Wang S, Guo Y, Jia J. TRIM21 improves apatinib treatment in gastric cancer through suppressing EZH1 stability. Biochem Bioph Res Co. 2022;586:177\u201384. https:\/\/doi.org\/10.1016\/j.bbrc.2021.07.040.","journal-title":"Biochem Bioph Res Co"},{"key":"8661_CR74","doi-asserted-by":"publisher","unstructured":"Zhou Z, Gao W, Yuan B, Zhang S, Wang K, Du T. TRIM22 inhibits the proliferation of gastric cancer cells through the Smad2 protein. Cell Death Discov. 2021;7(1). https:\/\/doi.org\/10.1038\/s41420-021-00627-5.","DOI":"10.1038\/s41420-021-00627-5"},{"key":"8661_CR75","doi-asserted-by":"publisher","unstructured":"Chen J-J, Ren Y-L, Shu C-J, Zhang Y, Chen M-J, Xu J, et al. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25\/SP1\/MMP2 axis. J Exp Clin Cancer Res. 2020;39(1). https:\/\/doi.org\/10.1186\/s13046-020-01617-8.","DOI":"10.1186\/s13046-020-01617-8"},{"key":"8661_CR76","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tranon.2025.102489","volume":"60","author":"NS Al-Abbas","year":"2025","unstructured":"Al-Abbas NS. TRIM26 as a dual regulator of ferroptosis and chemoresistance in gastric cancer through HSF1 ubiquitination and exosomal miR-24-3p signaling. Transl Oncol. 2025;60:60. https:\/\/doi.org\/10.1016\/j.tranon.2025.102489.","journal-title":"Transl Oncol"},{"key":"8661_CR77","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1177\/15330338221114505","volume":"21","author":"F Wang","year":"2022","unstructured":"Wang F, Wang W, Wu X, Tang C, Du F, Lu Z, et al. Downregulation of TRIM33 promotes survival and epithelial\u2013mesenchymal transition in gastric cancer. Technol Cancer Res Treat. 2022;21:21. https:\/\/doi.org\/10.1177\/15330338221114505.","journal-title":"Technol Cancer Res Treat"},{"issue":"7","key":"8661_CR78","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/carcin\/bgr068","volume":"32","author":"K Noguchi","year":"2011","unstructured":"Noguchi K, Okumura F, Takahashi N, Kataoka A, Kamiyama T, Todo S, et al. TRIM40 promotes neddylation of IKK and is downregulated in gastrointestinal cancers. Carcinogenesis. 2011;32(7):995\u20131004. https:\/\/doi.org\/10.1093\/carcin\/bgr068.","journal-title":"Carcinogenesis"},{"issue":"3","key":"8661_CR79","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/15384047.2019.1679554","volume":"21","author":"X Liu","year":"2020","unstructured":"Liu X, Long Z, Cai H, Yu S, Wu J. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of \u03b2-catenin signaling via ubiquitination. Cancer Biol Ther. 2020;21(3):203\u201312. https:\/\/doi.org\/10.1080\/15384047.2019.1679554.","journal-title":"Cancer Biol Ther"},{"issue":"49","key":"8661_CR80","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/s41388-023-02873-6","volume":"42","author":"L Sun","year":"2023","unstructured":"Sun L, Chen Y, Xia L, Wang J, Zhu J, Li J, et al. TRIM69 suppressed the anoikis resistance and metastasis of gastric cancer through ubiquitin\u2012proteasome-mediated degradation of PRKCD. Oncogene. 2023;42(49):3619\u201332. https:\/\/doi.org\/10.1038\/s41388-023-02873-6.","journal-title":"Oncogene"},{"issue":"2","key":"8661_CR81","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/00365521.2019.1575463","volume":"54","author":"H Cao","year":"2019","unstructured":"Cao H, Fang Y, Liang Q, Wang J, Luo B, Zeng G, et al. TRIM2 is a novel promoter of human colorectal cancer. Scand J Gastroenterol. 2019;54(2):210\u201318. https:\/\/doi.org\/10.1080\/00365521.2019.1575463.","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"8661_CR82","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3109\/00365521.2015.1124285","volume":"51","author":"M-Y Piao","year":"2016","unstructured":"Piao M-Y, Cao H-L, He N-N, Xu M-Q, Dong W-X, Wang W-Q, et al. Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development. Scand J Gastroenterol. 2016;51(5):572\u201382. https:\/\/doi.org\/10.3109\/00365521.2015.1124285.","journal-title":"Scand J Gastroenterol"},{"key":"8661_CR83","doi-asserted-by":"publisher","unstructured":"Zheng S, Zhou C, Wang Y, Li H, Sun Y, Shen Z. TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21\/FoxM1. J Exp Clin Cancer Res. 2020;39(1). https:\/\/doi.org\/10.1186\/s13046-019-1504-5.","DOI":"10.1186\/s13046-019-1504-5"},{"issue":"11","key":"8661_CR84","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1111\/cas.15548","volume":"113","author":"T Han","year":"2022","unstructured":"Han T, Jiang Y, Wang X, Deng S, Hu Y, Jin Q, et al. 3D matrix promotes cell dedifferentiation into colorectal cancer stem cells via integrin\/cytoskeleton\/glycolysis signaling. Cancer Sci. 2022;113(11):3826\u201337. https:\/\/doi.org\/10.1111\/cas.15548.","journal-title":"Cancer Sci"},{"key":"8661_CR85","doi-asserted-by":"publisher","unstructured":"Shen W, Jin Z, Tong X, Wang H, Zhuang L, Lu X, et al. <p>TRIM14 promotes cell proliferation and inhibits apoptosis by suppressing PTEN in colorectal cancer<\/p>. CMAR. 2019, Volume, 11: 5725\u201335. https:\/\/doi.org\/10.2147\/CMAR.S210782.","DOI":"10.2147\/CMAR.S210782"},{"issue":"6","key":"8661_CR86","first-page":"2695","volume":"12","author":"B Ju","year":"2020","unstructured":"Ju B, Liu Z, Nai C, Zhu X. Long non-coding RNA CASC2 induces apoptosis and autophagy in human colon cancer cells via modulation of TRIM16 expression. Am J Transl Res. 2020;12(6):2695\u2013702.","journal-title":"Am J Transl Res"},{"issue":"1","key":"8661_CR87","doi-asserted-by":"publisher","first-page":"112735","DOI":"10.1016\/j.yexcr.2021.112735","volume":"406","author":"L Ruan","year":"2021","unstructured":"Ruan L, Liu W, Yang Y, Chu Z, Yang C, Yang T, et al. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating snail degradation. Exp Cell Res. 2021;406(1):112735. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112735.","journal-title":"Exp Cell Res"},{"key":"8661_CR88","doi-asserted-by":"publisher","unstructured":"Liu J, Wei X, Xie Y, Yan Y, Xue S, Wang X, et al. MDM4 inhibits ferroptosis in p53 mutant colon cancer via regulating TRIM21\/GPX4 expression. Cell Death Dis. 2024;15(11). https:\/\/doi.org\/10.1038\/s41419-024-07227-y.","DOI":"10.1038\/s41419-024-07227-y"},{"key":"8661_CR89","doi-asserted-by":"publisher","unstructured":"Cao M, Shao Z, Qian X, Chen M, Deng C, Chen X, et al. TRIM21-mediated PRMT1 degradation attenuates colorectal cancer malignant progression. Cell Death Dis. 2025;16(1). https:\/\/doi.org\/10.1038\/s41419-025-07383-9.","DOI":"10.1038\/s41419-025-07383-9"},{"issue":"3\u20134","key":"8661_CR90","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10495-024-02060-2","volume":"30","author":"S Wei","year":"2025","unstructured":"Wei S, Xia W, Feng J, Lu J, Zhang L, Wang W, et al. TRIM23 promotes 5-fluorouracil resistance in colorectal cancer by upregulating GALNT4 expression. Apoptosis. 2025;30(3\u20134):751\u201367. https:\/\/doi.org\/10.1007\/s10495-024-02060-2.","journal-title":"Apoptosis"},{"issue":"10","key":"8661_CR91","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.prp.2017.08.008","volume":"213","author":"F-Q Wang","year":"2017","unstructured":"Wang F-Q, Han Y, Yao W, Yu J. Prognostic relevance of tripartite motif containing 24 expression in colorectal cancer. Pathol - Res Pract. 2017;213(10):1271\u201375. https:\/\/doi.org\/10.1016\/j.prp.2017.08.008.","journal-title":"Pathol - Res Pract"},{"key":"8661_CR92","doi-asserted-by":"publisher","unstructured":"Zhou S, Peng J, Xiao L, Zhou C, Fang Y, Ou Q, et al. TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability. Cell Death Dis. 2021;12(5). https:\/\/doi.org\/10.1038\/s41419-021-03734-4.","DOI":"10.1038\/s41419-021-03734-4"},{"issue":"11","key":"8661_CR93","doi-asserted-by":"publisher","first-page":"113426","DOI":"10.1016\/j.celrep.2023.113426","volume":"42","author":"Y Huang","year":"2023","unstructured":"Huang Y, Xiong C, Wang C, Deng J, Zuo Z, Wu H, et al. p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP. Cell Rep. 2023;42(11):113426. https:\/\/doi.org\/10.1016\/j.celrep.2023.113426.","journal-title":"Cell Rep"},{"issue":"6","key":"8661_CR94","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/s41418-025-01463-1","volume":"32","author":"Z Tan","year":"2025","unstructured":"Tan Z, Ko HM, Naji P, Zhu R, Wang J, Huang S, et al. Tripartite motif-containing protein 26 promotes colorectal cancer growth by inactivating p53. Cell Death Differ. 2025;32(6):1142\u201352. https:\/\/doi.org\/10.1038\/s41418-025-01463-1.","journal-title":"Cell Death Differ"},{"key":"8661_CR95","doi-asserted-by":"publisher","unstructured":"Zhu J, Zhi S, Zeng J, Zhou S, Ji Y, Han F. Development and validation of a TRIM27-based nomogram for predicting metachronous liver metastasis and prognosis in postoperative colorectal cancer patients. BMC Cancer. 2024;24(1). https:\/\/doi.org\/10.1186\/s12885-024-12890-7.","DOI":"10.1186\/s12885-024-12890-7"},{"key":"8661_CR96","doi-asserted-by":"publisher","unstructured":"Fitzgerald S, Espina V, Liotta L, Sheehan KM, O\u2019Grady A, Cummins R, et al. Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment. J Transl Med. 2018;16(1). https:\/\/doi.org\/10.1186\/s12967-018-1465-z.","DOI":"10.1186\/s12967-018-1465-z"},{"key":"8661_CR97","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cellsig.2025.111871","volume":"134","author":"Y Fu","year":"2025","unstructured":"Fu Y, Huang R, Qin G, Huang S, Li J, Zhan W, et al. TRIM29 promotes liver metastasis via enhancing hepatic colonization by stabilizing FAM83H to regulate keratin network in colorectal cancer. Cellular Signalling. 2025;134:134. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111871.","journal-title":"Cellular Signalling"},{"key":"8661_CR98","doi-asserted-by":"publisher","unstructured":"Li X, Wu Y, Guo J, Huang P, Li Q, Gao Z, et al. TRIM31 triggers colorectal carcinogenesis and progression by maintaining YBX1 protein stability through ubiquitination modification. Cell Death Dis. 2025;16(1). https:\/\/doi.org\/10.1038\/s41419-025-07922-4.","DOI":"10.1038\/s41419-025-07922-4"},{"issue":"11","key":"8661_CR99","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.3390\/ijms26115047","volume":"26","author":"J Ning","year":"2025","unstructured":"Ning J, Cai X, Su Y, Fan X, Shen M. Inhibitory effect and mechanism of the down-regulation of TRIM32 in colorectal cancer. IJMS. 2025;26(11):5047. https:\/\/doi.org\/10.3390\/ijms26115047.","journal-title":"IJMS"},{"issue":"3","key":"8661_CR100","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3892\/mmr.2017.6125","volume":"15","author":"C-E Hu","year":"2017","unstructured":"Hu C-E, Gan J. TRIM37 promotes epithelial-mesenchymal transition in colorectal cancer. Mol Med Rep. 2017;15(3):1057\u201362. https:\/\/doi.org\/10.3892\/mmr.2017.6125.","journal-title":"Mol Med Rep"},{"key":"8661_CR101","doi-asserted-by":"publisher","unstructured":"Hu J, Ding X, Tian S, Chu Y, Liu Z, Li Y, et al. TRIM39 deficiency inhibits tumor progression and autophagic flux in colorectal cancer via suppressing the activity of Rab7. Cell Death Dis. 2021;12(4). https:\/\/doi.org\/10.1038\/s41419-021-03670-3.","DOI":"10.1038\/s41419-021-03670-3"},{"key":"8661_CR102","doi-asserted-by":"publisher","first-page":"10693","DOI":"10.2147\/OTT.S228637","volume":"12","author":"C-G Li","year":"2019","unstructured":"Li C-G, Hu H, Yang X-J, Huang C-Q, Yu X-Q. <p>TRIM44 promotes colorectal cancer proliferation, migration, and invasion through the Akt\/mTOR signaling pathway<\/p>. Onco Targets Ther. 2019;12:10693\u2013701. https:\/\/doi.org\/10.2147\/OTT.S228637.","journal-title":"Onco Targets Ther"},{"key":"8661_CR103","doi-asserted-by":"publisher","unstructured":"Liang Q, Tang C, Tang M, Zhang Q, Gao Y, Ge Z. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4. J Exp Clin Cancer Res. 2019;38(1). https:\/\/doi.org\/10.1186\/s13046-019-1143-x.","DOI":"10.1186\/s13046-019-1143-x"},{"key":"8661_CR104","doi-asserted-by":"publisher","unstructured":"Pan S, Deng Y, Fu J, Zhang Y, Zhang Z, Ru X, et al. TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling. Cancer Cell Int. 2019;19(1). https:\/\/doi.org\/10.1186\/s12935-019-0775-4.","DOI":"10.1186\/s12935-019-0775-4"},{"issue":"1","key":"8661_CR105","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3892\/or.2017.5654","volume":"38","author":"Y Sun","year":"2017","unstructured":"Sun Y, Ji B, Feng Y, Zhang Y, Ji D, Zhu C, et al. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K\/AKT pathway. Oncol Rep. 2017;38(1):43\u201352. https:\/\/doi.org\/10.3892\/or.2017.5654.","journal-title":"Oncol Rep"},{"issue":"37","key":"8661_CR106","doi-asserted-by":"publisher","first-page":"6429","DOI":"10.1038\/s41388-019-0891-6","volume":"38","author":"D Chen","year":"2019","unstructured":"Chen D, Li Y, Zhang X, Wu H, Wang Q, Cai J, et al. Ubiquitin ligase TRIM65 promotes colorectal cancer metastasis by targeting ARHGAP35 for protein degradation. Oncogene. 2019;38(37):6429\u201344. https:\/\/doi.org\/10.1038\/s41388-019-0891-6.","journal-title":"Oncogene"},{"key":"8661_CR107","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.lfs.2019.116799","volume":"235","author":"T He","year":"2019","unstructured":"He T, Cui J, Wu Y, Sun X, Chen N. Knockdown of TRIM66 inhibits cell proliferation, migration and invasion in colorectal cancer through JAK2\/STAT3 pathway. Life Sci. 2019;235:235. https:\/\/doi.org\/10.1016\/j.lfs.2019.116799.","journal-title":"Life Sci"},{"key":"8661_CR108","doi-asserted-by":"publisher","unstructured":"Shi L, Fang X, Du L, Yang J, Xue J, Yue X, et al. An E3 ligase TRIM1 promotes colorectal cancer progression via K63-linked ubiquitination and activation of HIF1\u03b1. Oncogenesis. 2024;13(1). https:\/\/doi.org\/10.1038\/s41389-024-00517-2.","DOI":"10.1038\/s41389-024-00517-2"},{"key":"8661_CR109","doi-asserted-by":"publisher","unstructured":"Mastropasqua F, Marzano F, Valletti A, Aiello I, Di Tullio G, Morgano A, et al. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours. Mol Cancer. 2017;16(1). https:\/\/doi.org\/10.1186\/s12943-017-0634-7.","DOI":"10.1186\/s12943-017-0634-7"},{"issue":"52","key":"8661_CR110","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1039\/C9CC01944H","volume":"55","author":"SU Moon","year":"2019","unstructured":"Moon SU, Park Y, Park MG, Song SK, Jeong SH, Lee YS, et al. Theragnosis by a miR-141-3p molecular beacon: simultaneous detection and sensitization of 5-fluorouracil resistant colorectal cancer cells through the activation of the TRIM13-associated apoptotic pathway. Chem Commun. 2019;55(52):7466\u201369. https:\/\/doi.org\/10.1039\/C9CC01944H.","journal-title":"Chem Commun"},{"issue":"2","key":"8661_CR111","doi-asserted-by":"publisher","first-page":"114473","DOI":"10.1016\/j.yexcr.2025.114473","volume":"446","author":"H Hu","year":"2025","unstructured":"Hu H, Li W, Ma P, Song J, Zhang X, Ruan L, et al. TRIM22 inhibits the metastasis of colorectal cancer through facilitating \u03b2-catenin degradation. Exp Cell Res. 2025;446(2):114473. https:\/\/doi.org\/10.1016\/j.yexcr.2025.114473.","journal-title":"Exp Cell Res"},{"issue":"4","key":"8661_CR112","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mc.23871","volume":"64","author":"J Wu","year":"2025","unstructured":"Wu J, Yang Z, Chen X, Hou S, Li N, Chang Y, et al. TRIM36 inhibits the development of AOM\/DSS-Induced colitis-associated colorectal cancer by promoting the ubiquitination and degradation of GRB7. Mol CarcinogMolecular Carcinog. 2025;64(4):668\u201379. https:\/\/doi.org\/10.1002\/mc.23871.","journal-title":"Mol CarcinogMolecular Carcinog"},{"key":"8661_CR113","doi-asserted-by":"publisher","unstructured":"Zhang Y, Tan X, Wang L, Ji D, Zhang C, Peng W, et al. TRIM38 suppresses the progression of colorectal cancer via enhancing CCT6A ubiquitination to inhibit the MYC pathway. Adv Sci. 2025;12(16). https:\/\/doi.org\/10.1002\/advs.202411285.","DOI":"10.1002\/advs.202411285"},{"issue":"8","key":"8661_CR114","doi-asserted-by":"publisher","first-page":"119855","DOI":"10.1016\/j.bbamcr.2024.119855","volume":"1871","author":"F Hu","year":"2024","unstructured":"Hu F, Zhao L, Wang J, Li X, Xue Z, Ma Y, et al. TRIM40 interacts with ROCK1 directly and inhibits colorectal cancer cell proliferation through the c-Myc\/p21 axis. Biochim et Biophys Acta (BBA) - Mol Cell Res. 2024;1871(8):119855. https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119855.","journal-title":"Biochim et Biophys Acta (BBA) - Mol Cell Res"},{"issue":"12","key":"8661_CR115","doi-asserted-by":"publisher","first-page":"13511","DOI":"10.1002\/cam4.6020","volume":"12","author":"M Lin","year":"2023","unstructured":"Lin M, Fang Z, Lin X, Zhou W, Wang Y, Han S, et al. TRIM55 inhibits colorectal cancer development via enhancing protein degradation of c-myc. Cancer Med. 2023;12(12):13511\u201321. https:\/\/doi.org\/10.1002\/cam4.6020.","journal-title":"Cancer Med"},{"key":"8661_CR116","doi-asserted-by":"publisher","unstructured":"Liu M, Zhang X, Cai J, Li Y, Luo Q, Wu H, et al. Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion. Oncol Rep. 2018. https:\/\/doi.org\/10.3892\/or.2018.6525.","DOI":"10.3892\/or.2018.6525"},{"issue":"20","key":"8661_CR117","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.7150\/jca.47538","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wang G, Jiang X, Li W, Zhai C, Shang F, et al. TRIM67 inhibits tumor proliferation and metastasis by mediating MAPK11 in colorectal cancer. J Cancer. 2020;11(20):6025\u201337. https:\/\/doi.org\/10.7150\/jca.47538.","journal-title":"J Cancer"},{"key":"8661_CR118","doi-asserted-by":"publisher","unstructured":"Chi X-J, Song Y-B, Liu D-H, Wei L-Q, Zhao A-R, An X, et al. TRIM69: a marker of metastasis and potential sensitizer to 5-fluorouracil and PD-1 blockers in colon adenocarcinoma. BMC Gastroenterol. 2023;23(1). https:\/\/doi.org\/10.1186\/s12876-023-02927-9.","DOI":"10.1186\/s12876-023-02927-9"},{"key":"8661_CR119","doi-asserted-by":"publisher","unstructured":"Faleti OD, Gong Y, Long J, Luo Q, Tan H, Deng S, et al. TRIM72 inhibits cell migration and epithelial-mesenchymal transition by attenuating FAK\/akt signaling in colorectal cancer. Heliyon. 2024;10(18):e37714. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37714.","DOI":"10.1016\/j.heliyon.2024.e37714"},{"key":"8661_CR120","doi-asserted-by":"publisher","unstructured":"Liu H, Tang Y, Zhang J, Wu G, Peng Q, Chen C, et al. TRIM5 as a promising diagnostic biomarker of hepatocellular carcinoma: integrated analysis and experimental validation. Funct Integr Genomics. 2024;24(2). https:\/\/doi.org\/10.1007\/s10142-024-01339-6.","DOI":"10.1007\/s10142-024-01339-6"},{"issue":"5","key":"8661_CR121","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.55730\/1300-0144.5668","volume":"53","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yuan L, Cui S, Wu S. Tripartite motif protein 6 promotes hepatocellular carcinoma progression via multiple pathways. Turk J Med Sci. 2023;53(5):1032\u201344. https:\/\/doi.org\/10.55730\/1300-0144.5668.","journal-title":"Turk J Med Sci"},{"issue":"4","key":"8661_CR122","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.bbrc.2019.02.001","volume":"511","author":"X Hu","year":"2019","unstructured":"Hu X, Tang Z, Ma S, Yu Y, Chen X, Zang G. Tripartite motif-containing protein 7 regulates hepatocellular carcinoma cell proliferation via the DUSP6\/p38 pathway. Biochem Bioph Res Co. 2019;511(4):889\u201395. https:\/\/doi.org\/10.1016\/j.bbrc.2019.02.001.","journal-title":"Biochem Bioph Res Co"},{"issue":"6","key":"8661_CR123","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1038\/s41418-019-0464-9","volume":"27","author":"L Zhu","year":"2020","unstructured":"Zhu L, Qin C, Li T, Ma X, Qiu Y, Lin Y, et al. The E3 ubiquitin ligase TRIM7 suppressed hepatocellular carcinoma progression by directly targeting Src protein. Cell Death Differ. 2020;27(6):1819\u201331. https:\/\/doi.org\/10.1038\/s41418-019-0464-9.","journal-title":"Cell Death Differ"},{"key":"8661_CR124","doi-asserted-by":"publisher","unstructured":"Peng Y, Qian H, Xu W-P, Xiao M-C, Ding C-H, Liu F, et al. Tripartite motif 8 promotes the progression of hepatocellular carcinoma via mediating ubiquitination of HNF1\u03b1. Cell Death Dis. 2024;15(6). https:\/\/doi.org\/10.1038\/s41419-024-06819-y.","DOI":"10.1038\/s41419-024-06819-y"},{"key":"8661_CR125","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijbiomac.2024.138949","volume":"290","author":"L Xiao","year":"2025","unstructured":"Xiao L, Lu Z, Fang H, Zhou Y, Che W, Zhang W, et al. Explorations of novel MDR-related hub genes and the potential roles TRIM9 played in drug-resistant hepatocellular carcinoma. Int J Biol Macromolecules. 2025;290:290. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138949.","journal-title":"Int J Biol Macromolecules"},{"issue":"2","key":"8661_CR126","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.clinre.2016.09.010","volume":"41","author":"Y Chen","year":"2017","unstructured":"Chen Y, Li L, Qian X, Ge Y, Xu G. High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2017;41(2):190\u201396. https:\/\/doi.org\/10.1016\/j.clinre.2016.09.010.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"8661_CR127","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000485625","volume":"41","author":"B Dong","year":"2018","unstructured":"Dong B, Zhang W. High levels of TRIM14 are associated with poor prognosis in hepatocellular carcinoma. Oncol Res Treat. 2018;41(3):129\u201334. https:\/\/doi.org\/10.1159\/000485625.","journal-title":"Oncol Res Treat"},{"key":"8661_CR128","doi-asserted-by":"publisher","unstructured":"Yang C, Jin X, Liu X, Wu G, Yang W, Pang B, et al. TRIM15 forms a regulatory loop with the AKT\/FOXO1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIs. Cell Death Dis. 2023;14(1). https:\/\/doi.org\/10.1038\/s41419-023-05577-7.","DOI":"10.1038\/s41419-023-05577-7"},{"key":"8661_CR129","doi-asserted-by":"publisher","unstructured":"Guo D, Zhang M, Wei T, Zhang X, Shi X, Tang H, et al. NFKBIZ regulates NF\u03baB signaling pathway to mediate tumorigenesis and metastasis of hepatocellular carcinoma by direct interaction with TRIM16. Cell Mol Life Sci. 2024;81(1). https:\/\/doi.org\/10.1007\/s00018-024-05182-7.","DOI":"10.1007\/s00018-024-05182-7"},{"issue":"1","key":"8661_CR130","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.canlet.2015.06.014","volume":"366","author":"X Zhang","year":"2015","unstructured":"Zhang X, Yang X-R, Sun C, Hu B, Sun Y-F, Huang X-W, et al. Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma. Cancer Lett. 2015;366(1):112\u201322. https:\/\/doi.org\/10.1016\/j.canlet.2015.06.014.","journal-title":"Cancer Lett"},{"issue":"4","key":"8661_CR131","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/path.4195","volume":"230","author":"YL Chung","year":"2013","unstructured":"Chung YL, Wu ML. Promyelocytic leukaemia protein links DNA damage response and repair to hepatitis B virus-related hepatocarcinogenesis. The J Pathol. 2013;230(4):377\u201387. https:\/\/doi.org\/10.1002\/path.4195.","journal-title":"The J Pathol"},{"issue":"5","key":"8661_CR132","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/cas.16134","volume":"115","author":"B Shu","year":"2024","unstructured":"Shu B, Zhou Y, Lei G, Peng Y, Ding C, Li Z, et al. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1\/YAP pathway. Cancer Sci. 2024;115(5):1476\u201391. https:\/\/doi.org\/10.1111\/cas.16134.","journal-title":"Cancer Sci"},{"issue":"41","key":"8661_CR133","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1038\/s41388-025-03556-0","volume":"44","author":"C Sun","year":"2025","unstructured":"Sun C, Cai S, Yang J, Du M, Pan Q, Wang Y, et al. OTUB1 antagonizes TRIM21 to induce deubiquitination of SPHK1 and promote the progression of hepatocellular carcinoma. Oncogene. 2025;44(41):3985\u201398. https:\/\/doi.org\/10.1038\/s41388-025-03556-0.","journal-title":"Oncogene"},{"key":"8661_CR134","doi-asserted-by":"publisher","unstructured":"Wang M, Weng C, Xu J, Xu K. Hexahydrocurcumin suppresses hepatocellular carcinoma by regulating TRIM23\/MBNL1 pathway. Sci Rep. 2025;15(1). https:\/\/doi.org\/10.1038\/s41598-024-82982-8.","DOI":"10.1038\/s41598-024-82982-8"},{"key":"8661_CR135","doi-asserted-by":"publisher","unstructured":"Liu X, Huang Y, Yang D, Li X, Li J, Lin L, et al. Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinoma. PLoS ONE. 2014;9(1):e85462. https:\/\/doi.org\/10.1371\/journal.pone.0085462.","DOI":"10.1371\/journal.pone.0085462"},{"key":"8661_CR136","doi-asserted-by":"publisher","unstructured":"Liu Y, Tao S, Liao L, Li Y, Li H, Li Z, et al. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway. Nat Commun. 2020;11(1). https:\/\/doi.org\/10.1038\/s41467-019-14190-2.","DOI":"10.1038\/s41467-019-14190-2"},{"issue":"1","key":"8661_CR137","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.yexcr.2018.04.010","volume":"368","author":"Y-H Li","year":"2018","unstructured":"Li Y-H, Zhong M, Zang H-L, Tian X-F. The E3 ligase for metastasis associated 1 protein, TRIM25, is targeted by microRNA-873 in hepatocellular carcinoma. Exp Cell Res. 2018;368(1):37\u201341. https:\/\/doi.org\/10.1016\/j.yexcr.2018.04.010.","journal-title":"Exp Cell Res"},{"issue":"1","key":"8661_CR138","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/liv.15346","volume":"43","author":"T Sakamoto","year":"2023","unstructured":"Sakamoto T, Kuboki S, Furukawa K, Takayashiki T, Takano S, Yoshizumi A, et al. TRIM27-USP7 complex promotes tumour progression via STAT3 activation in human hepatocellular carcinoma. Liver Int. 2023;43(1):194\u2013207. https:\/\/doi.org\/10.1111\/liv.15346.","journal-title":"Liver Int"},{"key":"8661_CR139","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.canlet.2023.216259","volume":"568","author":"W-Y Han","year":"2023","unstructured":"Han W-Y, Wang J, Zhao J, Zheng Y-M, Chai X-Q, Gao C, et al. WDR4\/TRIM28 is a novel molecular target linked to lenvatinib resistance that helps retain the stem characteristics in hepatocellular carcinomas. Cancer Lett. 2023;568:568. https:\/\/doi.org\/10.1016\/j.canlet.2023.216259.","journal-title":"Cancer Lett"},{"key":"8661_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2019.03.028","volume":"224","author":"H Du","year":"2019","unstructured":"Du H, Xu Q, Xiao S, Wu Z, Gong J, Liu C, et al. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Life Sci. 2019;224:1\u201311. https:\/\/doi.org\/10.1016\/j.lfs.2019.03.028.","journal-title":"Life Sci"},{"issue":"4","key":"8661_CR141","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/onc.2017.349","volume":"37","author":"P Guo","year":"2018","unstructured":"Guo P, Ma X, Zhao W, Huai W, Li T, Qiu Y, et al. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1\u2013TSC2 complex. Oncogene. 2018;37(4):478\u201388. https:\/\/doi.org\/10.1038\/onc.2017.349.","journal-title":"Oncogene"},{"issue":"1\u20132","key":"8661_CR142","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11010-016-2793-z","volume":"421","author":"X Cui","year":"2016","unstructured":"Cui X, Lin Z, Chen Y, Mao X, Ni W, Liu J, et al. Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinoma. Mol Cell Biochem. 2016;421(1\u20132):127\u201337. https:\/\/doi.org\/10.1007\/s11010-016-2793-z.","journal-title":"Mol Cell Biochem"},{"key":"8661_CR143","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.canlet.2024.216935","volume":"593","author":"F Yao","year":"2024","unstructured":"Yao F, Zhou S, Zhang R, Chen Y, Huang W, Yu K, et al. CRISPR\/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma. Cancer Lett. 2024;593:593. https:\/\/doi.org\/10.1016\/j.canlet.2024.216935.","journal-title":"Cancer Lett"},{"issue":"4","key":"8661_CR144","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.bbrc.2015.07.089","volume":"464","author":"J Jiang","year":"2015","unstructured":"Jiang J, Yu C, Chen M, Tian S, Sun C. Over-expression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt\/\u03b2-catenin signaling. Biochem Bioph Res Co. 2015;464(4):1120\u201327. https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.089.","journal-title":"Biochem Bioph Res Co"},{"issue":"1","key":"8661_CR145","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7150\/jca.47526","volume":"12","author":"L Chen","year":"2021","unstructured":"Chen L, Yi C, Li W, Tseng Y, Zhang J, Liu J. Inhibition of SPATS2 suppresses proliferation and invasion of hepatocellular carcinoma cells through TRIM44-STAT3 signaling pathway. J Cancer. 2021;12(1):89\u201398. https:\/\/doi.org\/10.7150\/jca.47526.","journal-title":"J Cancer"},{"issue":"27","key":"8661_CR146","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1038\/s41388-024-03056-7","volume":"43","author":"X Li","year":"2024","unstructured":"Li X, He W, Chen X, Zhang Y, Zhang J, Liu F, et al. TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation. Oncogene. 2024;43(27):2063\u201377. https:\/\/doi.org\/10.1038\/s41388-024-03056-7.","journal-title":"Oncogene"},{"key":"8661_CR147","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.freeradbiomed.2024.04.222","volume":"219","author":"J Zhang","year":"2024","unstructured":"Zhang J, Yimamu M, Cheng Z, Ji J, Wu L, Feng J, et al. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin\u2012proteasome system. Free Radical Biol Med. 2024;219:31\u201348. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.04.222.","journal-title":"Free Radical Biol Med"},{"key":"8661_CR148","doi-asserted-by":"publisher","unstructured":"Zhang Y, Tao R, Wu S-S, Xu C-C, Wang J-L, Chen J, et al. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A. J Exp Clin Cancer Res. 2018;37(1). https:\/\/doi.org\/10.1186\/s13046-018-0780-9.","DOI":"10.1186\/s13046-018-0780-9"},{"key":"8661_CR149","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fonc.2021.759842","volume":"11","author":"J Zhu","year":"2021","unstructured":"Zhu J, Wu Y, Lao S, Shen J, Yu Y, Fang C, et al. Targeting TRIM54\/Axin1\/\u03b2-catenin axis prohibits proliferation and metastasis in hepatocellular carcinoma. Front Oncol. 2021;11:11. https:\/\/doi.org\/10.3389\/fonc.2021.759842.","journal-title":"Front Oncol"},{"key":"8661_CR150","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2019.12.030","volume":"473","author":"H Ying","year":"2020","unstructured":"Ying H, Ji L, Xu Z, Fan X, Tong Y, Liu H, et al. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B. Cancer Lett. 2020;473:13\u201324. https:\/\/doi.org\/10.1016\/j.canlet.2019.12.030.","journal-title":"Cancer Lett"},{"key":"8661_CR151","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.taap.2022.116035","volume":"445","author":"W Fan","year":"2022","unstructured":"Fan W, Liu X, Ren D. TRIM62 silencing represses the proliferation and invasion and increases the chemosensitivity of hepatocellular carcinoma cells by affecting the NF-\u03baB pathway. Toxicol Appl Pharm. 2022;445:445. https:\/\/doi.org\/10.1016\/j.taap.2022.116035.","journal-title":"Toxicol Appl Pharm"},{"key":"8661_CR152","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.intimp.2024.111494","volume":"128","author":"M Jiang","year":"2024","unstructured":"Jiang M, Wang D, Su N, Lou W, Chen Y, Yang H, et al. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1\/STAT1 signaling pathway. Int Immunopharmacol. 2024;128:128. https:\/\/doi.org\/10.1016\/j.intimp.2024.111494.","journal-title":"Int Immunopharmacol"},{"key":"8661_CR153","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejphar.2019.01.054","volume":"850","author":"W Fan","year":"2019","unstructured":"Fan W, Du F, Liu X. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3\u03b2-dependent Wnt\/\u03b2-catenin signaling. Eur J Pharmacol. 2019;850:109\u201317. https:\/\/doi.org\/10.1016\/j.ejphar.2019.01.054.","journal-title":"Eur J Pharmacol"},{"issue":"13","key":"8661_CR154","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.7150\/thno.99633","volume":"14","author":"Y Su","year":"2024","unstructured":"Su Y, Li Z, Li Q, Guo X, Zhang H, Li Y, et al. Oncofetal TRIM71 drives liver cancer carcinogenesis through remodeling CEBPA-mediated serine\/glycine metabolism. Theranostics. 2024;14(13):4948\u201366. https:\/\/doi.org\/10.7150\/thno.99633.","journal-title":"Theranostics"},{"key":"8661_CR155","doi-asserted-by":"publisher","unstructured":"Chao J, Zhang X-F, Pan Q-Z, Zhao J-J, Jiang S-S, Wang Y, et al. Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma. Med Oncol. 2014;31(8). https:\/\/doi.org\/10.1007\/s12032-014-0102-9.","DOI":"10.1007\/s12032-014-0102-9"},{"issue":"14","key":"8661_CR156","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.7150\/jca.37164","volume":"11","author":"Z-R Dong","year":"2020","unstructured":"Dong Z-R, Zhou W, Sun D, Yan Y-C, Yang C-C, Yang Y-F, et al. Role of the E3 ubiquitin ligase TRIM4 in predicting the prognosis of hepatocellular carcinoma. J Cancer. 2020;11(14):4007\u201314. https:\/\/doi.org\/10.7150\/jca.37164.","journal-title":"J Cancer"},{"issue":"10","key":"8661_CR157","doi-asserted-by":"publisher","first-page":"107818","DOI":"10.1016\/j.isci.2023.107818","volume":"26","author":"M Lai","year":"2023","unstructured":"Lai M, Liu M, Li D, Zhang R, Wang L, Li X, et al. circELMOD3 increases and stabilizes TRIM13 by sponging miR-6864-5p and direct binding to inhibit HCC progression. iScience. 2023;26(10):107818. https:\/\/doi.org\/10.1016\/j.isci.2023.107818.","journal-title":"iScience"},{"key":"8661_CR158","doi-asserted-by":"publisher","unstructured":"Kang D, Hwang HJ, Baek Y, Sung JY, Kim K, Park HJ, et al. TRIM22 induces cellular senescence by targeting PHLPP2 in hepatocellular carcinoma. Cell Death Dis. 2024;15(1). https:\/\/doi.org\/10.1038\/s41419-024-06427-w.","DOI":"10.1038\/s41419-024-06427-w"},{"issue":"8","key":"8661_CR159","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1038\/s41418-021-00754-7","volume":"28","author":"X Li","year":"2021","unstructured":"Li X, Yuan J, Song C, Lei Y, Xu J, Zhang G, et al. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma. Cell Death Differ. 2021;28(8):2315\u201332. https:\/\/doi.org\/10.1038\/s41418-021-00754-7.","journal-title":"Cell Death Differ"},{"issue":"5","key":"8661_CR160","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.27273","volume":"60","author":"Z-Y Ding","year":"2014","unstructured":"Ding Z-Y, Jin G-N, Wang W, Chen W-X, Wu Y-H, Ai X, et al. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Hepatology. 2014;60(5):1620\u201336. https:\/\/doi.org\/10.1002\/hep.27273.","journal-title":"Hepatology"},{"issue":"4","key":"8661_CR161","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hep.24495","volume":"54","author":"D Jia","year":"2011","unstructured":"Jia D, Wei L, Guo W, Zha R, Bao M, Chen Z, et al. Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma. Hepatology. 2011;54(4):1227\u201336. https:\/\/doi.org\/10.1002\/hep.24495.","journal-title":"Hepatology"},{"key":"8661_CR162","doi-asserted-by":"publisher","unstructured":"Tong Q, Yi M, Kong P, Xu L, Huang W, Niu Y, et al. TRIM36 inhibits tumorigenesis through the Wnt\/\u03b2-catenin pathway and promotes caspase-dependent apoptosis in hepatocellular carcinoma. Cancer Cell Int. 2022;22(1). https:\/\/doi.org\/10.1186\/s12935-022-02692-x.","DOI":"10.1186\/s12935-022-02692-x"},{"key":"8661_CR163","doi-asserted-by":"publisher","unstructured":"Ma X, Ma X, Qiu Y, Zhu L, Lin Y, You Y, et al. TRIM50 suppressed hepatocarcinoma progression through directly targeting SNAIL for ubiquitous degradation. Cell Death Dis. 2018;9(6). https:\/\/doi.org\/10.1038\/s41419-018-0644-4.","DOI":"10.1038\/s41419-018-0644-4"},{"key":"8661_CR164","doi-asserted-by":"publisher","first-page":"771","DOI":"10.12659\/MSM.910984","volume":"25","author":"X Li","year":"2019","unstructured":"Li X, Huang L, Gao W. Overexpression of tripartite motif Conaining 55 (TRIM55) inhibits migration and invasion of hepatocellular carcinoma (HCC) cells via epithelial-mesenchymal transition and matrix metalloproteinase-2 (MMP2). Med Sci Monit. 2019;25:771\u201377. https:\/\/doi.org\/10.12659\/MSM.910984.","journal-title":"Med Sci Monit"},{"issue":"12","key":"8661_CR165","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.7150\/ijbs.85431","volume":"19","author":"X Hu","year":"2023","unstructured":"Hu X, Yuan S, Zhou S, Sun T, Wang C, Ying S, et al. Golgi-protein 73 facilitates vimentin polymerization in hepatocellular carcinoma. Int J Biol Sci. 2023;19(12):3694\u2013708. https:\/\/doi.org\/10.7150\/ijbs.85431.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"8661_CR166","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41418-024-01406-2","volume":"32","author":"X Jin","year":"2025","unstructured":"Jin X, Lv Y, Bie F, Duan J, Ma C, Dai M, et al. METTL3 confers oxaliplatin resistance through the activation of G6PD-enhanced pentose phosphate pathway in hepatocellular carcinoma. Cell Death Differ. 2025;32(3):466\u201379. https:\/\/doi.org\/10.1038\/s41418-024-01406-2.","journal-title":"Cell Death Differ"},{"key":"8661_CR167","doi-asserted-by":"publisher","unstructured":"Ma X, Ma X, Zhu L, Zhao Y, Chen M, Li T, et al. The E3 ubiquitin ligase MG53 inhibits hepatocellular carcinoma by targeting RAC1 signaling. Oncogenesis. 2022;11(1). https:\/\/doi.org\/10.1038\/s41389-022-00414-6.","DOI":"10.1038\/s41389-022-00414-6"},{"issue":"42","key":"8661_CR168","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.1038\/s41388-020-01452-3","volume":"39","author":"Q Sun","year":"2020","unstructured":"Sun Q, Ye Z, Qin Y, Fan G, Ji S, Zhuo Q, et al. Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2\/ITGB7\/FAK axis. Oncogene. 2020;39(42):6572\u201388. https:\/\/doi.org\/10.1038\/s41388-020-01452-3.","journal-title":"Oncogene"},{"issue":"10","key":"8661_CR169","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.1002\/jcp.30346","volume":"236","author":"M Shang","year":"2021","unstructured":"Shang M, Weng L, Xu G, Wu S, Liu B, Yin X, et al. TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N\/TAX1BP1 signaling in pancreatic ductal adenocarcinoma. J Cellular Physiol. 2021;236(10):6868\u201383. https:\/\/doi.org\/10.1002\/jcp.30346.","journal-title":"J Cellular Physiol"},{"issue":"11","key":"8661_CR170","doi-asserted-by":"publisher","first-page":"166213","DOI":"10.1016\/j.bbadis.2021.166213","volume":"1867","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ren D, Yang C, Yang W, Zhao J, Zhou Y, et al. TRIM15 promotes the invasion and metastasis of pancreatic cancer cells by mediating APOA1 ubiquitination and degradation. Biochim Et Biophys Acta (BBA) - Mol Basis Disease. 2021;1867(11):166213. https:\/\/doi.org\/10.1016\/j.bbadis.2021.166213.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"11","key":"8661_CR171","first-page":"5205","volume":"12","author":"B Zhou","year":"2022","unstructured":"Zhou B, Huang Y, Feng Q, Zhu H, Xu Z, Chen L, et al. TRIM16 promotes aerobic glycolysis and pancreatic cancer metastasis by modulating the NIK-SIX1 axis in a ligase-independent manner. Am J Cancer Res. 2022;12(11):5205\u201325.","journal-title":"Am J Cancer Res"},{"key":"8661_CR172","doi-asserted-by":"publisher","unstructured":"Rauth S, Karmakar S, Shah A, Seshacharyulu P, Nimmakayala RK, Ganguly K, et al. SUMO modification of PAF1\/PD2 enables PML interaction and promotes radiation resistance in pancreatic ductal adenocarcinoma. Mol Cell Biol. 2021;41(12). https:\/\/doi.org\/10.1128\/MCB.00135-21.","DOI":"10.1128\/MCB.00135-21"},{"key":"8661_CR173","doi-asserted-by":"publisher","unstructured":"Li Z, Gao F, Liu X, Fan S, Qi Y, He M, et al. The E3 ligase TRIM21 promotes progression of pancreatic ductal adenocarcinoma by down-regulating TAp63\u03b1 and derepressing IL20RB. Sci Signal. 2025;18(889):eadv 4579. https:\/\/doi.org\/10.1126\/scisignal.adv4579.","DOI":"10.1126\/scisignal.adv4579"},{"key":"8661_CR174","doi-asserted-by":"publisher","unstructured":"Li J, Liu J, Zhou Z, Wu R, Chen X, Yu C, et al. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer. Sci Transl Med. 2023;15(720):eadg 3049. https:\/\/doi.org\/10.1126\/scitranslmed.adg3049.","DOI":"10.1126\/scitranslmed.adg3049"},{"key":"8661_CR175","doi-asserted-by":"publisher","unstructured":"Deng X, Fu X, Teng H, Fang L, Liang B, Zeng R, et al. E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing yes-associated protein 1. J Transl Med. 2021;19(1). https:\/\/doi.org\/10.1186\/s12967-021-03007-w.","DOI":"10.1186\/s12967-021-03007-w"},{"issue":"12","key":"8661_CR176","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.7150\/thno.23259","volume":"8","author":"C Yu","year":"2018","unstructured":"Yu C, Chen S, Guo Y, Sun C. Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-\u03baB signaling pathway. Theranostics. 2018;8(12):3224\u201336. https:\/\/doi.org\/10.7150\/thno.23259.","journal-title":"Theranostics"},{"key":"8661_CR177","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fonc.2020.00010","volume":"10","author":"L Chen","year":"2020","unstructured":"Chen L, Wei Q, Bi S, Xie S, et al. Maternal embryonic leucine zipper kinase promotes tumor growth and metastasis via stimulating FOXM1 signaling in esophageal squamous cell carcinoma. Front Oncol. 2020;10:10. https:\/\/doi.org\/10.3389\/fonc.2020.00010.","journal-title":"Front Oncol"},{"key":"8661_CR178","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.bbrc.2025.151705","volume":"759","author":"L Xu","year":"2025","unstructured":"Xu L, Wan X, Shan X, Zha W, Shi Y, Fan R. ONECUT3 activates the TRIM46-NF-\u03baB pathway to promote the development of pancreatic cancer. Biochem Bioph Res Co. 2025;759:759. https:\/\/doi.org\/10.1016\/j.bbrc.2025.151705.","journal-title":"Biochem Bioph Res Co"},{"key":"8661_CR179","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.phrs.2021.105429","volume":"166","author":"L Li","year":"2021","unstructured":"Li L, Yu Y, Zhang Z, Guo Y, Yin T, Wu H, et al. TRIM47 accelerates aerobic glycolysis and tumor progression through regulating ubiquitination of FBP1 in pancreatic cancer. Pharmacological Res. 2021;166:166. https:\/\/doi.org\/10.1016\/j.phrs.2021.105429.","journal-title":"Pharmacological Res"},{"key":"8661_CR180","doi-asserted-by":"publisher","unstructured":"Jiang C, Li H, Li D, Li X, Luo S, You L. The oncogenic role of TRIM56 in pancreatic cancer via the TRAF6\/NF-kB axis. J Mol Histol. 2025;56(4). https:\/\/doi.org\/10.1007\/s10735-025-10429-z.","DOI":"10.1007\/s10735-025-10429-z"},{"issue":"2","key":"8661_CR181","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/jcb.29433","volume":"121","author":"R Li","year":"2020","unstructured":"Li R, Weng L, Liu B, Zhu L, Zhang X, Tian G, et al. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K\/AKT\/mTOR-glycolysis signaling axis. J Cellular Biochem. 2020;121(2):1986\u201397. https:\/\/doi.org\/10.1002\/jcb.29433.","journal-title":"J Cellular Biochem"},{"key":"8661_CR182","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canlet.2020.07.025","volume":"491","author":"SE Mulder","year":"2020","unstructured":"Mulder SE, Dasgupta A, King RJ, Abrego J, Attri KS, Murthy D, et al. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia. Cancer Lett. 2020;491:70\u201377. https:\/\/doi.org\/10.1016\/j.canlet.2020.07.025.","journal-title":"Cancer Lett"},{"issue":"2","key":"8661_CR183","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7150\/jca.79905","volume":"14","author":"Y Jia","year":"2023","unstructured":"Jia Y, Li H-Y, Wang J, Chen X, Lou L, Wei Y-Y, et al. Tripartite motif containing 69 elicits ERK2-dependent EYA4 turnover to impart pancreatic tumorigenesis. J Cancer. 2023;14(2):200\u201318. https:\/\/doi.org\/10.7150\/jca.79905.","journal-title":"J Cancer"},{"issue":"20","key":"8661_CR184","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1158\/0008-5472.CAN-14-3426","volume":"75","author":"RM Pommier","year":"2015","unstructured":"Pommier RM, Gout J, Vincent DF, Alcaraz LB, Chuvin N, Arfi V, et al. TIF1\u03b3 suppresses tumor progression by regulating mitotic checkpoints and chromosomal stability. Cancer Res. 2015;75(20):4335\u201350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3426.","journal-title":"Cancer Res"},{"key":"8661_CR185","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fonc.2021.695740","volume":"11","author":"R Li","year":"2021","unstructured":"Li R, Zhu L, Peng Y, Zhang X, Dai C, Liu D. TRIM50 suppresses pancreatic cancer progression and reverses the epithelial-mesenchymal transition via facilitating the ubiquitous degradation of Snail1. Front Oncol. 2021;11:11. https:\/\/doi.org\/10.3389\/fonc.2021.695740.","journal-title":"Front Oncol"},{"key":"8661_CR186","doi-asserted-by":"publisher","unstructured":"Zhang K, Li Y-J, Peng L-J, Gao H-F, Liu L-M, Chen H. M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62. Biol Direct. 2023;18(1). https:\/\/doi.org\/10.1186\/s13062-023-00356-y.","DOI":"10.1186\/s13062-023-00356-y"},{"key":"8661_CR187","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tranon.2024.102118","volume":"50","author":"X-L Wang","year":"2024","unstructured":"Wang X-L, He X, Gao T, Zhou X, Cruz-Monserrate Z, Tsung A, et al. MG53 suppresses tumor growth via transcriptional inhibition of KIF11 in pancreatic cancer. Transl Oncol. 2024;50:50. https:\/\/doi.org\/10.1016\/j.tranon.2024.102118.","journal-title":"Transl Oncol"},{"issue":"6","key":"8661_CR188","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/jgh.12157","volume":"28","author":"S Fitzgerald","year":"2013","unstructured":"Fitzgerald S, Sheehan KM, O\u2019Grady A, Kenny D, O\u2019Kennedy R, Kay EW, et al. Relationship between epithelial and stromal TRIM28 expression predicts survival in colorectal cancer patients. J Gastro Hepatol. 2013;28(6):967\u201374. https:\/\/doi.org\/10.1111\/jgh.12157.","journal-title":"J Gastro Hepatol"},{"key":"8661_CR189","doi-asserted-by":"publisher","unstructured":"Lu K, Pan Y, Huang Z, Liang H, Ding Z-Y, Zhang B. TRIM proteins in hepatocellular carcinoma. J Biomed Sci. 2022;29(1). https:\/\/doi.org\/10.1186\/s12929-022-00854-7.","DOI":"10.1186\/s12929-022-00854-7"},{"key":"8661_CR190","doi-asserted-by":"publisher","unstructured":"Gerlach D, Kriventseva EV, Rahman N, Vejnar CE, Zdobnov EM. miRortho: computational survey of microRNA genes. Nucleic Acids Res. 2009;37(Database):D111\u201317. https:\/\/doi.org\/10.1093\/nar\/gkn707.","DOI":"10.1093\/nar\/gkn707"},{"key":"8661_CR191","doi-asserted-by":"publisher","first-page":"37","DOI":"10.20517\/cdr.2024.66","volume":"7","author":"KKW To","year":"2024","unstructured":"To KKW, Zhang H, Cho WC. Competing endogenous RNAs (ceRnas) and drug resistance to cancer therapy. Cancer Drug Resist. 2024;7:37. https:\/\/doi.org\/10.20517\/cdr.2024.66.","journal-title":"Cancer Drug Resist"},{"key":"8661_CR192","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.drup.2024.101079","volume":"74","author":"W Huang","year":"2024","unstructured":"Huang W, Hu X, He X, Pan D, Huang Z, Gu Z, et al. TRIM29 facilitates gemcitabine resistance via MEK\/ERK pathway and is modulated by circRps29\/miR-770\u20135p axis in PDAC. Drug Resist Updates. 2024;74:74. https:\/\/doi.org\/10.1016\/j.drup.2024.101079.","journal-title":"Drug Resist Updates"},{"issue":"1","key":"8661_CR193","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10120-020-01096-y","volume":"24","author":"T Fu","year":"2021","unstructured":"Fu T, Ji K, Jin L, Zhang J, Wu X, Ji X, et al. ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-\u03baB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer. Gastric Cancer. 2021;24(1):45\u201359. https:\/\/doi.org\/10.1007\/s10120-020-01096-y.","journal-title":"Gastric Cancer"},{"issue":"1","key":"8661_CR194","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s43556-025-00361-9","volume":"6","author":"Y Jin","year":"2025","unstructured":"Jin Y, He X, Wu Y. Gastrointestinal cancer: molecular pathogenesis and targeted therapy. Mol Biomed. 2025;6(1):136. https:\/\/doi.org\/10.1186\/s43556-025-00361-9.","journal-title":"Mol Biomed"},{"issue":"1","key":"8661_CR195","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12935-019-0823-0","volume":"19","author":"K Sun","year":"2019","unstructured":"Sun K, He S-B, Yao Y-Z, Qu J-G, Xie R, Ma Y-Q, et al. Tre2 (USP6NL) promotes colorectal cancer cell proliferation via Wnt\/\u03b2-catenin pathway. Cancer Cell Int. 2019;19(1):102. https:\/\/doi.org\/10.1186\/s12935-019-0823-0.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"8661_CR196","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-025-02363-1","volume":"24","author":"X Wu","year":"2025","unstructured":"Wu X, Que H, Li Q, Wei X. Wnt\/\u03b2-catenin mediated signaling pathways in cancer: recent advances, and applications in cancer therapy. Mol Cancer. 2025;24(1):171. https:\/\/doi.org\/10.1186\/s12943-025-02363-1.","journal-title":"Mol Cancer"},{"key":"8661_CR197","doi-asserted-by":"publisher","unstructured":"Wang W, Lei Y, Zhang G, Li X, Yuan J, Li T, et al. USP39 stabilizes \u03b2-catenin by deubiquitination and suppressing E3 ligase TRIM26 pre-mRNA maturation to promote HCC progression. Cell Death Dis. 2023;14(1). https:\/\/doi.org\/10.1038\/s41419-023-05593-7.","DOI":"10.1038\/s41419-023-05593-7"},{"issue":"27","key":"8661_CR198","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1038\/s41388-022-02367-x","volume":"41","author":"X-L Ma","year":"2022","unstructured":"Ma X-L, Zhu K-Y, Chen Y-D, Tang W-G, Xie S-H, Zheng H, et al. Identification of a novel calpain-2-SRC feed-back loop as necessity for \u03b2-Catenin accumulation and signaling activation in hepatocellular carcinoma. Oncogene. 2022;41(27):3554\u201369. https:\/\/doi.org\/10.1038\/s41388-022-02367-x.","journal-title":"Oncogene"},{"issue":"10","key":"8661_CR199","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1007\/s10620-024-08584-6","volume":"69","author":"H Xia","year":"2024","unstructured":"Xia H, Chen J, Zhang W, Xu Y, Nai Y, Wei X. CRYAB promotes colorectal cancer progression by inhibiting Ferroptosis through blocking TRIM55-mediated \u03b2-Catenin Ubiquitination and degradation. Dig Dis Sci. 2024;69(10):3799\u2013809. https:\/\/doi.org\/10.1007\/s10620-024-08584-6.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"8661_CR200","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3727\/096504016X14732772150181","volume":"25","author":"P Zhao","year":"2017","unstructured":"Zhao P, Guan H-T, Dai Z-J, Ma Y-G, Liu X-X, Wang X-J. Knockdown of tripartite motif-containing protein 37 (TRIM37) inhibits the proliferation and Tumorigenesis in colorectal cancer cells. Oncol Res. 2017;25(1):115\u201322. https:\/\/doi.org\/10.3727\/096504016X14732772150181.","journal-title":"Oncol Res"},{"issue":"1","key":"8661_CR201","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12964-024-01482-4","volume":"22","author":"L Qiu","year":"2024","unstructured":"Qiu L, Sun Y, Ning H, Chen G, Zhao W, Gao Y. The scaffold protein AXIN1: gene ontology, signal network, and physiological function. Cell Commun Signal. 2024;22(1):77. https:\/\/doi.org\/10.1186\/s12964-024-01482-4.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"8661_CR202","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41392-025-02142-w","volume":"10","author":"C Xue","year":"2025","unstructured":"Xue C, Chu Q, Shi Q, Zeng Y, Lu J, Li L. Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances. Sig Transduct Target Ther. 2025;10(1):106. https:\/\/doi.org\/10.1038\/s41392-025-02142-w.","journal-title":"Sig Transduct Target Ther"},{"key":"8661_CR203","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tranon.2023.101732","volume":"35","author":"M Xu","year":"2023","unstructured":"Xu M, Jiang B, Man Z, Zhu H. TRIM37 promotes gallbladder cancer proliferation by activating the Wnt\/\u03b2-catenin pathway via ubiquitination of Axin1. Transl Oncol. 2023;35:35. https:\/\/doi.org\/10.1016\/j.tranon.2023.101732.","journal-title":"Transl Oncol"},{"issue":"18","key":"8661_CR204","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1242\/jcs.206623","volume":"130","author":"Y-F Yang","year":"2017","unstructured":"Yang Y-F, Zhang M-F, Tian Q-H, Zhang CZ. TRIM65 triggers \u03b2-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma. J Cell Sci. 2017;130(18):3108\u201315. https:\/\/doi.org\/10.1242\/jcs.206623.","journal-title":"J Cell Sci"},{"key":"8661_CR205","doi-asserted-by":"publisher","unstructured":"Zhang Y, Feng Y, Ji D, Wang Q, Qian W, Wang S, et al. TRIM27 functions as an oncogene by activating epithelial-mesenchymal transition and p-AKT in colorectal cancer. Int J Oncol. 2018. https:\/\/doi.org\/10.3892\/ijo.2018.4408.","DOI":"10.3892\/ijo.2018.4408"},{"issue":"1","key":"8661_CR206","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s13577-022-00790-6","volume":"36","author":"Y Chen","year":"2022","unstructured":"Chen Y, Liu H, Zou J, Cao G, Li Y, Xing C, et al. Exosomal circ_0091741 promotes gastric cancer cell autophagy and chemoresistance via the miR-330-3p\/TRIM14\/Dvl2\/Wnt\/\u03b2-catenin axis. Hum Cell. 2022;36(1):258\u201375. https:\/\/doi.org\/10.1007\/s13577-022-00790-6.","journal-title":"Hum Cell"},{"issue":"6","key":"8661_CR207","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1158\/0008-5472.CAN-13-2289","volume":"74","author":"L Wang","year":"2014","unstructured":"Wang L, Yang H, Palmbos PL, Ney G, Detzler TA, Coleman D, et al. ATDC\/TRIM29 phosphorylation by ATM\/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells. Cancer Res. 2014;74(6):1778\u201388. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2289.","journal-title":"Cancer Res"},{"key":"8661_CR208","doi-asserted-by":"publisher","first-page":"115694","DOI":"10.1016\/j.biopha.2023.115694","volume":"168","author":"P Li","year":"2023","unstructured":"Li P, Huang D, Gu X. Exploring the dual role of circRNA and PI3K\/AKT pathway in tumors of the digestive system. Biomed Pharmacother. 2023;168:115694. https:\/\/doi.org\/10.1016\/j.biopha.2023.115694.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"8661_CR209","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","volume":"19","author":"Y-R Lee","year":"2018","unstructured":"Lee Y-R, Chen M, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol. 2018;19(9):547\u201362. https:\/\/doi.org\/10.1038\/s41580-018-0015-0.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"8661_CR210","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/1440-1681.13119","volume":"46","author":"W Li","year":"2019","unstructured":"Li W, Xue H, Li Y, Li P, Ma F, Liu M, et al. ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK-3\u03b2\/Wnt\/\u03b2-catenin signalling. Clin Exp Pharma Physio. 2019;46(9):845\u201353. https:\/\/doi.org\/10.1111\/1440-1681.13119.","journal-title":"Clin Exp Pharma Physio"},{"key":"8661_CR211","doi-asserted-by":"publisher","unstructured":"Quan Z, Peng B, Hu K, Liang L, Liu M, Liao L, et al. AP5Z1 affects hepatocellular carcinoma growth and autophagy by regulating PTEN ubiquitination and modulating the PI3K\/Akt\/mTOR pathway. J Transl Med. 2025;23(1). https:\/\/doi.org\/10.1186\/s12967-025-06537-9.","DOI":"10.1186\/s12967-025-06537-9"},{"issue":"7","key":"8661_CR212","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/cbin.11346","volume":"44","author":"P Yuan","year":"2020","unstructured":"Yuan P, Zheng A, Tang Q. Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN\/AKT pathway. Cell Biol Int. 2020;44(7):1503\u201313. https:\/\/doi.org\/10.1002\/cbin.11346.","journal-title":"Cell Biol Int"},{"issue":"6","key":"8661_CR213","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.molcel.2007.02.017","volume":"25","author":"J Brognard","year":"2007","unstructured":"Brognard J, Sierecki E, Gao T, Newton AC. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of akt signaling by regulating distinct akt isoforms. Mol Cell. 2007;25(6):917\u201331. https:\/\/doi.org\/10.1016\/j.molcel.2007.02.017.","journal-title":"Mol Cell"},{"issue":"3","key":"8661_CR214","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/hep.32234","volume":"76","author":"J Yang","year":"2022","unstructured":"Yang J, Ye J, Ma T, Tang F, Huang L, Liu Z, et al. Tripartite motif-containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin-proteasome\u2013mediated degradation of pleckstrin homology domain leucine-rich repeats protein phosphatase 1. Hepatology. 2022;76(3):612\u201329. https:\/\/doi.org\/10.1002\/hep.32234.","journal-title":"Hepatology"},{"key":"8661_CR215","doi-asserted-by":"publisher","unstructured":"Jiang T, Wang H, Liu L, Song H, Zhang Y, Wang J, et al. CircIL4R activates the PI3K\/AKT signaling pathway via the miR-761\/TRIM29\/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer. Mol Cancer. 2021;20(1). https:\/\/doi.org\/10.1186\/s12943-021-01474-9.","DOI":"10.1186\/s12943-021-01474-9"},{"key":"8661_CR216","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bcp.2023.115811","volume":"217","author":"B Xiao","year":"2023","unstructured":"Xiao B, Ge Y, Zhao R, Zhang Y, Guo Y, Zhang S, et al. NAP1L5 facilitates pancreatic ductal adenocarcinoma progression via TRIM29-mediated ubiquitination of PHLPP1. Biochemical Pharmacol. 2023;217:217. https:\/\/doi.org\/10.1016\/j.bcp.2023.115811.","journal-title":"Biochemical Pharmacol"},{"issue":"5","key":"8661_CR217","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/s41375-025-02569-8","volume":"39","author":"F Perner","year":"2025","unstructured":"Perner F, Pahl HL, Zeiser R, Heidel FH. Malignant JAK-signaling: at the interface of inflammation and malignant transformation. Leukemia. 2025;39(5):1011\u201330. https:\/\/doi.org\/10.1038\/s41375-025-02569-8.","journal-title":"Leukemia"},{"key":"8661_CR218","doi-asserted-by":"publisher","unstructured":"Qiu Y, Zhang H, Yu X, Pan J, Xiao D, Miao H, et al. Decoding the epigenetic-immune nexus in hepatocellular carcinoma: a Mendelian randomization study reveals BTN3A2, S100A12 and TRIM27 as white blood cell regulators. BMC Cancer. 2025;25(1). https:\/\/doi.org\/10.1186\/s12885-025-14693-w.","DOI":"10.1186\/s12885-025-14693-w"},{"key":"8661_CR219","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fonc.2021.695525","volume":"11","author":"H Zhao","year":"2021","unstructured":"Zhao H, Huang J, Chen M, Li B, Chen X, Zhou M. Tripartite motif protein 6 promotes colorectal cancer cell migration and metastasis via SOCS2-STAT3 signaling. Front Oncol. 2021;11:11. https:\/\/doi.org\/10.3389\/fonc.2021.695525.","journal-title":"Front Oncol"},{"issue":"2","key":"8661_CR220","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bbrc.2015.04.040","volume":"461","author":"M Kato","year":"2015","unstructured":"Kato M, Muromoto R, Togi S, Iwakami M, Kitai Y, Kon S, et al. PML suppresses IL-6-induced STAT3 activation by interfering with STAT3 and HDAC3 interaction. Biochem Bioph Res Co. 2015;461(2):366\u201371. https:\/\/doi.org\/10.1016\/j.bbrc.2015.04.040.","journal-title":"Biochem Bioph Res Co"},{"issue":"1","key":"8661_CR221","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/cac2.12386","volume":"43","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li Q, Yang J, Xu P, Xuan Z, Xu J, et al. Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination\/degradation of STAT1 in a GTP binding-dependent modality. Cancer Commun. 2023;43(1):123\u201349. https:\/\/doi.org\/10.1002\/cac2.12386.","journal-title":"Cancer Commun"},{"issue":"17","key":"8661_CR222","doi-asserted-by":"publisher","first-page":"15335","DOI":"10.1007\/s00432-023-05307-8","volume":"149","author":"C Huo","year":"2023","unstructured":"Huo C, Gu Y, Wang D, Zhang X, Tang F, Zhao B, et al. STAT1 suppresses the transcriptional activity of TRIM21 in gastric cancer. J Cancer Res Clin Oncol. 2023;149(17):15335\u201348. https:\/\/doi.org\/10.1007\/s00432-023-05307-8.","journal-title":"J Cancer Res Clin Oncol"},{"key":"8661_CR223","doi-asserted-by":"publisher","unstructured":"Wang H, Lou J, Liu H, Liu Y, Xie B, Zhang W, et al. TRIM59 deficiency promotes M1 macrophage activation and inhibits colorectal cancer through the STAT1 signaling pathway. Sci Rep. 2024;14(1). https:\/\/doi.org\/10.1038\/s41598-024-66388-0.","DOI":"10.1038\/s41598-024-66388-0"},{"issue":"6642","key":"8661_CR224","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/41493","volume":"388","author":"JA DiDonato","year":"1997","unstructured":"DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive I\u03baB kinase that activates the transcription factor NF-\u03baB. Nature. 1997;388(6642):548\u201354. https:\/\/doi.org\/10.1038\/41493.","journal-title":"Nature"},{"issue":"4","key":"8661_CR225","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1515\/hsz-2023-0292","volume":"405","author":"L Xin","year":"2024","unstructured":"Xin L, Yuan Y-W, Liu C-X, Sheng J, Zhou Q, Liu Z-Y, et al. Methionine restriction attenuates the migration and invasion of gastric cancer cells by inhibiting nuclear p65 translocation through TRIM47. Biol Chem. 2024;405(4):257\u201365. https:\/\/doi.org\/10.1515\/hsz-2023-0292.","journal-title":"Biol Chem"},{"issue":"4","key":"8661_CR226","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.gendis.2023.101092","volume":"11","author":"Z Liu","year":"2024","unstructured":"Liu Z, Jian C, Yuan W, Jia G, Cheng D, Liu Y, et al. Epinephrine promotes tumor progression and M2 polarization of tumor-associated macrophages by regulating the TRIM2- NF-\u03baB pathway in colorectal cancer cells. Genes & Dis. 2024;11(4):101092. https:\/\/doi.org\/10.1016\/j.gendis.2023.101092.","journal-title":"Genes & Dis"},{"issue":"19","key":"8661_CR227","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1038\/s44318-024-00201-6","volume":"43","author":"X Qian","year":"2024","unstructured":"Qian X, Cai J, Zhang Y, Shen S, Wang M, Liu S, et al. EPDR1 promotes PD-L1 expression and tumor immune evasion by inhibiting TRIM21-dependent ubiquitylation of IkappaB kinase-\u03b2. Embo J. 2024;43(19):4248\u201373. https:\/\/doi.org\/10.1038\/s44318-024-00201-6.","journal-title":"Embo J"},{"issue":"22","key":"8661_CR228","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1038\/sj.emboj.7600845","volume":"24","author":"T Geetha","year":"2005","unstructured":"Geetha T, Kenchappa RS, Wooten MW, Carter BD. TRAF6-mediated ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor. Embo J. 2005;24(22):3859\u201368. https:\/\/doi.org\/10.1038\/sj.emboj.7600845.","journal-title":"Embo J"},{"issue":"4","key":"8661_CR229","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41416-025-03072-8","volume":"133","author":"W Zhong","year":"2025","unstructured":"Zhong W, Zhang Y, Wang W, Shao Z, Xu Z, Zhang G, et al. TRIM26 deficiency potentially suppresses colorectal cancer liver metastasis through NF-\u03baB-mediated M1-like tumor-associated macrophage polarization. Br J Cancer. 2025;133(4):435\u201347. https:\/\/doi.org\/10.1038\/s41416-025-03072-8.","journal-title":"Br J Cancer"},{"issue":"21","key":"8661_CR230","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.3390\/cancers14215237","volume":"14","author":"G-Y Zhong","year":"2022","unstructured":"Zhong G-Y, Tan J-N, Huang J, Zhou S-N, Yu J-H, Zhong L, et al. LncRNA LINC01537 promotes gastric cancer metastasis and tumorigenesis by stabilizing RIPK4 to activate NF-\u03baB signaling. Cancers. 2022;14(21):5237. https:\/\/doi.org\/10.3390\/cancers14215237.","journal-title":"Cancers"},{"issue":"4","key":"8661_CR231","doi-asserted-by":"publisher","first-page":"112340","DOI":"10.1016\/j.celrep.2023.112340","volume":"42","author":"Y-K Wang","year":"2023","unstructured":"Wang Y-K, Ma N, Xu S, Huang J-Y, Ni Q-Z, Cao H-J, et al. PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1. Cell Rep. 2023;42(4):112340. https:\/\/doi.org\/10.1016\/j.celrep.2023.112340.","journal-title":"Cell Rep"},{"issue":"1","key":"8661_CR232","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures and advances in therapy. Sig Transduct Target Ther. 2023;8(1):92. https:\/\/doi.org\/10.1038\/s41392-023-01347-1.","journal-title":"Sig Transduct Target Ther"},{"issue":"5","key":"8661_CR233","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1053\/j.gastro.2014.07.021","volume":"147","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Ji Z, Wang Y, Li J, Cao H, Zhu HH, et al. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53. Gastroenterology. 2014;147(5):1043\u201354. https:\/\/doi.org\/10.1053\/j.gastro.2014.07.021.","journal-title":"Gastroenterology"},{"issue":"44","key":"8661_CR234","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1038\/s41388-023-02843-y","volume":"42","author":"B Che","year":"2023","unstructured":"Che B, Du Y, Yuan R, Xiao H, Zhang W, Shao J, et al. SLC35F2\u2013SYVN1\u2013TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. Oncogene. 2023;42(44):3260\u201373. https:\/\/doi.org\/10.1038\/s41388-023-02843-y.","journal-title":"Oncogene"},{"key":"8661_CR235","doi-asserted-by":"publisher","unstructured":"Gong L-P, Chen J-N, Dong M, Xiao Z-D, Feng Z-Y, Pan Y-H, et al. Epstein\u2013barr virus-derived circular RNA LMP2A induces stemness in EBV-associated gastric cancer. EMBO Rep. 2020;21(10):e49689. https:\/\/doi.org\/10.15252\/embr.201949689.","DOI":"10.15252\/embr.201949689"},{"key":"8661_CR236","doi-asserted-by":"publisher","unstructured":"Zhou Z, Shu Y, Bao H, Han S, Liu Z, Zhao N, et al. RETRACTED ARTICLE: stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB\/TRIM2\/P53 axis. J Transl Med. 2022;20(1). https:\/\/doi.org\/10.1186\/s12967-022-03467-8.","DOI":"10.1186\/s12967-022-03467-8"},{"issue":"10","key":"8661_CR237","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1111\/jcmm.15203","volume":"24","author":"Y Han","year":"2020","unstructured":"Han Y, Tan Y, Zhao Y, Zhang Y, He X, Yu L, et al. TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer. J Cellular Mol Medi. 2020;24(10):5491\u2013500. https:\/\/doi.org\/10.1111\/jcmm.15203.","journal-title":"J Cellular Mol Medi"},{"key":"8661_CR238","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.intimp.2024.112139","volume":"134","author":"Y Ge","year":"2024","unstructured":"Ge Y, Xiao B, Zhao R, Li B, Yang S, He KF, et al. CARMIL1 regulates liver cancer cell proliferation by activating the ERK\/mTOR pathway through the TRIM27\/p53 axis. Int Immunopharmacol. 2024;134:134. https:\/\/doi.org\/10.1016\/j.intimp.2024.112139.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"8661_CR239","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.yexcr.2018.04.013","volume":"368","author":"P Guo","year":"2018","unstructured":"Guo P, Qiu Y, Ma X, Li T, Ma X, Zhu L, et al. Tripartite motif 31 promotes resistance to anoikis of hepatocarcinoma cells through regulation of p53-AMPK axis. Exp Cell Res. 2018;368(1):59\u201366. https:\/\/doi.org\/10.1016\/j.yexcr.2018.04.013.","journal-title":"Exp Cell Res"},{"issue":"2","key":"8661_CR240","doi-asserted-by":"publisher","first-page":"113377","DOI":"10.1016\/j.yexcr.2022.113377","volume":"421","author":"Y Ge","year":"2022","unstructured":"Ge Y, Zhao R, Li B, Xiao B, Zhou L, Zuo S. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37. Exp Cell Res. 2022;421(2):113377. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113377.","journal-title":"Exp Cell Res"},{"issue":"3","key":"8661_CR241","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/biomedicines9030241","volume":"9","author":"F Marzano","year":"2021","unstructured":"Marzano F, Caratozzolo MF, Pesole G, Sbis\u00e0 E, Tullo A. TRIM proteins in colorectal cancer: TRIM8 as a promising therapeutic target in chemo resistance. Biomedicines. 2021;9(3):241. https:\/\/doi.org\/10.3390\/biomedicines9030241.","journal-title":"Biomedicines"},{"issue":"16","key":"8661_CR242","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1158\/0008-5472.CAN-18-3614","volume":"79","author":"S Wang","year":"2019","unstructured":"Wang S, Zhang Y, Huang J, Wong CC, Zhai J, Li C, et al. TRIM67 activates p53 to suppress colorectal cancer initiation and progression. Cancer Res. 2019;79(16):4086\u201398. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3614.","journal-title":"Cancer Res"},{"issue":"3","key":"8661_CR243","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1245\/s10434-009-0795-8","volume":"17","author":"T Yokoe","year":"2010","unstructured":"Yokoe T, Toiyama Y, Okugawa Y, Tanaka K, Ohi M, Inoue Y, et al. KAP1 is associated with peritoneal carcinomatosis in gastric cancer. Ann Surg Oncol. 2010;17(3):821\u201328. https:\/\/doi.org\/10.1245\/s10434-009-0795-8.","journal-title":"Ann Surg Oncol"},{"key":"8661_CR244","doi-asserted-by":"publisher","unstructured":"Ding Z, Pan Y, Shang T, Jiang T, Lin Y, Yang C, et al. URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers. Nat Commun. 2023;14(1). https:\/\/doi.org\/10.1038\/s41467-023-41852-z.","DOI":"10.1038\/s41467-023-41852-z"},{"issue":"12","key":"8661_CR245","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1128\/MCB.01023-09","volume":"30","author":"Z Yuan","year":"2010","unstructured":"Yuan Z, Villagra A, Peng L, Coppola D, Glozak M, Sotomayor EM, et al. The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions. Mol Cell Biol. 2010;30(12):3004\u201315. https:\/\/doi.org\/10.1128\/MCB.01023-09.","journal-title":"Mol Cell Biol"},{"key":"8661_CR246","doi-asserted-by":"publisher","unstructured":"Liu J, Zhang C, Xu D, Zhang T, Chang C-Y, Wang J, et al. The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer. J Clin Investigation. 2023;133(6). https:\/\/doi.org\/10.1172\/JCI164354.","DOI":"10.1172\/JCI164354"},{"key":"8661_CR247","doi-asserted-by":"publisher","unstructured":"Ma L, Yao N, Chen P, Zhuang Z. TRIM27 promotes the development of esophagus cancer via regulating PTEN\/AKT signaling pathway. Cancer Cell Int. 2019;19(1). https:\/\/doi.org\/10.1186\/s12935-019-0998-4.","DOI":"10.1186\/s12935-019-0998-4"},{"issue":"1","key":"8661_CR248","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/cbdd.13937","volume":"99","author":"L Wen","year":"2022","unstructured":"Wen L, Mao W, Xu L, Cai B, Gu L. Sesamin exerts anti-tumor activity in esophageal squamous cell carcinoma via inhibition of TRIM44 and NF-\u03baB signaling. Chem Biol Drug Des. 2022;99(1):118\u201325. https:\/\/doi.org\/10.1111\/cbdd.13937.","journal-title":"Chem Biol Drug Des"},{"key":"8661_CR249","doi-asserted-by":"publisher","unstructured":"Chen L, Zhang W, Chen D, Yang Q, Sun S, Dai Z, et al. RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis. Sig Transduct Target Ther. 2023;8(1). https:\/\/doi.org\/10.1038\/s41392-023-01367-x.","DOI":"10.1038\/s41392-023-01367-x"},{"issue":"5","key":"8661_CR250","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/10799893.2020.1756327","volume":"40","author":"G Liu","year":"2020","unstructured":"Liu G, Song J, Zhao Y, Zhang L, Qin J, Cui Y. Tripartite motif containing 59 (TRIM59) promotes esophageal cancer progression via promoting MST4 expression and ERK pathway. J Recept Signal Transduct Res. 2020;40(5):471\u201378. https:\/\/doi.org\/10.1080\/10799893.2020.1756327.","journal-title":"J Recept Signal Transduct Res"},{"issue":"1","key":"8661_CR251","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1128\/JVI.05623-11","volume":"86","author":"N Sivachandran","year":"2012","unstructured":"Sivachandran N, Dawson CW, Young LS, Liu F-F, Middeldorp J, Frappier L. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol. 2012;86(1):60\u201368. https:\/\/doi.org\/10.1128\/JVI.05623-11.","journal-title":"J Virol"},{"issue":"8","key":"8661_CR252","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1080\/15384047.2015.1056411","volume":"16","author":"L Zhou","year":"2015","unstructured":"Zhou L, Shang Y, Jin Z, Zhang W, Lv C, Zhao X, et al. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation. Cancer Biol Ther. 2015;16(8):1241\u201351. https:\/\/doi.org\/10.1080\/15384047.2015.1056411.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"8661_CR253","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10120-023-01437-7","volume":"27","author":"R Xie","year":"2024","unstructured":"Xie R, Liu L, Lu X, He C, Yao H, Li G. N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation. Gastric Cancer. 2024;27(1):49\u201371. https:\/\/doi.org\/10.1007\/s10120-023-01437-7.","journal-title":"Gastric Cancer"},{"issue":"2","key":"8661_CR254","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s11010-024-05005-0","volume":"480","author":"L He","year":"2025","unstructured":"He L, Zhou J, Ding D, Jiang Y, Yang R, Li Z. MiR-99a-3p downregulates TRIM21 to promote gastric cancer development. Mol Cell Biochem. 2025;480(2):1001\u201312. https:\/\/doi.org\/10.1007\/s11010-024-05005-0.","journal-title":"Mol Cell Biochem"},{"key":"8661_CR255","doi-asserted-by":"publisher","unstructured":"Yang F, Ma Q, Huang B, Wang X, Pan X, Yu T, et al. CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability. J Transl Med. 2023;21(1). https:\/\/doi.org\/10.1186\/s12967-023-04235-y.","DOI":"10.1186\/s12967-023-04235-y"},{"key":"8661_CR256","doi-asserted-by":"publisher","unstructured":"Zhu G-W, Chen H, Liu S-Y, Lin P-H, Lin L, Ye J-X. PPM1B degradation mediated by TRIM25 ubiquitination modulates cell cycle and promotes gastric cancer growth. Sci Rep. 2025;15(1). https:\/\/doi.org\/10.1038\/s41598-025-89519-7.","DOI":"10.1038\/s41598-025-89519-7"},{"key":"8661_CR257","doi-asserted-by":"publisher","unstructured":"Jia Y, Yan Q, Zheng Y, Li L, Zhang B, Chang Z, et al. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun\/c-Fos\/SREBP1 axis in gastric cancer. J Exp Clin Cancer Res. 2022;41(1). https:\/\/doi.org\/10.1186\/s13046-022-02449-4.","DOI":"10.1186\/s13046-022-02449-4"},{"issue":"3","key":"8661_CR258","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3724\/abbs.2023023","volume":"55","author":"J Huang","year":"2023","unstructured":"Huang J, Yuan W, Chen B, Li G, Chen X. lncRNA ELFN1-AS1 upregulates TRIM29 by suppressing miR-211-3p to promote gastric cancer progression. ABBS. 2023;55(3):484\u201397. https:\/\/doi.org\/10.3724\/abbs.2023023.","journal-title":"ABBS"},{"issue":"3","key":"8661_CR259","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.3892\/ol.2017.5604","volume":"13","author":"Z Fang","year":"2017","unstructured":"Fang Z, Deng J, Zhang L, Xiang X, Yu F, Chen J, et al. TRIM24 promotes the aggression of gastric cancer via the Wnt\/\u03b2-catenin signaling pathway. Oncol Lett. 2017;13(3):1797\u2013806. https:\/\/doi.org\/10.3892\/ol.2017.5604.","journal-title":"Oncol Lett"},{"key":"8661_CR260","doi-asserted-by":"publisher","unstructured":"Fang Z, Zhang L, Liao Q, Wang Y, Yu F, Feng M, et al. Regulation of TRIM24 by miR-511 modulates cell proliferation in gastric cancer. J Exp Clin Cancer Res. 2017;36(1). https:\/\/doi.org\/10.1186\/s13046-017-0489-1.","DOI":"10.1186\/s13046-017-0489-1"},{"issue":"13","key":"8661_CR261","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.7150\/jca.95094","volume":"15","author":"Z Huang","year":"2024","unstructured":"Huang Z, Dong J, Guo T, Jiang W, Hu R, Zhang S, et al. TRIM28 regulates proliferation of gastric cancer cells partly through SRF\/IDO1 Axis. J Cancer. 2024;15(13):4417\u201329. https:\/\/doi.org\/10.7150\/jca.95094.","journal-title":"J Cancer"},{"key":"8661_CR262","doi-asserted-by":"publisher","unstructured":"Chen Y, Li Q, Yu X, Lu L, Zhou Z, Li M, et al. The microprotein HDSP promotes gastric cancer progression through activating the MECOM-SPINK1-EGFR signaling axis. Nat Commun. 2024;15(1). https:\/\/doi.org\/10.1038\/s41467-024-50986-7.","DOI":"10.1038\/s41467-024-50986-7"},{"issue":"5","key":"8661_CR263","first-page":"5053","volume":"8","author":"F Qiu","year":"2015","unstructured":"Qiu F, Xiong J-P, Deng J, Xiang X-J. TRIM29 functions as an oncogene in gastric cancer and is regulated by miR-185. Int J Clin Exp Pathol. 2015;8(5):5053\u201361.","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"8661_CR264","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/jcb.21908","volume":"105","author":"T Sugiura","year":"2008","unstructured":"Sugiura T, Miyamoto K. Characterization of TRIM31, upregulated in gastric adenocarcinoma, as a novel RBCC protein. J Cellular Biochem. 2008;105(4):1081\u201391. https:\/\/doi.org\/10.1002\/jcb.21908.","journal-title":"J Cellular Biochem"},{"key":"8661_CR265","doi-asserted-by":"publisher","unstructured":"Wang J, Fang Y, Liu T, Franco P. TRIM32 promotes the growth of gastric cancer cells through enhancing AKT activity and glucose transportation. Biomed Res Int. 2020;2020(1). https:\/\/doi.org\/10.1155\/2020\/4027627.","DOI":"10.1155\/2020\/4027627"},{"issue":"6","key":"8661_CR266","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.gendis.2023.02.006","volume":"10","author":"F Wang","year":"2023","unstructured":"Wang F, Chen S, Peng S, Zhou X, Tang H, Liang H, et al. PRMT1 promotes the proliferation and metastasis of gastric cancer cells by recruiting MLXIP for the transcriptional activation of the \u03b2-catenin pathway. Genes & Dis. 2023;10(6):2622\u201338. https:\/\/doi.org\/10.1016\/j.gendis.2023.02.006.","journal-title":"Genes & Dis"},{"issue":"10","key":"8661_CR267","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1158\/1541-7786.MCR-23-0113","volume":"21","author":"J Hu","year":"2023","unstructured":"Hu J, Huang R, Liang C, Wang Y, Wang M, Chen Y, et al. TRIM50 inhibits gastric cancer progression by regulating the ubiquitination and nuclear translocation of JUP. Mol Cancer Res. 2023;21(10):1107\u201319. https:\/\/doi.org\/10.1158\/1541-7786.MCR-23-0113.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"8661_CR268","doi-asserted-by":"publisher","first-page":"239","DOI":"10.14670\/HH-18-627","volume":"39","author":"Q Zuo","year":"2024","unstructured":"Zuo Q, Xu Q, Li Z, Luo D, Peng H, Duan Z. TRIM3 inhibits colorectal cancer cell migration and lipid droplet formation by promoting FABP4 degradation. Histol Histopathol. 2024;39(2):239\u201350. https:\/\/doi.org\/10.14670\/HH-18-627.","journal-title":"Histol Histopathol"},{"issue":"4","key":"8661_CR269","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI133264","volume":"130","author":"Y Xie","year":"2020","unstructured":"Xie Y, Zhao Y, Shi L, Li W, Chen K, Li M, et al. Gut epithelial TSC1\/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer. J Clin Investigation. 2020;130(4):2111\u201328. https:\/\/doi.org\/10.1172\/JCI133264.","journal-title":"J Clin Investigation"},{"issue":"1","key":"8661_CR270","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1080\/15548627.2021.1909406","volume":"18","author":"EG Foerster","year":"2022","unstructured":"Foerster EG, Mukherjee T, Cabral-Fernandes L, Rocha JDB, Girardin SE, Philpott DJ. How autophagy controls the intestinal epithelial barrier. Autophagy. 2022;18(1):86\u2013103. https:\/\/doi.org\/10.1080\/15548627.2021.1909406.","journal-title":"Autophagy"},{"key":"8661_CR271","doi-asserted-by":"publisher","unstructured":"Chen Q, Zhou L, Ma D, Hou J, Lin Y, Wu J, et al. LncRNA GAS6-AS1 facilitates tumorigenesis and metastasis of colorectal cancer by regulating TRIM14 through miR-370-3p\/miR-1296-5p and FUS. J Transl Med. 2022;20(1). https:\/\/doi.org\/10.1186\/s12967-022-03550-0.","DOI":"10.1186\/s12967-022-03550-0"},{"key":"8661_CR272","doi-asserted-by":"publisher","unstructured":"Wang X, Cheng H, Zhao J, Li J, Chen Y, Cui K, et al. Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21\/ELOA\/LHPP axis in colorectal cancer. Mol Cancer. 2022;21(1). https:\/\/doi.org\/10.1186\/s12943-022-01675-w.","DOI":"10.1186\/s12943-022-01675-w"},{"key":"8661_CR273","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fphar.2022.806682","volume":"13","author":"X Jing","year":"2022","unstructured":"Jing X, Du L, Shi S, Niu A, Wu J, Wang Y, et al. Hypoxia-induced Upregulation of lncRNA ELFN1-AS1 promotes colon cancer growth and metastasis through targeting TRIM14 via sponging miR-191-5p. Front Pharmacol. 2022;13:13. https:\/\/doi.org\/10.3389\/fphar.2022.806682.","journal-title":"Front Pharmacol"},{"key":"8661_CR274","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fonc.2020.00182","volume":"10","author":"F Fei","year":"2020","unstructured":"Fei F, Liu K, Li C, Du J, Wei Z, Li B, et al. Molecular mechanisms by which S100A4 regulates the migration and invasion of PGCCs with their daughter cells in human colorectal cancer. Front Oncol. 2020;10:10. https:\/\/doi.org\/10.3389\/fonc.2020.00182.","journal-title":"Front Oncol"},{"key":"8661_CR275","doi-asserted-by":"publisher","unstructured":"Bian Z, Zhou M, Cui K, Yang F, Cao Y, Sun S, et al. SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop. J Exp Clin Cancer Res. 2021;40(1). https:\/\/doi.org\/10.1186\/s13046-021-02162-8.","DOI":"10.1186\/s13046-021-02162-8"},{"issue":"13","key":"8661_CR276","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s44318-024-00120-6","volume":"43","author":"W Zhan","year":"2024","unstructured":"Zhan W, Li Z, Zhang J, Liu Y, Liu G, Li B, et al. Energy stress promotes P-bodies formation via lysine-63-linked polyubiquitination of HAX1. Embo J. 2024;43(13):2759\u201388. https:\/\/doi.org\/10.1038\/s44318-024-00120-6.","journal-title":"Embo J"},{"issue":"4","key":"8661_CR277","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.7150\/ijbs.91206","volume":"20","author":"L Xia","year":"2024","unstructured":"Xia L, Lin J, Peng M, Jiang X, Peng Q, Cui S, et al. Diallyl disulfide induces DNA damage and growth inhibition in colorectal cancer cells by promoting POU2F1 ubiquitination. Int J Biol Sci. 2024;20(4):1125\u201341. https:\/\/doi.org\/10.7150\/ijbs.91206.","journal-title":"Int J Biol Sci"},{"key":"8661_CR278","doi-asserted-by":"publisher","unstructured":"Lu Y, Zou R, Gu Q, Wang X, Zhang J, Ma R, et al. CRNDE mediated hnRNPA2B1 stability facilitates nuclear export and translation of KRAS in colorectal cancer. Cell Death Dis. 2023;14(9). https:\/\/doi.org\/10.1038\/s41419-023-06137-9.","DOI":"10.1038\/s41419-023-06137-9"},{"key":"8661_CR279","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cbi.2023.110408","volume":"374","author":"Z Gui","year":"2023","unstructured":"Gui Z, Li J, Li J, Li X, Chen L, Ma Z, et al. Berberine promotes IGF2BP3 ubiquitination by TRIM21 to induce G1\/S phase arrest in colorectal cancer cells. Chemico-Biol Interact. 2023;374:374. https:\/\/doi.org\/10.1016\/j.cbi.2023.110408.","journal-title":"Chemico-Biol Interact"},{"issue":"10","key":"8661_CR280","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/s41418-025-01498-4","volume":"32","author":"H Wang","year":"2025","unstructured":"Wang H, Hu J, Wang D, Cai Y, Zhu W, Deng R, et al. TM9SF1 inhibits colorectal cancer metastasis by targeting Vimentin for Tollip-mediated selective autophagic degradation. Cell Death Differ. 2025;32(10):1871\u201385. https:\/\/doi.org\/10.1038\/s41418-025-01498-4.","journal-title":"Cell Death Differ"},{"issue":"3","key":"8661_CR281","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1158\/1541-7786.MCR-24-0434","volume":"23","author":"H Yao","year":"2025","unstructured":"Yao H, Xu J, Zhou A, Shen D, Dong Q, Yang X, et al. Gut microbiota\u2013mediated hsa_circ_0126925 targets BCAA metabolic enzyme BCAT2 to exacerbate colorectal cancer progression. Mol Cancer Res. 2025;23(3):202\u201318. https:\/\/doi.org\/10.1158\/1541-7786.MCR-24-0434.","journal-title":"Mol Cancer Res"},{"key":"8661_CR282","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.canlet.2023.216427","volume":"577","author":"J Yang","year":"2023","unstructured":"Yang J, Liao Y, Wang B, Cui L, Yu X, Wu F, et al. EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of snail. Cancer Lett. 2023;577:577. https:\/\/doi.org\/10.1016\/j.canlet.2023.216427.","journal-title":"Cancer Lett"},{"issue":"11","key":"8661_CR283","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/s41416-020-0779-9","volume":"122","author":"B Qin","year":"2020","unstructured":"Qin B, Zou S, Li K, Wang H, Wei W, Zhang B, et al. CSN6\u2013TRIM21 axis instigates cancer stemness during tumorigenesis. Br J Cancer. 2020;122(11):1673\u201385. https:\/\/doi.org\/10.1038\/s41416-020-0779-9.","journal-title":"Br J Cancer"},{"key":"8661_CR284","doi-asserted-by":"publisher","unstructured":"Wei Z, Song J, Wang G, Cui X, Zheng J, Tang Y, et al. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis. Nat Commun. 2018;9(1). https:\/\/doi.org\/10.1038\/s41467-018-06812-y.","DOI":"10.1038\/s41467-018-06812-y"},{"key":"8661_CR285","doi-asserted-by":"publisher","unstructured":"Du L, Li Y-J, Fakih M, Wiatrek RL, Duldulao M, Chen Z, et al. Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal. Nat Commun. 2016;7(1). https:\/\/doi.org\/10.1038\/ncomms12326.","DOI":"10.1038\/ncomms12326"},{"issue":"17","key":"8661_CR286","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.1002\/cam4.3310","volume":"9","author":"W Xie","year":"2020","unstructured":"Xie W, Zhang Y, Wang B, Hu Y, Zhan B, Wei F, et al. Tripartite motif containing 24 regulates cell proliferation in colorectal cancer through YAP signaling. Cancer Med. 2020;9(17):6367\u201376. https:\/\/doi.org\/10.1002\/cam4.3310.","journal-title":"Cancer Med"},{"key":"8661_CR287","doi-asserted-by":"publisher","unstructured":"Xiao M, Liang Z, Yin Z. Long non\u2011coding RNA ZFPM2\u2011AS1 promotes colorectal cancer progression by sponging miR\u2011137 to regulate TRIM24. Mol Med Rep. 2020;23(2). https:\/\/doi.org\/10.3892\/mmr.2020.11737.","DOI":"10.3892\/mmr.2020.11737"},{"issue":"17","key":"8661_CR288","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41388-023-02656-z","volume":"42","author":"S Huang","year":"2023","unstructured":"Huang S, Li J, Wu S, Zheng Z, Wang C, Li H, et al. C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17\/Elk-1\/CDK6 axis. Oncogene. 2023;42(17):1333\u201346. https:\/\/doi.org\/10.1038\/s41388-023-02656-z.","journal-title":"Oncogene"},{"issue":"9","key":"8661_CR289","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41388-022-02581-7","volume":"42","author":"T Wang","year":"2023","unstructured":"Wang T, Jin C, Yang P, Chen Z, Ji J, Sun Q, et al. UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3. Oncogene. 2023;42(9):651\u201364. https:\/\/doi.org\/10.1038\/s41388-022-02581-7.","journal-title":"Oncogene"},{"key":"8661_CR290","doi-asserted-by":"publisher","unstructured":"Ren G, Li H, Hong D, Hu F, Jin R, Wu S, et al. LINC00955 suppresses colorectal cancer growth by acting as a molecular scaffold of TRIM25 and Sp1 to inhibit DNMT3B-mediated methylation of the PHIP promoter. BMC Cancer. 2023;23(1). https:\/\/doi.org\/10.1186\/s12885-023-11403-2.","DOI":"10.1186\/s12885-023-11403-2"},{"key":"8661_CR291","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bbrc.2022.01.036","volume":"594","author":"Y Tong","year":"2022","unstructured":"Tong Y, Li J, Peng M, Qian Q, Shi W, Chen Z, et al. ATAD2 drives colorectal cancer progression by regulating TRIM25 expression via a positive feedback loop with E2F transcriptional factors. Biochem Bioph Res Co. 2022;594:146\u201352. https:\/\/doi.org\/10.1016\/j.bbrc.2022.01.036.","journal-title":"Biochem Bioph Res Co"},{"key":"8661_CR292","doi-asserted-by":"publisher","unstructured":"Ni X, Feng Y, Fu X. Role of salt\u2011inducible kinase 2 in the malignant behavior and glycolysis of colorectal cancer cells. Mol Med Rep. 2021;24(5). https:\/\/doi.org\/10.3892\/mmr.2021.12460.","DOI":"10.3892\/mmr.2021.12460"},{"key":"8661_CR293","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.omtn.2022.08.037","volume":"30","author":"SR Ali","year":"2022","unstructured":"Ali SR, Humphreys KJ, Simpson KJ, McKinnon RA, Meech R, Michael MZ. Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells. Mol Ther - Nucleic Acids. 2022;30:30\u201347. https:\/\/doi.org\/10.1016\/j.omtn.2022.08.037.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"8661_CR294","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2147\/OTT.S185858","volume":"12","author":"Q Han","year":"2019","unstructured":"Han Q, Sun M-L, Liu W-S, Zhao H-S, Jiang L-Y, Yu Z-J, et al. <p>Upregulated expression of ACTL8 contributes to invasion and metastasis and indicates poor prognosis in colorectal cancer<\/p>. OTT. 2019, Volume, 12: 1749\u201363. https:\/\/doi.org\/10.2147\/OTT.S185858.","journal-title":"OTT"},{"issue":"3","key":"8661_CR295","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.21037\/jgo-22-365","volume":"13","author":"J Han","year":"2022","unstructured":"Han J, Zuo J, Zhang X, Wang L, Li D, Wang Y, et al. TRIM29 is differentially expressed in colorectal cancers of different primary locations and affects survival by regulating tumor immunity based on retrospective study and bioinformatics analysis. J Gastrointest Oncol. 2022;13(3):1132\u201351. https:\/\/doi.org\/10.21037\/jgo-22-365.","journal-title":"J Gastrointest Oncol"},{"key":"8661_CR296","doi-asserted-by":"publisher","unstructured":"Sun Z, Li X, Shi Y, Yao Y. LncRNA PVT1 facilitates the growth and metastasis of colorectal cancer by sponging with miR-3619-5p to regulate TRIM29 expression. Cancer Rep. 2024;7(6). https:\/\/doi.org\/10.1002\/cnr2.2085.","DOI":"10.1002\/cnr2.2085"},{"issue":"1","key":"8661_CR297","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/diagnostics12010198","volume":"12","author":"R Baharudin","year":"2022","unstructured":"Baharudin R, Ishak M, Muhamad Yusof A, Saidin S, Syafruddin SE, Wan Mohamad Nazarie WF, et al. Epigenome-wide DNA methylation profiling in colorectal cancer and normal adjacent colon using infinium human methylation 450K. Diagnostics. 2022;12(1):198. https:\/\/doi.org\/10.3390\/diagnostics12010198.","journal-title":"Diagnostics"},{"key":"8661_CR298","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.intimp.2025.115445","volume":"165","author":"N Li","year":"2025","unstructured":"Li N, Zhang R, Zhao X-X, Zhou L, Li Y-L, Cui Z-G, et al. RNF180 suppressed aggressiveness by degrading NOTCH1, TRIM24 and FOXC1, and chemoresistance by degrading ACC1 and ACLY in colorectal cancer. Int Immunopharmacol. 2025;165:165. https:\/\/doi.org\/10.1016\/j.intimp.2025.115445.","journal-title":"Int Immunopharmacol"},{"key":"8661_CR299","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neo.2024.100971","volume":"49","author":"S Wu","year":"2024","unstructured":"Wu S, Dai X, Zhu Z, Fan D, Jiang S, Dong Y, et al. Reciprocal regulation of lncRNA MEF and c-myc drives colorectal cancer tumorigenesis. Neoplasia. 2024;49:49. https:\/\/doi.org\/10.1016\/j.neo.2024.100971.","journal-title":"Neoplasia"},{"key":"8661_CR300","doi-asserted-by":"publisher","unstructured":"Sun L, Wang D, Chen Z, Zhu X. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5. Open Life Sci. 2023;18(1). https:\/\/doi.org\/10.1515\/biol-2022-0711.","DOI":"10.1515\/biol-2022-0711"},{"key":"8661_CR301","doi-asserted-by":"publisher","unstructured":"Lei G, Liu S, Yang X, He C, Caspa Gokulan R. TRIM29 reverses oxaliplatin resistance of P53 mutant colon cancer cell. Can J Gastroenterol Hepatol. 2021;2021(1). https:\/\/doi.org\/10.1155\/2021\/8870907.","DOI":"10.1155\/2021\/8870907"},{"key":"8661_CR302","doi-asserted-by":"publisher","first-page":"8179","DOI":"10.2147\/OTT.S215769","volume":"12","author":"H Zhang","year":"2019","unstructured":"Zhang H, Deng Y, Liang L, Shen L, Zhu J, Wang Y, et al. <p>Knockdown of TRIM31 enhances colorectal cancer radiosensitivity by inducing DNA damage and activating apoptosis<\/p>. OTT. 2019, Volume, 12: 8179\u201388. https:\/\/doi.org\/10.2147\/OTT.S215769.","journal-title":"OTT"},{"issue":"7","key":"8661_CR303","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/carcin\/bgr068","volume":"32","author":"K Noguchi","year":"2011","unstructured":"Noguchi K, Okumura F, Takahashi N, Kataoka A, Kamiyama T, Todo S, et al. TRIM40 promotes neddylation of IKK and is downregulated in gastrointestinal cancers. Carcinogenesis. 2011;32(7):995\u20131004. https:\/\/doi.org\/10.1093\/carcin\/bgr068.","journal-title":"Carcinogenesis"},{"issue":"4","key":"8661_CR304","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000500195","volume":"101","author":"S Sun","year":"2020","unstructured":"Sun S, Li W, Ma X, Luan H. Long noncoding RNA LINC00265 promotes glycolysis and lactate production of colorectal cancer through regulating of miR-216b-5p\/TRIM44 axis. Digestion. 2020;101(4):391\u2013400. https:\/\/doi.org\/10.1159\/000500195.","journal-title":"Digestion"},{"issue":"2","key":"8661_CR305","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s10620-021-06859-w","volume":"67","author":"B Han","year":"2022","unstructured":"Han B, Wang X, Yin X. Knockdown of circRAD23B exerts antitumor response in colorectal cancer via the regulation of miR-1205\/TRIM44 axis. Dig Dis Sci. 2022;67(2):504\u201315. https:\/\/doi.org\/10.1007\/s10620-021-06859-w.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"8661_CR306","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12013-020-00955-w","volume":"79","author":"T Kou","year":"2021","unstructured":"Kou T, Sha D, Wang F, He T, He X. The novel target of colorectal carcinoma: TRIM44 regulates cell migration and invasion via activation of CXCR4\/NF-\u03baB signaling. Cell Biochem Biophys. 2021;79(1):113\u201321. https:\/\/doi.org\/10.1007\/s12013-020-00955-w.","journal-title":"Cell Biochem Biophys"},{"issue":"4","key":"8661_CR307","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3233\/CBM-190559","volume":"27","author":"R Lei","year":"2020","unstructured":"Lei R, Feng L, Hong D. ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644\/TRIM44 axis. CBM. 2020;27(4):433\u201343. https:\/\/doi.org\/10.3233\/CBM-190559.","journal-title":"CBM"},{"key":"8661_CR308","doi-asserted-by":"publisher","unstructured":"Sun N, Shen J, Shi Y, Liu B, Gao S, Chen Y, et al. TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway. World J Surg Onc. 2023;21(1). https:\/\/doi.org\/10.1186\/s12957-023-03124-4.","DOI":"10.1186\/s12957-023-03124-4"},{"issue":"6","key":"8661_CR309","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1007\/s10637-022-01306-7","volume":"40","author":"X Feng","year":"2022","unstructured":"Feng X, Yang G, Zhang L, Tao S, Shim JS, Chen L, et al. TRIM59 guards ER proteostasis and prevents Bortezomib-mediated colorectal cancer (CRC) cells\u2019 killing. Invest New Drugs. 2022;40(6):1244\u201353. https:\/\/doi.org\/10.1007\/s10637-022-01306-7.","journal-title":"Invest New Drugs"},{"key":"8661_CR310","doi-asserted-by":"publisher","unstructured":"Lv H, Zhou D, Liu G. LncRNA LINC00963 promotes colorectal cancer cell proliferation and metastasis by regulating miR\u20111281 and TRIM65. Mol Med Rep. 2021;24(5). https:\/\/doi.org\/10.3892\/mmr.2021.12421.","DOI":"10.3892\/mmr.2021.12421"},{"key":"8661_CR311","doi-asserted-by":"publisher","first-page":"6865","DOI":"10.2147\/OTT.S219421","volume":"12","author":"W Jin","year":"2019","unstructured":"Jin W, Shi J, Liu M. <p>Overexpression of miR-671-5p indicates a poor prognosis in colon cancer and accelerates proliferation, migration, and invasion of colon cancer cells<\/p>. OTT. 2019, Volume, 12: 6865\u201373. https:\/\/doi.org\/10.2147\/OTT.S219421.","journal-title":"OTT"},{"issue":"4","key":"8661_CR312","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.3892\/ol.2017.5787","volume":"13","author":"Z Tan","year":"2017","unstructured":"Tan Z, Liu X, Yu E, Wang H, Tang L, Wang H, et al. Lentivirus-mediated RNA interference of tripartite motif 68 inhibits the proliferation of colorectal cancer cell lines SW1116 and HCT116 in vitro. Oncol Lett. 2017;13(4):2649\u201355. https:\/\/doi.org\/10.3892\/ol.2017.5787.","journal-title":"Oncol Lett"},{"key":"8661_CR313","doi-asserted-by":"publisher","unstructured":"Huang X-Q, Zhang X-F, Xia J-H, Chao J, Pan Q-Z, Zhao J-J, et al. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer. Chin J Cancer. 2017;36(1). https:\/\/doi.org\/10.1186\/s40880-017-0240-5.","DOI":"10.1186\/s40880-017-0240-5"},{"issue":"1","key":"8661_CR314","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000484678","volume":"44","author":"J Liu","year":"2017","unstructured":"Liu J, Rao J, Lou X, Zhai J, Ni Z, Wang X. Upregulated TRIM11 exerts its oncogenic effects in hepatocellular carcinoma through inhibition of P53. Cell Physiol Biochem. 2017;44(1):255\u201366. https:\/\/doi.org\/10.1159\/000484678.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"8661_CR315","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3727\/096504016X14774897404770","volume":"25","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Xu C, Zhang X, Huang L, Zheng C, Chen H, et al. TRIM11 upregulation contributes to proliferation, invasion, and EMT of hepatocellular carcinoma cells. Oncol Res. 2017;25(5):691\u201399. https:\/\/doi.org\/10.3727\/096504016X14774897404770.","journal-title":"Oncol Res"},{"issue":"23","key":"8661_CR316","doi-asserted-by":"publisher","first-page":"10830","DOI":"10.1158\/0008-5472.CAN-05-0880","volume":"65","author":"K Herzer","year":"2005","unstructured":"Herzer K, Weyer S, Krammer PH, Galle PR, Hofmann TG. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. Cancer Res. 2005;65(23):10830\u201337. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0880.","journal-title":"Cancer Res"},{"issue":"1","key":"8661_CR317","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.cgt.7700755","volume":"12","author":"S-H Son","year":"2005","unstructured":"Son S-H, Yu E, Choi EK, Lee H, Choi J. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells. Cancer Gene Ther. 2005;12(1):1\u201311. https:\/\/doi.org\/10.1038\/sj.cgt.7700755.","journal-title":"Cancer Gene Ther"},{"issue":"10","key":"8661_CR318","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/35036365","volume":"2","author":"A Guo","year":"2000","unstructured":"Guo A, Salomoni P, Luo J, Shih A, Zhong S, Gu W, et al. The function of PML in p53-dependent apoptosis. Nat Cell Biol. 2000;2(10):730\u201336. https:\/\/doi.org\/10.1038\/35036365.","journal-title":"Nat Cell Biol"},{"issue":"7","key":"8661_CR319","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3727\/096504010X12626118079868","volume":"18","author":"L Cui","year":"2009","unstructured":"Cui L, Zhang S, Zhang W, Hu Z, Cao Z, Li T. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line. Oncol Res. 2009;18(7):305\u201314. https:\/\/doi.org\/10.3727\/096504010X12626118079868.","journal-title":"Oncol Res"},{"key":"8661_CR320","doi-asserted-by":"publisher","unstructured":"Herzer K, Carbow A, Sydor S, Sowa J-P, Biesterfeld S, Hofmann T-G, et al. Deficiency of the promyelocytic leukemia protein fosters hepatitis C-Associated hepatocarcinogenesis in mice. PLoS ONE. 2012;7(9):e44474. https:\/\/doi.org\/10.1371\/journal.pone.0044474.","DOI":"10.1371\/journal.pone.0044474"},{"issue":"3","key":"8661_CR321","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1158\/0008-5472.CAN-08-2831","volume":"69","author":"K Herzer","year":"2009","unstructured":"Herzer K, Hofmann TG, Teufel A, Schimanski CC, Moehler M, Kanzler S, et al. IFN-\u03b1\u2013Induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53. Cancer Res. 2009;69(3):855\u201362. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-2831.","journal-title":"Cancer Res"},{"issue":"18","key":"8661_CR322","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1097\/CM9.0000000000002792","volume":"136","author":"Y Tie","year":"2023","unstructured":"Tie Y, Chen M, Zhang S. Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease. Chin Med J. 2023;136(18):2143\u201346. https:\/\/doi.org\/10.1097\/CM9.0000000000002792.","journal-title":"Chin Med J"},{"issue":"4","key":"8661_CR323","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1080\/15548627.2024.2435236","volume":"21","author":"J Mo","year":"2025","unstructured":"Mo J, Su C, Li P, Yang Z, Tao R, Liu Q, et al. CKAP4 in hepatocellular carcinoma: competitive RETREG1\/FAM134B binding, reticulophagy regulation, and cancer progression. Autophagy. 2025;21(4):840\u201359. https:\/\/doi.org\/10.1080\/15548627.2024.2435236.","journal-title":"Autophagy"},{"key":"8661_CR324","doi-asserted-by":"publisher","unstructured":"Zhan P, Cheng Y, Wu Y, Lu J, Wen J, Chi X, et al. METTL21A promotes hepatocellular carcinoma progression via methylating and stabilizing BAG3. npj Precis. Onc. 2025;9(1). https:\/\/doi.org\/10.1038\/s41698-025-01021-5.","DOI":"10.1038\/s41698-025-01021-5"},{"key":"8661_CR325","doi-asserted-by":"publisher","unstructured":"Feng X, Jiang T, Yang C, Pang S, Ding Z, Hu H, et al. RPRD1A stabilizes NRF2 and aggravates HCC progression through competing with p62 for TRIM21 binding. Cell Death Dis. 2021;13(1). https:\/\/doi.org\/10.1038\/s41419-021-04447-4.","DOI":"10.1038\/s41419-021-04447-4"},{"issue":"16","key":"8661_CR326","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41388-025-03274-7","volume":"44","author":"N Sha","year":"2025","unstructured":"Sha N, Zhou B, Hou G, Xi Z, Wang W, Yan M, et al. The protection of UCK2 protein stability by GART maintains pyrimidine salvage synthesis for HCC growth under glucose limitation. Oncogene. 2025;44(16):1078\u201392. https:\/\/doi.org\/10.1038\/s41388-025-03274-7.","journal-title":"Oncogene"},{"issue":"5","key":"8661_CR327","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1097\/HEP.0000000000000268","volume":"78","author":"F Liu","year":"2023","unstructured":"Liu F, Liao Z, Qin L, Zhang Z, Zhang Q, Han S, et al. Targeting VPS72 inhibits ACTL6A\/MYC axis activity in HCC progression. Hepatology. 2023;78(5):1384\u2013401. https:\/\/doi.org\/10.1097\/HEP.0000000000000268.","journal-title":"Hepatology"},{"issue":"3","key":"8661_CR328","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13402-023-00780-2","volume":"46","author":"K Rao","year":"2023","unstructured":"Rao K, Zheng K, Zhao Q, He J, Zhou B, Hou G, et al. The negative effect of G1958A polymorphism on MTHFD1 protein stability and HCC growth. Cell Oncol. 2023;46(3):735\u201344. https:\/\/doi.org\/10.1007\/s13402-023-00780-2.","journal-title":"Cell Oncol"},{"key":"8661_CR329","doi-asserted-by":"publisher","unstructured":"Hu X, Chen G, Huang Y, Cheng Q, Zhuo J, Su R, et al. Integrated Multiomics reveals silencing of has_circ_0006646 promotes TRIM21-mediated NCL ubiquitination to inhibit hepatocellular carcinoma metastasis. Adv Sci. 2024;11(16). https:\/\/doi.org\/10.1002\/advs.202306915.","DOI":"10.1002\/advs.202306915"},{"issue":"11","key":"8661_CR330","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1038\/s41388-020-1156-0","volume":"39","author":"L Gu","year":"2020","unstructured":"Gu L, Zhu Y, Lin X, Tan X, Lu B, Li Y. Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis. Oncogene. 2020;39(11):2437\u201349. https:\/\/doi.org\/10.1038\/s41388-020-1156-0.","journal-title":"Oncogene"},{"key":"8661_CR331","doi-asserted-by":"publisher","unstructured":"Bao C, Li Y, Huan L, Zhang Y, Zhao F, Wang Q, et al. NF-\u03baB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1\u03b1. Sci Signal. 2015;8(387):ra75. https:\/\/doi.org\/10.1126\/scisignal.aaa8441.","DOI":"10.1126\/scisignal.aaa8441"},{"key":"8661_CR332","doi-asserted-by":"publisher","first-page":"12945","DOI":"10.2147\/CMAR.S280478","volume":"12","author":"N Bu","year":"2020","unstructured":"Bu N, Dong Z, Zhang L, Zhu W, Wei F, Zheng S. <p>CircPVT1 regulates cell proliferation, apoptosis and glycolysis in hepatocellular carcinoma via miR-377\/TRIM23 axis<\/p>. CMAR. 2020, Volume, 12: 12945\u201356. https:\/\/doi.org\/10.2147\/CMAR.S280478.","journal-title":"CMAR"},{"issue":"2","key":"8661_CR333","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41416-022-01784-9","volume":"127","author":"W Zhao","year":"2022","unstructured":"Zhao W, Mo H, Liu R, Chen T, Yang N, Liu Z. Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression. Br J Cancer. 2022;127(2):202\u201310. https:\/\/doi.org\/10.1038\/s41416-022-01784-9.","journal-title":"Br J Cancer"},{"issue":"2","key":"8661_CR334","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.yexcr.2018.04.006","volume":"367","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Zhao L, Shi K, Huang Z, Chen B. TRIM24 promotes hepatocellular carcinoma progression via AMPK signaling. Exp Cell Res. 2018;367(2):274\u201381. https:\/\/doi.org\/10.1016\/j.yexcr.2018.04.006.","journal-title":"Exp Cell Res"},{"issue":"38","key":"8661_CR335","doi-asserted-by":"publisher","first-page":"33369","DOI":"10.1074\/jbc.M111.225680","volume":"286","author":"J Tisserand","year":"2011","unstructured":"Tisserand J, Khetchoumian K, Thibault C, Demb\u00e9l\u00e9 D, Chambon P, Losson R. Tripartite motif 24 (Trim24\/Tif1\u03b1) tumor suppressor protein is a novel negative regulator of interferon (Ifn)\/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor \u03b1 (Rar\u03b1) inhibition. J Biol Chem. 2011;286(38):33369\u201379. https:\/\/doi.org\/10.1074\/jbc.M111.225680.","journal-title":"J Biol Chem"},{"issue":"12","key":"8661_CR336","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/ng.2007.15","volume":"39","author":"K Khetchoumian","year":"2007","unstructured":"Khetchoumian K, Teletin M, Tisserand J, Mark M, Herquel B, Ignat M, et al. Loss of Trim24 (Tif1\u03b1) gene function confers oncogenic activity to retinoic acid receptor alpha. Nat Genet. 2007;39(12):1500\u201306. https:\/\/doi.org\/10.1038\/ng.2007.15.","journal-title":"Nat Genet"},{"issue":"2","key":"8661_CR337","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jhep.2014.09.026","volume":"62","author":"S Jiang","year":"2015","unstructured":"Jiang S, Minter LC, Stratton SA, Yang P, Abbas HA, Akdemir ZC, et al. TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice. J Hepatol. 2015;62(2):371\u201379. https:\/\/doi.org\/10.1016\/j.jhep.2014.09.026.","journal-title":"J Hepatol"},{"key":"8661_CR338","doi-asserted-by":"publisher","unstructured":"Ignat M, Akladios CY, Lindner V, Khetchoumian K, Teletin M, Muttter D, et al. Development of a methodology for in vivo follow-up of hepatocellular carcinoma in hepatocyte specific Trim24-null mice treated with myo-inositol trispyrophosphate. J Exp Clin Cancer Res. 2016;35(1). https:\/\/doi.org\/10.1186\/s13046-016-0434-8.","DOI":"10.1186\/s13046-016-0434-8"},{"issue":"2","key":"8661_CR339","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41418-019-0363-0","volume":"27","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Li X, Cui K, Liu C, Wu M, Prochownik EV, et al. The MAP3K13-TRIM25-FBXW7\u03b1 axis affects c-myc protein stability and tumor development. Cell Death Differ. 2020;27(2):420\u201333. https:\/\/doi.org\/10.1038\/s41418-019-0363-0.","journal-title":"Cell Death Differ"},{"issue":"6","key":"8661_CR340","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41416-022-02115-8","volume":"128","author":"H You","year":"2023","unstructured":"You H, Zhang N, Yu T, Ma L, Li Q, Wang X, et al. Hepatitis B virus X protein promotes MAN1B1 expression by enhancing stability of GRP78 via TRIM25 to facilitate hepatocarcinogenesis. Br J Cancer. 2023;128(6):992\u20131004. https:\/\/doi.org\/10.1038\/s41416-022-02115-8.","journal-title":"Br J Cancer"},{"key":"8661_CR341","doi-asserted-by":"publisher","unstructured":"Wang J, Yin G, Bian H, Yang J, Zhou P, Yan K, et al. LncRNA XIST upregulates TRIM25 via negatively regulating miR-192 in hepatitis B virus-related hepatocellular carcinoma. Mol Med. 2021;27(1). https:\/\/doi.org\/10.1186\/s10020-021-00278-3.","DOI":"10.1186\/s10020-021-00278-3"},{"key":"8661_CR342","doi-asserted-by":"publisher","unstructured":"Zhang W, Zhu L, Yang G, Zhou B, Wang J, Qu X, et al. Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p. Biosci Rep. 2020;40(7). https:\/\/doi.org\/10.1042\/BSR20191418.","DOI":"10.1042\/BSR20191418"},{"key":"8661_CR343","doi-asserted-by":"publisher","unstructured":"Ye Y, Zhang X, Wang C, Huang Y, Xu L, Liu H, et al. DAPK enhances DDX20 protein stability via suppression of TRIM25-mediated ubiquitination-based DDX20 degradation. Cancer Cell Int. 2024;24(1). https:\/\/doi.org\/10.1186\/s12935-024-03567-z.","DOI":"10.1186\/s12935-024-03567-z"},{"issue":"1","key":"8661_CR344","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.yexcr.2018.08.018","volume":"371","author":"Y-H Li","year":"2018","unstructured":"Li Y-H, Zhong M, Zang H-L, Tian X-F. Mechanism of TRIM25 mediated ubiquitination of metastasis associated protein (MTA) 1 in normal liver cells. Exp Cell Res. 2018;371(1):250\u201354. https:\/\/doi.org\/10.1016\/j.yexcr.2018.08.018.","journal-title":"Exp Cell Res"},{"issue":"10","key":"8661_CR345","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/iub.1661","volume":"69","author":"H-L Zang","year":"2017","unstructured":"Zang H-L, Ren S-N, Cao H, Tian X-F. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein. IUBMB Life. 2017;69(10):795\u2013801. https:\/\/doi.org\/10.1002\/iub.1661.","journal-title":"IUBMB Life"},{"key":"8661_CR346","doi-asserted-by":"publisher","unstructured":"Kong F, Bao E, Zhong Y, Wang Y, Liu R, Zhang H, et al. HBV core protein enhances WDR46 stabilization to upregulate NUSAP1 and promote HCC progression. Hepatol Commun. 2025;9(6). https:\/\/doi.org\/10.1097\/HC9.0000000000000680.","DOI":"10.1097\/HC9.0000000000000680"},{"key":"8661_CR347","doi-asserted-by":"publisher","unstructured":"Zhang H, Liu Y, Wang W, Liu F, Wang W, Su C, et al. ALKBH5-mediated m6A modification of lincRNA LINC02551 enhances the stability of DDX24 to promote hepatocellular carcinoma growth and metastasis. Cell Death Dis. 2022;13(11). https:\/\/doi.org\/10.1038\/s41419-022-05386-4.","DOI":"10.1038\/s41419-022-05386-4"},{"issue":"6","key":"8661_CR348","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.bj.2021.12.009","volume":"45","author":"Y Mao","year":"2022","unstructured":"Mao Y, Ding Z, Jiang M, Yuan B, Zhang Y, Zhang X. Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136-5p\/TRIM27. Biomed J. 2022;45(6):883\u201395. https:\/\/doi.org\/10.1016\/j.bj.2021.12.009.","journal-title":"Biomed J"},{"key":"8661_CR349","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fgene.2019.01274","volume":"10","author":"D Gao","year":"2019","unstructured":"Gao D, Zhou Z, Huang H. miR-30b-3p inhibits proliferation and invasion of hepatocellular carcinoma cells via suppressing PI3K\/Akt pathway. Front Genet. 2019;10:10. https:\/\/doi.org\/10.3389\/fgene.2019.01274.","journal-title":"Front Genet"},{"key":"8661_CR350","doi-asserted-by":"publisher","unstructured":"Jin X, Pan Y, Wang L, Zhang L, Ravichandran R, Potts PR, et al. MAGE-TRIM28 complex promotes the warburg effect and hepatocellular carcinoma progression by targeting FBP1 for degradation. Oncogenesis. 2017;6(4):e312\u2013e. https:\/\/doi.org\/10.1038\/oncsis.2017.21.","DOI":"10.1038\/oncsis.2017.21"},{"key":"8661_CR351","doi-asserted-by":"publisher","unstructured":"Zhu Y, Li J, Li S, Yang Z, Qiao Z, Gu X, et al. ZMAT2 condensates regulate the alternative splicing of TRIM28 to reduce cellular ROS accumulation, thereby promoting the proliferation of HCC cells. Cell Commun Signal. 2024;22(1). https:\/\/doi.org\/10.1186\/s12964-024-01790-9.","DOI":"10.1186\/s12964-024-01790-9"},{"key":"8661_CR352","doi-asserted-by":"publisher","unstructured":"Huang H, Fang Y, Li Z, Qu S, Yuan B, Gan K, et al. SF3B4 regulates proliferation and apoptosis in hepatocellular carcinoma via alternative splicing and interaction with TRIM28 and SETD5. J Transl Med. 2025;23(1). https:\/\/doi.org\/10.1186\/s12967-025-06420-7.","DOI":"10.1186\/s12967-025-06420-7"},{"key":"8661_CR353","doi-asserted-by":"publisher","unstructured":"Liu J, Zhang N, Zeng J, Wang T, Shen Y, Ma C, et al. N6-methyladenosine-modified lncRNA ARHGAP5-AS1 stabilises CSDE1 and coordinates oncogenic RNA regulons in hepatocellular carcinoma. Clin Transl Med. 2022;12(11). https:\/\/doi.org\/10.1002\/ctm2.1107.","DOI":"10.1002\/ctm2.1107"},{"key":"8661_CR354","doi-asserted-by":"publisher","unstructured":"Zhang R-Y, Liu Z-K, Wei D, Yong Y-L, Lin P, Li H, et al. UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development. Sig Transduct Target Ther. 2021;6(1). https:\/\/doi.org\/10.1038\/s41392-020-00432-z.","DOI":"10.1038\/s41392-020-00432-z"},{"key":"8661_CR355","doi-asserted-by":"publisher","unstructured":"Zhang J, Fan X, Liao L, Zhu Y, Wan X, Rao H, et al. TRIM28 attenuates bortezomib sensitivity of hepatocellular carcinoma cells through enhanced proteasome expression. Clin Transl Med. 2022;12(1). https:\/\/doi.org\/10.1002\/ctm2.603.","DOI":"10.1002\/ctm2.603"},{"issue":"9","key":"8661_CR356","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.3390\/ijms26093933","volume":"26","author":"S Butey","year":"2025","unstructured":"Butey S, Brown ML, Julson JR, Marayati R, Atigadda VR, Shaikh MG, et al. A novel rexinoid agonist, UAB116, decreases metastatic phenotype in Hepatoblastoma by inhibiting the Wnt\/\u03b2-catenin pathway via upregulation of TRIM29. IJMS. 2025;26(9):3933. https:\/\/doi.org\/10.3390\/ijms26093933.","journal-title":"IJMS"},{"issue":"20","key":"8661_CR357","doi-asserted-by":"publisher","first-page":"6400","DOI":"10.1111\/febs.16531","volume":"289","author":"R Wang","year":"2022","unstructured":"Wang R, Fu Y, Yao M, Cui X, Zhao Y, Lu X, et al. The HN1\/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin. The FEBS J. 2022;289(20):6400\u201319. https:\/\/doi.org\/10.1111\/febs.16531.","journal-title":"The FEBS J"},{"key":"8661_CR358","doi-asserted-by":"publisher","unstructured":"Zhao L, Su H, Liu X, Wang H, Feng Y, Wang Y, et al. mTORC1-c-myc pathway rewires methionine metabolism for HCC progression through suppressing SIRT4 mediated ADP ribosylation of MAT2A. Cell Biosci. 2022;12(1). https:\/\/doi.org\/10.1186\/s13578-022-00919-y.","DOI":"10.1186\/s13578-022-00919-y"},{"issue":"30","key":"8661_CR359","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1038\/onc.2014.325","volume":"34","author":"Z Chen","year":"2015","unstructured":"Chen Z, Wang Z, Guo W, Zhang Z, Zhao F, Zhao Y, et al. TRIM35 interacts with pyruvate kinase isoform M2 to suppress the warburg effect and tumorigenicity in hepatocellular carcinoma. Oncogene. 2015;34(30):3946\u201356. https:\/\/doi.org\/10.1038\/onc.2014.325.","journal-title":"Oncogene"},{"key":"8661_CR360","doi-asserted-by":"publisher","unstructured":"Ding Y, Luan W, Wang Z, Xie B, Sun C. HBO regulates the warburg effect of hypoxic HCC cells through miR-103a-3p\/TRIM35. Discov Onc. 2024;15(1). https:\/\/doi.org\/10.1007\/s12672-024-00985-3.","DOI":"10.1007\/s12672-024-00985-3"},{"issue":"8\u20139","key":"8661_CR361","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/1751-2980.13218","volume":"24","author":"Y Fang","year":"2023","unstructured":"Fang Y, Lu ZH, Liu BZ, Li N, Yang MZ, Wang P. IRF5 promotes glycolysis in the progression of hepatocellular carcinoma and is regulated by TRIM35. J Dig Dis. 2023;24(8\u20139):480\u201390. https:\/\/doi.org\/10.1111\/1751-2980.13218.","journal-title":"J Dig Dis"},{"key":"8661_CR362","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.canlet.2020.11.038","volume":"499","author":"X Jiang","year":"2021","unstructured":"Jiang X, Wang G, Liu Y, Mei C, Yao Y, Wu X, et al. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4. Cancer Lett. 2021;499:109\u201321. https:\/\/doi.org\/10.1016\/j.canlet.2020.11.038.","journal-title":"Cancer Lett"},{"issue":"4","key":"8661_CR363","doi-asserted-by":"publisher","first-page":"608","DOI":"10.14218\/JCTH.2021.00301","volume":"10","author":"H Yan","year":"2022","unstructured":"Yan H, Ma X, Mi Z, He Z, Rong P. Extracellular polysaccharide from Rhizopus nigricans inhibits hepatocellular carcinoma via miR-494-3p\/TRIM36 Axis and cyclin E ubiquitination. J Clin Transl Hepatol. 2022;10(4):608\u201319. https:\/\/doi.org\/10.14218\/JCTH.2021.00301.","journal-title":"J Clin Transl Hepatol"},{"key":"8661_CR364","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cellsig.2025.111919","volume":"134","author":"H Zhang","year":"2025","unstructured":"Zhang H, He X, Yang L, Yang F, Chen R, Wen Z, et al. Trim45: An emerging E3 ubiquitin ligases in cancer. Cellular Signalling. 2025;134:134. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111919.","journal-title":"Cellular Signalling"},{"issue":"1","key":"8661_CR365","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/15384047.2021.2004835","volume":"23","author":"T Guo","year":"2022","unstructured":"Guo T, Zhang Z, Zhu L, Chen W, Ding Y, Li W, et al. TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1. Cancer Biol Ther. 2022;23(1):17\u201326. https:\/\/doi.org\/10.1080\/15384047.2021.2004835.","journal-title":"Cancer Biol Ther"},{"key":"8661_CR366","doi-asserted-by":"publisher","unstructured":"Peng Y, Yu J, Liu F, Tang L, Li B, Zhang W, et al. Accumulation of TOX high mobility group box family member 3 promotes the oncogenesis and development of hepatocellular carcinoma through the MAPK signaling pathway. MedComm. 2024;5(3). https:\/\/doi.org\/10.1002\/mco2.510.","DOI":"10.1002\/mco2.510"},{"issue":"6","key":"8661_CR367","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.cmet.2023.03.017","volume":"35","author":"Q Li","year":"2023","unstructured":"Li Q, Zhang L, Yang Q, Li M, Pan X, Xu J, et al. Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners. Cell MetabCell Metab. 2023;35(6):912\u201327.e7. https:\/\/doi.org\/10.1016\/j.cmet.2023.03.017.","journal-title":"Cell MetabCell Metab"},{"key":"8661_CR368","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.12659\/MSM.907242","volume":"23","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Wu S-S, Chen X-H, Tang Z-H, Yu Y-S, Zang G-Q. Tripartite motif containing 52 (TRIM52) promotes cell proliferation in hepatitis B virus-associated hepatocellular carcinoma. Med Sci Monit. 2017;23:5202\u201310. https:\/\/doi.org\/10.12659\/MSM.907242.","journal-title":"Med Sci Monit"},{"issue":"11","key":"8661_CR369","doi-asserted-by":"publisher","first-page":"674","DOI":"10.31083\/ph.2017.7659","volume":"72","author":"G Sun","year":"2017","unstructured":"Sun G, Sui X, Han D, Gao J, Liu Y, Zhou L. TRIM59 promotes cell proliferation, migration and invasion in human hepatocellular carcinoma cells. Pharmazie. 2017;72(11):674\u201379. https:\/\/doi.org\/10.31083\/ph.2017.7659.","journal-title":"Pharmazie"},{"issue":"6","key":"8661_CR370","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.2741\/4849","volume":"25","author":"C Xu","year":"2020","unstructured":"Xu C. miR-4698-Trim59 axis plays a suppressive role in hepatocellular carcinoma. Front Biosci (Landmark Ed). 2020;25(6):1120\u201331. https:\/\/doi.org\/10.2741\/4849.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"3","key":"8661_CR371","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/path.4130","volume":"229","author":"YL Chen","year":"2013","unstructured":"Chen YL, Yuan RH, Yang WC, Hsu HC, Jeng YM. The stem cell E3-ligase lin-41 promotes liver cancer progression through inhibition of microRNA-mediated gene silencing. The J Pathol. 2013;229(3):486\u201396. https:\/\/doi.org\/10.1002\/path.4130.","journal-title":"The J Pathol"},{"issue":"6","key":"8661_CR372","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/mc.23526","volume":"62","author":"L Fan","year":"2023","unstructured":"Fan L, Xia P, Wang J, Xu S, Qiu Z, Wu Y, et al. Circ_0007429\/miR-637\/TRIM71\/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC. Mol CarcinogMolecular Carcinog. 2023;62(6):820\u201332. https:\/\/doi.org\/10.1002\/mc.23526.","journal-title":"Mol CarcinogMolecular Carcinog"},{"key":"8661_CR373","doi-asserted-by":"publisher","unstructured":"Chang JJ-S, Lin T, Jhang X-Y, Chan S-P, Chan S-P. hnRNP Q\/SYNCRIP interacts with LIN28B and modulates the LIN28B\/let-7 axis in human hepatoma cells. PLoS ONE. 2024;19(7):e0304947. https:\/\/doi.org\/10.1371\/journal.pone.0304947.","DOI":"10.1371\/journal.pone.0304947"},{"issue":"5","key":"8661_CR374","doi-asserted-by":"publisher","first-page":"167183","DOI":"10.1016\/j.bbadis.2024.167183","volume":"1870","author":"H Cai","year":"2024","unstructured":"Cai H, Zhao J, Zhang Q, Wu H, Sun Y, Guo F, et al. Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis. Biochim Et Biophys Acta (BBA) - Mol Basis Disease. 2024;1870(5):167183. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167183.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"11","key":"8661_CR375","doi-asserted-by":"publisher","first-page":"12447","DOI":"10.1096\/fj.201901091R","volume":"33","author":"M Swayden","year":"2019","unstructured":"Swayden M, Alzeeb G, Masoud R, Berthois Y, Audebert S, Camoin L, et al. PML hyposumoylation is responsible for the resistance of pancreatic cancer. Faseb J. 2019;33(11):12447\u201363. https:\/\/doi.org\/10.1096\/fj.201901091R.","journal-title":"Faseb J"},{"issue":"6","key":"8661_CR376","doi-asserted-by":"publisher","first-page":"111623","DOI":"10.1016\/j.celrep.2022.111623","volume":"41","author":"G Ramakrishnan","year":"2022","unstructured":"Ramakrishnan G, Parajuli P, Singh P, Friend C, Hurwitz E, Prunier C, et al. NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. Cell Rep. 2022;41(6):111623. https:\/\/doi.org\/10.1016\/j.celrep.2022.111623.","journal-title":"Cell Rep"},{"key":"8661_CR377","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.canlet.2023.216288","volume":"568","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Kong R, Yang W, Hu K, Zhao Z, Li L, et al. DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer. Cancer Lett. 2023;568:568. https:\/\/doi.org\/10.1016\/j.canlet.2023.216288.","journal-title":"Cancer Lett"},{"issue":"1","key":"8661_CR378","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/15384047.2016.1252880","volume":"18","author":"JQ Nguyen","year":"2017","unstructured":"Nguyen JQ, Irby RB. TRIM21 is a novel regulator of par-4 in colon and pancreatic cancer cells. Cancer Biol Ther. 2017;18(1):16\u201325. https:\/\/doi.org\/10.1080\/15384047.2016.1252880.","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"8661_CR379","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41388-019-0992-2","volume":"39","author":"J Sun","year":"2020","unstructured":"Sun J, Yan J, Qiao H-Y, Zhao F-Y, Li C, Jiang J-Y, et al. Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation. Oncogene. 2020;39(3):546\u201359. https:\/\/doi.org\/10.1038\/s41388-019-0992-2.","journal-title":"Oncogene"},{"key":"8661_CR380","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fonc.2025.1616968","volume":"15","author":"R Cheng","year":"2025","unstructured":"Cheng R, Tang Y, Cao X, Huang Z, Guo Y, Jin R, et al. Hypoxia promotes pancreatic adenocarcinoma progression by stabilizing ID1 via TRIM21 suppression. Front Oncol. 2025;15:15. https:\/\/doi.org\/10.3389\/fonc.2025.1616968.","journal-title":"Front Oncol"},{"key":"8661_CR381","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.canlet.2024.216733","volume":"587","author":"J Yuan","year":"2024","unstructured":"Yuan J, Zhu Z, Zhang P, Ashrafizadeh M, Abd El-Aty AM, Hac\u0131m\u00fcft\u00fco\u011flu A, et al. SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation. Cancer Lett. 2024;587:587. https:\/\/doi.org\/10.1016\/j.canlet.2024.216733.","journal-title":"Cancer Lett"},{"issue":"2","key":"8661_CR382","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41556-019-0455-6","volume":"22","author":"J-T Li","year":"2020","unstructured":"Li J-T, Yin M, Wang D, Wang J, Lei M-Z, Zhang Y, et al. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma. Nat Cell Biol. 2020;22(2):167\u201374. https:\/\/doi.org\/10.1038\/s41556-019-0455-6.","journal-title":"Nat Cell Biol"},{"key":"8661_CR383","doi-asserted-by":"publisher","unstructured":"Wang B, Fan P, Zhao J, Wu H, Jin X, Wu H. FBP1 loss contributes to BET inhibitors resistance by undermining c-myc expression in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2018;37(1). https:\/\/doi.org\/10.1186\/s13046-018-0888-y.","DOI":"10.1186\/s13046-018-0888-y"},{"key":"8661_CR384","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.omtn.2021.01.027","volume":"24","author":"L Hao","year":"2021","unstructured":"Hao L, Zhang Q, Qiao H-Y, Zhao F-Y, Jiang J-Y, Huyan L-Y, et al. TRIM29 alters bioenergetics of pancreatic cancer cells via cooperation of miR-2355-3p and DDX3X recruitment to AK4 transcript. Mol Ther Nucleic Acids. 2021;24:579\u201390. https:\/\/doi.org\/10.1016\/j.omtn.2021.01.027.","journal-title":"Mol Ther Nucleic Acids"},{"key":"8661_CR385","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.biopha.2018.04.101","volume":"103","author":"F Li","year":"2018","unstructured":"Li F, Liang J, Bai L. MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression. Biomed Pharmacother. 2018;103:782\u201389. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.101.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"8661_CR386","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ccr.2009.01.018","volume":"15","author":"L Wang","year":"2009","unstructured":"Wang L, Heidt DG, Lee CJ, Yang H, Logsdon CD, Zhang L, et al. Oncogenic function of ATDC in pancreatic cancer through wnt pathway activation and \u03b2-Catenin stabilization. Cancer Cell. 2009;15(3):207\u201319. https:\/\/doi.org\/10.1016\/j.ccr.2009.01.018.","journal-title":"Cancer Cell"},{"issue":"2","key":"8661_CR387","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1053\/j.gastro.2024.01.051","volume":"167","author":"J-J Escuder-Rodr\u00edguez","year":"2024","unstructured":"Escuder-Rodr\u00edguez J-J, Liang D, Jiang X, Sinicrope FA. Ferroptosis: biology and role in gastrointestinal disease. Gastroenterology. 2024;167(2):231\u201349. https:\/\/doi.org\/10.1053\/j.gastro.2024.01.051.","journal-title":"Gastroenterology"},{"issue":"8","key":"8661_CR388","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s12276-023-01077-y","volume":"55","author":"JW Kim","year":"2023","unstructured":"Kim JW, Lee J-Y, Oh M, Lee E-W. An integrated view of lipid metabolism in ferroptosis revisited via lipidomic analysis. Exp Mol Med. 2023;55(8):1620\u201331. https:\/\/doi.org\/10.1038\/s12276-023-01077-y.","journal-title":"Exp Mol Med"},{"key":"8661_CR389","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cellsig.2024.111268","volume":"121","author":"W Ji","year":"2024","unstructured":"Ji W, Zhang W, Zhang X, Ke Y. TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis. Cellular Signalling. 2024;121:121. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111268.","journal-title":"Cellular Signalling"},{"issue":"11","key":"8661_CR390","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1007\/s12094-023-03193-7","volume":"25","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Ye B, Lin Y, Liu W, Deng J, Ji W. LncRNA OTUD6B-AS1 overexpression promoted GPX4-mediated ferroptosis to suppress radioresistance in colorectal cancer. Clin Transl Oncol. 2023;25(11):3217\u201329. https:\/\/doi.org\/10.1007\/s12094-023-03193-7.","journal-title":"Clin Transl Oncol"},{"key":"8661_CR391","doi-asserted-by":"publisher","unstructured":"Fan X, Dai Y, Mo C, Li H, Luan X, Wang B, et al. TRIM21 promotes tumor growth and gemcitabine resistance in pancreatic cancer by inhibiting EPHX1-mediated arachidonic acid metabolism. Adv Sci. 2025;12(8). https:\/\/doi.org\/10.1002\/advs.202413674.","DOI":"10.1002\/advs.202413674"},{"key":"8661_CR392","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.canlet.2024.217004","volume":"596","author":"Y Bian","year":"2024","unstructured":"Bian Y, Xu S, Gao Z, Ding J, Li C, Cui Z, et al. m6A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21\/IGF2BP2\/ FOXM1 positive feedback loop. Cancer Lett. 2024;596:596. https:\/\/doi.org\/10.1016\/j.canlet.2024.217004.","journal-title":"Cancer Lett"},{"key":"8661_CR393","doi-asserted-by":"publisher","unstructured":"Liu X, Yan C, Chang C, Meng F, Shen W, Wang S, et al. FOXA2 suppression by TRIM36 exerts anti-tumor role in colorectal cancer via inducing NRF2\/GPX4-regulated ferroptosis. Adv Sci. 2023;10(35). https:\/\/doi.org\/10.1002\/advs.202304521.","DOI":"10.1002\/advs.202304521"},{"issue":"8","key":"8661_CR394","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.14670\/HH-18-856","volume":"40","author":"W Wang","year":"2025","unstructured":"Wang W, Chen X, Wei W. TRIM22 mechanism promoting KAT2A ubiquitination degradation to regulate ferroptosis in hepatocellular carcinoma cell invasion and metastasis. Histol Histopathol. 2025;40(8):1295\u2013307. https:\/\/doi.org\/10.14670\/HH-18-856.","journal-title":"Histol Histopathol"},{"key":"8661_CR395","doi-asserted-by":"publisher","unstructured":"Yue X, Xiang Z, Yi Y, Wang X, Zhou W, Wu W, et al. Targeting the TRIM14\/USP14 axis enhances radiotherapy efficacy by inducing GPX4 degradation and disrupting ferroptotic defense in HCC. Cell Death Dis. 2025;16(1). https:\/\/doi.org\/10.1038\/s41419-025-07807-6.","DOI":"10.1038\/s41419-025-07807-6"},{"key":"8661_CR396","doi-asserted-by":"publisher","unstructured":"Yang H, Li Q, Chen X, Weng M, Huang Y, Chen Q, et al. Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer. Nat Commun. 2024;15(1). https:\/\/doi.org\/10.1038\/s41467-024-48307-z.","DOI":"10.1038\/s41467-024-48307-z"},{"key":"8661_CR397","doi-asserted-by":"publisher","unstructured":"Mao W, Jiang Q, Feng Y, Peng C, Peng H, Li X, et al. TRIM21-mediated METTL3 degradation promotes PDAC ferroptosis and enhances the efficacy of anti-PD-1 immunotherapy. Cell Death Dis. 2025;16(1). https:\/\/doi.org\/10.1038\/s41419-025-07550-y.","DOI":"10.1038\/s41419-025-07550-y"},{"key":"8661_CR398","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.canlet.2025.217726","volume":"623","author":"H Zhang","year":"2025","unstructured":"Zhang H, Ma T, Wen X, Jiang J, Chen J, Jiang J, et al. SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis. Cancer Lett. 2025;623:623. https:\/\/doi.org\/10.1016\/j.canlet.2025.217726.","journal-title":"Cancer Lett"},{"key":"8661_CR399","doi-asserted-by":"publisher","unstructured":"Liu M-R, Shi C, Song Q-Y, Kang M-J, Jiang X, Liu H, et al. Sorafenib induces ferroptosis by promoting TRIM54-mediated FSP1 ubiquitination and degradation in hepatocellular carcinoma. Hepatol Commun. 2023;7(10). https:\/\/doi.org\/10.1097\/HC9.0000000000000246.","DOI":"10.1097\/HC9.0000000000000246"},{"key":"8661_CR400","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.redox.2022.102546","volume":"58","author":"J Yuan","year":"2022","unstructured":"Yuan J, Lv T, Yang J, Wu Z, Yan L, Yang J, et al. HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma. Redox Biol. 2022;58:58. https:\/\/doi.org\/10.1016\/j.redox.2022.102546.","journal-title":"Redox Biol"},{"key":"8661_CR401","doi-asserted-by":"publisher","unstructured":"Gong J, Liu Y, Wang W, He R, Xia Q, Chen L, et al. TRIM21-promoted FSP1 plasma membrane translocation confers ferroptosis resistance in human cancers. Adv Sci. 2023;10(29). https:\/\/doi.org\/10.1002\/advs.202302318.","DOI":"10.1002\/advs.202302318"},{"key":"8661_CR402","doi-asserted-by":"publisher","first-page":"217285","DOI":"10.1016\/j.canlet.2024.217285","volume":"605","author":"JM Pimentel","year":"2024","unstructured":"Pimentel JM, Zhou JY, Wu GS. Autophagy and cancer therapy. Cancer Lett. 2024;605:217285. https:\/\/doi.org\/10.1016\/j.canlet.2024.217285.","journal-title":"Cancer Lett"},{"key":"8661_CR403","doi-asserted-by":"publisher","unstructured":"Guo JY, White E. Role of tumor cell intrinsic and Host autophagy in cancer. Cold Spring Harb Perspect Med. 2024;14(7):a041539. https:\/\/doi.org\/10.1101\/cshperspect.a041539.","DOI":"10.1101\/cshperspect.a041539"},{"key":"8661_CR404","doi-asserted-by":"publisher","first-page":"216857","DOI":"10.1016\/j.canlet.2024.216857","volume":"591","author":"W Wen","year":"2024","unstructured":"Wen W, Ertas YN, Erdem A, Zhang Y. Dysregulation of autophagy in gastric carcinoma: pathways to tumor progression and resistance to therapy. Cancer Lett. 2024;591:216857. https:\/\/doi.org\/10.1016\/j.canlet.2024.216857.","journal-title":"Cancer Lett"},{"issue":"7182","key":"8661_CR405","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature06639","volume":"451","author":"N Mizushima","year":"2008","unstructured":"Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008;451(7182):1069\u201375. https:\/\/doi.org\/10.1038\/nature06639.","journal-title":"Nature"},{"issue":"31","key":"8661_CR406","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.3748\/wjg.v30.i31.3628","volume":"30","author":"D Ramoni","year":"2024","unstructured":"Ramoni D, Carbone F, Montecucco F. Navigating the autophagic landscape: epigenetic modulation in gastrointestinal cancer. World J Gastroenterol. 2024;30(31):3628\u201334. https:\/\/doi.org\/10.3748\/wjg.v30.i31.3628.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"8661_CR407","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.dld.2023.06.010","volume":"56","author":"S Zhu","year":"2024","unstructured":"Zhu S, Mao J, Zhang X, Wang P, Zhou Y, Tong J, et al. CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer. Digestive Liver Disease. 2024;56(2):330\u201342. https:\/\/doi.org\/10.1016\/j.dld.2023.06.010.","journal-title":"Digestive Liver Disease"},{"issue":"5","key":"8661_CR408","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ddr.21650","volume":"81","author":"F Xiao","year":"2020","unstructured":"Xiao F, Ouyang B, Zou J, Yang Y, Yi L, Yan H. Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK\/mTOR pathway. Drug Dev Res. 2020;81(5):544\u201350. https:\/\/doi.org\/10.1002\/ddr.21650.","journal-title":"Drug Dev Res"},{"key":"8661_CR409","doi-asserted-by":"publisher","unstructured":"Liu Y, Xu Y, Wang F, Tong Y, Li H, Wan X, et al. Inhibition of AMPK activity by TRIM11 facilitates cell survival of hepatocellular carcinoma under metabolic stress. Clin Transl Med. 2021;11(12). https:\/\/doi.org\/10.1002\/ctm2.617.","DOI":"10.1002\/ctm2.617"},{"key":"8661_CR410","doi-asserted-by":"publisher","unstructured":"Li D, Xu L, Liu R, Yao Z, Zheng C, Jin S, et al. MAZ-mediated N6-methyladenosine modification of ZEB1 promotes hepatocellular carcinoma progression by regulating METTL3. J Transl Med. 2025;23(1). https:\/\/doi.org\/10.1186\/s12967-025-06314-8.","DOI":"10.1186\/s12967-025-06314-8"},{"key":"8661_CR411","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.intimp.2025.114733","volume":"156","author":"R Liu","year":"2025","unstructured":"Liu R, Huang Y, Li D, Cui H, Tang Y, Hu Y, et al. Dihydroartemisinin alleviates diethylnitrosamine-induced hepatocarcinogenesis by targeting a novel MAZ\/TRIM50 axis. Int Immunopharmacol. 2025;156:156. https:\/\/doi.org\/10.1016\/j.intimp.2025.114733.","journal-title":"Int Immunopharmacol"},{"key":"8661_CR412","doi-asserted-by":"publisher","unstructured":"Huang Y, Meng F, Zeng T, Thorne RF, He L, Zha Q, et al. IFRD1 promotes tumor cells \u201clow-cost\u201d survival under glutamine starvation via inhibiting histone H1.0 nucleophagy. Cell Discov. 2024;10(1). https:\/\/doi.org\/10.1038\/s41421-024-00668-x.","DOI":"10.1038\/s41421-024-00668-x"},{"key":"8661_CR413","doi-asserted-by":"publisher","unstructured":"Zhao R, He B, Bie Q, Cao J, Lu H, Zhang Z, et al. AQP5 complements LGR5 to determine the fates of gastric cancer stem cells through regulating ULK1 ubiquitination. J Exp Clin Cancer Res. 2022;41(1). https:\/\/doi.org\/10.1186\/s13046-022-02532-w.","DOI":"10.1186\/s13046-022-02532-w"},{"key":"8661_CR414","doi-asserted-by":"publisher","unstructured":"Guo D, Zhou S, Liu R, Yao W, Li S, Zhang X, et al. NEK2 contributes to radioresistance in esophageal squamous cell carcinoma by inducing protective autophagy via regulating TRIM21. Cancer Cell Int. 2024;24(1). https:\/\/doi.org\/10.1186\/s12935-024-03367-5.","DOI":"10.1186\/s12935-024-03367-5"},{"issue":"12","key":"8661_CR415","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1080\/15548627.2023.2239042","volume":"19","author":"K Wang","year":"2023","unstructured":"Wang K, Fu S, Dong L, Zhang D, Wang M, Wu X, et al. Periplocin suppresses the growth of colorectal cancer cells by triggering LGALS3 (galectin 3)-mediated lysophagy. Autophagy. 2023;19(12):3132\u201350. https:\/\/doi.org\/10.1080\/15548627.2023.2239042.","journal-title":"Autophagy"},{"issue":"9","key":"8661_CR416","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/cac2.12464","volume":"43","author":"L He","year":"2023","unstructured":"He L, Li H, Li C, Liu ZK, Lu M, Zhang RY, et al. HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress-driven hepatocellular carcinoma progression. Cancer Commun. 2023;43(9):981\u20131002. https:\/\/doi.org\/10.1002\/cac2.12464.","journal-title":"Cancer Commun"},{"issue":"1","key":"8661_CR417","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13046-025-03567-5","volume":"44","author":"J Weng","year":"2025","unstructured":"Weng J, Ju F, Lyu Z, Fan N, Smit DJ, Xu W, et al. Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers. J Exp Clin Cancer Res. 2025;44(1):314. https:\/\/doi.org\/10.1186\/s13046-025-03567-5.","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"8661_CR418","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","volume":"48","author":"C Sun","year":"2018","unstructured":"Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity. 2018;48(3):434\u201352. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.014.","journal-title":"Immunity"},{"key":"8661_CR419","doi-asserted-by":"publisher","unstructured":"Li Y, Wang Z, Gao P, Cao D, Dong R, Zhu M, et al. CircRHBDD1 promotes immune escape via IGF2BP2\/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. J Transl Med. 2024;22(1). https:\/\/doi.org\/10.1186\/s12967-024-05498-9.","DOI":"10.1186\/s12967-024-05498-9"},{"key":"8661_CR420","doi-asserted-by":"publisher","unstructured":"Ma X, Jia S, Wang G, Liang M, Guo T, Du H, et al. TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance. Sig Transduct Target Ther. 2023;8(1). https:\/\/doi.org\/10.1038\/s41392-023-01450-3.","DOI":"10.1038\/s41392-023-01450-3"},{"issue":"4","key":"8661_CR421","doi-asserted-by":"publisher","first-page":"109533","DOI":"10.1016\/j.isci.2024.109533","volume":"27","author":"R Deng","year":"2024","unstructured":"Deng R, Tian R, Li X, Xu Y, Li Y, Wang X, et al. ISG12a promotes immunotherapy of HBV-associated hepatocellular carcinoma through blocking TRIM21\/AKT\/\u03b2-catenin\/PD-L1 axis. iScience. 2024;27(4):109533. https:\/\/doi.org\/10.1016\/j.isci.2024.109533.","journal-title":"iScience"},{"issue":"6","key":"8661_CR422","doi-asserted-by":"publisher","first-page":"167236","DOI":"10.1016\/j.bbadis.2024.167236","volume":"1870","author":"K Wang","year":"2024","unstructured":"Wang K, Yan L, Qiu X, Chen H, Gao F, Ge W, et al. PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer. Biochim Et Biophys Acta (BBA) - Mol Basis Disease. 2024;1870(6):167236. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167236.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"6121","key":"8661_CR423","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1126\/science.1232458","volume":"339","author":"L Sun","year":"2013","unstructured":"Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013;339(6121):786\u201391. https:\/\/doi.org\/10.1126\/science.1232458.","journal-title":"Science"},{"issue":"9","key":"8661_CR424","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"K-P Hopfner","year":"2020","unstructured":"Hopfner K-P, Hornung V. Molecular mechanisms and cellular functions of cGAS\u2013STING signalling. Nat Rev Mol Cell Biol. 2020;21(9):501\u201321. https:\/\/doi.org\/10.1038\/s41580-020-0244-x.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"23","key":"8661_CR425","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1016\/j.molcel.2024.09.026","volume":"84","author":"S Nishimura","year":"2024","unstructured":"Nishimura S, Linares JF, L\u2019Hermitte A, Duran A, Cid-Diaz T, Martinez-Ordo\u00f1ez A, et al. Opposing regulation of the STING pathway in hepatic stellate cells by NBR1 and p62 determines the progression of hepatocellular carcinoma. Mol Cell. 2024;84(23):4660\u201376.e10. https:\/\/doi.org\/10.1016\/j.molcel.2024.09.026.","journal-title":"Mol Cell"},{"issue":"12","key":"8661_CR426","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1080\/15548627.2025.2551680","volume":"21","author":"T Cai","year":"2025","unstructured":"Cai T, Liang Z, Chen Z, Li Y, Xiao W, Liang W, et al. KDM4A-induced tumor senescence enhances the efficacy of immunotherapy by inhibiting AGT-PHB1 axis-mediated mitophagy in colorectal cancer. Autophagy. 2025;21(12):2982\u20133003. https:\/\/doi.org\/10.1080\/15548627.2025.2551680.","journal-title":"Autophagy"},{"key":"8661_CR427","doi-asserted-by":"publisher","unstructured":"Bian Z, Xu C, Wang X, Zhang B, Xiao Y, Liu L, et al. TRIM65\/NF2\/YAP1 signaling coordinately orchestrates metabolic and immune advantages in hepatocellular carcinoma. Adv Sci. 2024;11(35). https:\/\/doi.org\/10.1002\/advs.202402578.","DOI":"10.1002\/advs.202402578"},{"key":"8661_CR428","doi-asserted-by":"publisher","first-page":"8","DOI":"10.34133\/research.0549","volume":"8","author":"S Meng","year":"2025","unstructured":"Meng S, Liu H, Xu J, Deng C, Qian X, Chu S, et al. PRMT5-mediated ALKBH5 methylation promotes colorectal cancer immune evasion via increasing CD276 expression. Research. 2025;8:8. https:\/\/doi.org\/10.34133\/research.0549.","journal-title":"Research"},{"key":"8661_CR429","doi-asserted-by":"publisher","unstructured":"Kim HJ, Song DE, Lim SY, Lee S-H, Kang JL, Lee SJ, et al. Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes. PLoS ONE. 2011;6(10):e26264. https:\/\/doi.org\/10.1371\/journal.pone.0026264.","DOI":"10.1371\/journal.pone.0026264"},{"issue":"3","key":"8661_CR430","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3390\/ijms23031176","volume":"23","author":"TT Do","year":"2022","unstructured":"Do TT, Yeh C-C, Wu G-W, Hsu C-C, Chang H-C, Chen H-C. TRIM37 promotes pancreatic cancer progression through modulation of cell growth, migration, invasion, and tumor immune microenvironment. IJMS. 2022;23(3):1176. https:\/\/doi.org\/10.3390\/ijms23031176.","journal-title":"IJMS"},{"issue":"1","key":"8661_CR431","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12943-025-02375-x","volume":"24","author":"X Liang","year":"2025","unstructured":"Liang X, Weng J, You Z, Wang Y, Wen J, Xia Z, et al. Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers. Mol Cancer. 2025;24(1):219. https:\/\/doi.org\/10.1186\/s12943-025-02375-x.","journal-title":"Mol Cancer"},{"issue":"9","key":"8661_CR432","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.3390\/ijms22094376","volume":"22","author":"M-Y Song","year":"2021","unstructured":"Song M-Y, Lee D-Y, Chun K-S, Kim E-H. The role of NRF2\/KEAP1 signaling pathway in cancer metabolism. IJMS. 2021;22(9):4376. https:\/\/doi.org\/10.3390\/ijms22094376.","journal-title":"IJMS"},{"issue":"3\u20134","key":"8661_CR433","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1101\/gad.344184.120","volume":"35","author":"V Purohit","year":"2021","unstructured":"Purohit V, Wang L, Yang H, Li J, Ney GM, Gumkowski ER, et al. ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer. Genes Dev. 2021;35(3\u20134):218\u201333. https:\/\/doi.org\/10.1101\/gad.344184.120.","journal-title":"Genes Dev"},{"key":"8661_CR434","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.phymed.2024.156143","volume":"135","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang Y, Wang J, Wang X, Chen L, Han T, et al. Fangchinoline suppresses hepatocellular carcinoma by regulating ROS accumulation via the TRIM7\/Nrf2 signaling pathway. Phytomedicine. 2024;135:135. https:\/\/doi.org\/10.1016\/j.phymed.2024.156143.","journal-title":"Phytomedicine"},{"issue":"5","key":"8661_CR435","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jcmgh.2021.01.007","volume":"11","author":"F Wang","year":"2021","unstructured":"Wang F, Zhang Y, Shen J, Yang B, Dai W, Yan J, et al. The ubiquitin E3 ligase TRIM21 promotes hepatocarcinogenesis by suppressing the p62-Keap1-Nrf2 antioxidant pathway. Cellular Mol Gastroenterol Hepatol. 2021;11(5):1369\u201385. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.01.007.","journal-title":"Cellular Mol Gastroenterol Hepatol"},{"issue":"2","key":"8661_CR436","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/HEP.0000000000000523","volume":"79","author":"H Huang","year":"2024","unstructured":"Huang H, Tsui Y-M, Ho DW-H, Chung CY-S, Sze KM-F, Lee E, et al. LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stress. Hepatology. 2024;79(2):323\u201340. https:\/\/doi.org\/10.1097\/HEP.0000000000000523.","journal-title":"Hepatology"},{"key":"8661_CR437","doi-asserted-by":"publisher","first-page":"107983","DOI":"10.1016\/j.phrs.2025.107983","volume":"221","author":"R Roskoski","year":"2025","unstructured":"Roskoski R. Vascular endothelial cells and angiogenesis. Pharmacological Res. 2025;221:107983. https:\/\/doi.org\/10.1016\/j.phrs.2025.107983.","journal-title":"Pharmacological Res"},{"issue":"1","key":"8661_CR438","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12943-020-01288-1","volume":"20","author":"X Wei","year":"2021","unstructured":"Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, et al. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021;20(1):7. https:\/\/doi.org\/10.1186\/s12943-020-01288-1.","journal-title":"Mol Cancer"},{"key":"8661_CR439","doi-asserted-by":"publisher","unstructured":"Luo C, Lu Y, Fang Q, Lu J, Zhan P, Xi W, et al. TRIM55 restricts the progression of hepatocellular carcinoma through ubiquitin-proteasome-mediated degradation of NF90. Cell Death Discov. 2024;10(1). https:\/\/doi.org\/10.1038\/s41420-024-02212-y.","DOI":"10.1038\/s41420-024-02212-y"},{"key":"8661_CR440","doi-asserted-by":"publisher","unstructured":"Jin Z, Li H, Hong X, Ying G, Lu X, Zhuang L, et al. TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1\/STAT3 pathway. Cancer Cell Int. 2018;18(1). https:\/\/doi.org\/10.1186\/s12935-018-0701-1.","DOI":"10.1186\/s12935-018-0701-1"},{"issue":"2","key":"8661_CR441","first-page":"831","volume":"14","author":"H Tian","year":"2022","unstructured":"Tian H, Zhao H, Qu B, Chu X, Xin X, Zhang Q, et al. TRIM24 promotes colorectal cancer cell progression via the Wnt\/\u03b2-catenin signaling pathway activation. Am J Transl Res. 2022;14(2):831\u201348.","journal-title":"Am J Transl Res"},{"issue":"8","key":"8661_CR442","doi-asserted-by":"publisher","first-page":"113196","DOI":"10.1016\/j.isci.2025.113196","volume":"28","author":"C He","year":"2025","unstructured":"He C, Weng C, Lai Z, Luo H, Chen K, Li T, et al. Oroxin a suppresses colorectal tumor growth by regulating the TRIM24-mediated ferroptosis and TSPO pathway. iScience. 2025;28(8):113196. https:\/\/doi.org\/10.1016\/j.isci.2025.113196.","journal-title":"iScience"},{"issue":"21","key":"8661_CR443","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41388-025-03335-x","volume":"44","author":"J Zhu","year":"2025","unstructured":"Zhu J, Wang L, Nie X, Ou S, Shen J, Zhang S, et al. RBMS3-loss impedes TRIM21-induced ubiquitination of ANGPT2 in an RNA-independent manner and drives sorafenib resistance in hepatocellular carcinoma. Oncogene. 2025;44(21):1620\u201333. https:\/\/doi.org\/10.1038\/s41388-025-03335-x.","journal-title":"Oncogene"},{"issue":"4","key":"8661_CR444","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/ibd\/izaa229","volume":"27","author":"G Zhou","year":"2021","unstructured":"Zhou G, Wu H, Lin J, Lin R, Feng B, Liu Z. TRIM21 is decreased in colitis-associated cancer and negatively regulates epithelial carcinogenesis. Inflamm Bowel Dis. 2021;27(4):458\u201368. https:\/\/doi.org\/10.1093\/ibd\/izaa229.","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"8661_CR445","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00018-024-05182-7","volume":"81","author":"D Guo","year":"2024","unstructured":"Guo D, Zhang M, Wei T, Zhang X, Shi X, Tang H, et al. NFKBIZ regulates NF\u03baB signaling pathway to mediate tumorigenesis and metastasis of hepatocellular carcinoma by direct interaction with TRIM16. Cell Mol Life Sci. 2024;81(1):167. https:\/\/doi.org\/10.1007\/s00018-024-05182-7.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"8661_CR446","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41420-023-01386-1","volume":"9","author":"Y Han","year":"2023","unstructured":"Han Y, Lu S, Song C, Xuan Y, Zhang M, Cai H. Dual roles of TRIM3 in colorectal cancer by retaining p53 in the cytoplasm to decrease its nuclear expression. Cell Death Discov. 2023;9(1):85. https:\/\/doi.org\/10.1038\/s41420-023-01386-1.","journal-title":"Cell Death Discov"},{"issue":"1","key":"8661_CR447","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41392-023-01450-3","volume":"8","author":"X Ma","year":"2023","unstructured":"Ma X, Jia S, Wang G, Liang M, Guo T, Du H, et al. TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance. Sig Transduct Target Ther. 2023;8(1):246. https:\/\/doi.org\/10.1038\/s41392-023-01450-3.","journal-title":"Sig Transduct Target Ther"},{"issue":"23","key":"8661_CR448","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1177\/15353702231211970","volume":"248","author":"T Ning","year":"2023","unstructured":"Ning T, Zhao M, Zhang N, Wang Z, Zhang S, Liu M, et al. TRIM28 suppresses cancer stem-like characteristics in gastric cancer cells through Wnt\/\u03b2-catenin signaling pathways. Exp Biol Med (Maywood). 2023;248(23):2210\u201318. https:\/\/doi.org\/10.1177\/15353702231211970.","journal-title":"Exp Biol Med (Maywood)"},{"key":"8661_CR449","doi-asserted-by":"publisher","unstructured":"Ning T, Zhao M, Zhang N, Wang Z, Zhang S, Liu M, et al. TRIM28 suppresses cancer stem-like characteristics in gastric cancer cells through Wnt\/\u03b2-catenin signaling pathways. Exp Biol Med (Maywood). 2023. https:\/\/doi.org\/10.1177\/15353702231211970.","DOI":"10.1177\/15353702231211970"},{"key":"8661_CR450","doi-asserted-by":"publisher","unstructured":"Man Z, Chen T, Zhu Z, Zhang H, Ao L, Xi L, et al. High expression of TRIM36 is associated with radiosensitivity in gastric cancer. Oncol Lett. 2019. https:\/\/doi.org\/10.3892\/ol.2019.10122.","DOI":"10.3892\/ol.2019.10122"},{"key":"8661_CR451","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fonc.2021.626190","volume":"11","author":"H Peng","year":"2021","unstructured":"Peng H, Liu G, Bao Y, Zhang X, Zhou L, Huang C, et al. Prognostic factors of colorectal cancer: a comparative study on patients with or without liver metastasis. Front Oncol. 2021;11:11. https:\/\/doi.org\/10.3389\/fonc.2021.626190.","journal-title":"Front Oncol"},{"issue":"4","key":"8661_CR452","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.3892\/or.2017.5896","volume":"38","author":"W Wu","year":"2017","unstructured":"Wu W, Chen J, Wu J, Lin J, Yang S, Yu H. Knockdown of tripartite motif-59 inhibits the malignant processes in human colorectal cancer cells. Oncol Rep. 2017;38(4):2480\u201388. https:\/\/doi.org\/10.3892\/or.2017.5896.","journal-title":"Oncol Rep"},{"issue":"2","key":"8661_CR453","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s12253-019-00629-w","volume":"26","author":"MJ Fern\u00e1ndez-Ace\u00f1ero","year":"2020","unstructured":"Fern\u00e1ndez-Ace\u00f1ero MJ, Cruz M, Sastre-Varela J, Casal JI, Nieto MAC, Del Puerto-Nevado L, et al. TRIM72 immunohistochemical expression can predict relapse in colorectal carcinoma. Pathol Oncol Res. 2020;26(2):861\u201365. https:\/\/doi.org\/10.1007\/s12253-019-00629-w.","journal-title":"Pathol Oncol Res"},{"issue":"7","key":"8661_CR454","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.chembiol.2023.05.009","volume":"30","author":"Y-X Liu","year":"2023","unstructured":"Liu Y-X, Wan S, Yang X-Q, Wang Y, Gan W-J, Ye W-L, et al. TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2. Cell Chem Biol. 2023;30(7):709\u201325.e6. https:\/\/doi.org\/10.1016\/j.chembiol.2023.05.009.","journal-title":"Cell Chem Biol"},{"key":"8661_CR455","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tranon.2025.102294","volume":"53","author":"Y Tang","year":"2025","unstructured":"Tang Y, Fan S, Peng R, Liu H, Su B, Tu D, et al. TRIM29 reverses lenvatinib resistance in liver cancer cells by ubiquitinating and degrading YBX1 to inhibit the PI3K\/AKT pathway. Transl Oncol. 2025;53:53. https:\/\/doi.org\/10.1016\/j.tranon.2025.102294.","journal-title":"Transl Oncol"},{"key":"8661_CR456","doi-asserted-by":"publisher","unstructured":"Yin Y-T, Shi L, Wu C, Zhang M-Y, Li J-X, Zhou Y-F, et al. TRIM29 modulates proteins involved in PTEN\/AKT\/mTOR and JAK2\/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma. Med Oncol. 2024;41(3). https:\/\/doi.org\/10.1007\/s12032-024-02307-7.","DOI":"10.1007\/s12032-024-02307-7"},{"issue":"3","key":"8661_CR457","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.bbrc.2015.05.117","volume":"463","author":"Y Wang","year":"2015","unstructured":"Wang Y, He D, Yang L, Wen B, Dai J, Zhang Q, et al. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis. Biochem Bioph Res Co. 2015;463(3):458\u201365. https:\/\/doi.org\/10.1016\/j.bbrc.2015.05.117.","journal-title":"Biochem Bioph Res Co"},{"key":"8661_CR458","doi-asserted-by":"publisher","unstructured":"Lv T, Jiang L, Kong L, Yang J. MicroRNA\u201129c\u20113p acts as a tumor suppressor gene and inhibits tumor progression in hepatocellular carcinoma by targeting TRIM31. Oncol Rep. 2020. https:\/\/doi.org\/10.3892\/or.2020.7469.","DOI":"10.3892\/or.2020.7469"},{"key":"8661_CR459","doi-asserted-by":"publisher","unstructured":"Chen S, He Z, Cai K, Zhang Y, Zhu H, Pang C, et al. TRIM59\/RBPJ positive feedback circuit confers gemcitabine resistance in pancreatic cancer by activating the notch signaling pathway. Cell Death Dis. 2024;15(12). https:\/\/doi.org\/10.1038\/s41419-024-07324-y.","DOI":"10.1038\/s41419-024-07324-y"},{"key":"8661_CR460","doi-asserted-by":"publisher","first-page":"8803","DOI":"10.2147\/OTT.S178446","volume":"11","author":"D Chen","year":"2018","unstructured":"Chen D, You X, Pan Y, Liu Q, Cao G. TRIM37 promotes cell invasion and metastasis by regulating SIP1-mediated epithelial\u2013mesenchymal transition in gastric cancer. OTT. 2018;11:8803\u201313. https:\/\/doi.org\/10.2147\/OTT.S178446.","journal-title":"OTT"},{"key":"8661_CR461","doi-asserted-by":"publisher","unstructured":"Jiang T, Tang H-M, Lu S, Yan D-W, Yang Y, Peng Z-H. Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer. Med Oncol. 2013;30(4). https:\/\/doi.org\/10.1007\/s12032-013-0715-4.","DOI":"10.1007\/s12032-013-0715-4"},{"issue":"4","key":"8661_CR462","first-page":"1247","volume":"10","author":"H Wang","year":"2018","unstructured":"Wang H, Yao L, Gong Y, Zhang B. TRIM31 regulates chronic inflammation via NF-\u03baB signal pathway to promote invasion and metastasis in colorectal cancer. Am J Transl Res. 2018;10(4):1247\u201359.","journal-title":"Am J Transl Res"},{"key":"8661_CR463","doi-asserted-by":"publisher","unstructured":"Wang H, Zhang Y, Yan L, Lv Q, Lu J, Yun B. Analysis of TRIM27 prognosis value and immune infiltrates in hepatocellular carcinoma. Int J Immunopathol Pharmacol. 2022;36. https:\/\/doi.org\/10.1177\/03946320221132986.","DOI":"10.1177\/03946320221132986"},{"issue":"1","key":"8661_CR464","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/abbs\/gmy151","volume":"51","author":"M Xu","year":"2018","unstructured":"Xu M, Hu J, Zhou B, Zhong Y, Lin N, Xu R. TRIM29 prevents hepatocellular carcinoma progression by inhibiting Wnt\/\u03b2-catenin signaling pathway. ABBS. 2018;51(1):68\u201377. https:\/\/doi.org\/10.1093\/abbs\/gmy151.","journal-title":"ABBS"},{"issue":"2","key":"8661_CR465","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1101\/gad.253591.114","volume":"29","author":"L Wang","year":"2015","unstructured":"Wang L, Yang H, Abel EV, Ney GM, Palmbos PL, Bednar F, et al. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis. Genes Dev. 2015;29(2):171\u201383. https:\/\/doi.org\/10.1101\/gad.253591.114.","journal-title":"Genes Dev"},{"issue":"1","key":"8661_CR466","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/curroncol30010014","volume":"30","author":"S Chen","year":"2022","unstructured":"Chen S, Xu J, Yin S, Wang H, Liu G, Jin X, et al. Identification of a two-gene signature and establishment of a prognostic nomogram predicting overall survival in diffuse-type gastric cancer. Curr Oncol. 2022;30(1):171\u201383. https:\/\/doi.org\/10.3390\/curroncol30010014.","journal-title":"Curr Oncol"},{"issue":"1","key":"8661_CR467","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40246-024-00631-7","volume":"18","author":"Y Ding","year":"2024","unstructured":"Ding Y, Lu Y, Guo J, Chen S, Han X, Wang S, et al. An investigation of the molecular characterization of the tripartite motif (TRIM) family and primary validation of TRIM31 in gastric cancer. Hum Genomics. 2024;18(1):77. https:\/\/doi.org\/10.1186\/s40246-024-00631-7.","journal-title":"Hum Genomics"},{"issue":"7","key":"8661_CR468","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/biology14070742","volume":"14","author":"Y Huang","year":"2025","unstructured":"Huang Y, Xuan J, Liang J, Liu X, Luo Y, Gao X, et al. A TRIM family-based strategy for TRIMCIV target prediction in a pan-cancer context with multi-omics data and protein docking integration. Biol (Basel). 2025;14(7):742. https:\/\/doi.org\/10.3390\/biology14070742.","journal-title":"Biol (Basel)"},{"key":"8661_CR469","doi-asserted-by":"publisher","unstructured":"Liu Z, Gu S, Wu K, Li L, Dong C, Wang W, et al. CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated mcl-1 translation. J Exp Clin Cancer Res. 2021;40(1). https:\/\/doi.org\/10.1186\/s13046-021-02149-5.","DOI":"10.1186\/s13046-021-02149-5"},{"key":"8661_CR470","doi-asserted-by":"publisher","unstructured":"Ding Y, Lu Y, Guo J, Chen S, Han X, Wang S, et al. An investigation of the molecular characterization of the tripartite motif (TRIM) family and primary validation of TRIM31 in gastric cancer. Hum Genomics. 2024;18(1). https:\/\/doi.org\/10.1186\/s40246-024-00631-7.","DOI":"10.1186\/s40246-024-00631-7"},{"key":"8661_CR471","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2147\/IJGM.S401507","volume":"16","author":"W-Z Luo","year":"2023","unstructured":"Luo W-Z, Li X, Wu X-X, Shang Y-W, Meng D-H, Chen Y-L, et al. MAGED4B is a poor prognostic Marker of stomach adenocarcinoma and a potential therapeutic target for stomach adenocarcinoma tumorigenesis. IJGM. 2023;16:1681\u201393. https:\/\/doi.org\/10.2147\/IJGM.S401507.","journal-title":"IJGM"},{"issue":"9","key":"8661_CR472","doi-asserted-by":"publisher","first-page":"153048","DOI":"10.1016\/j.prp.2020.153048","volume":"216","author":"Y Yao","year":"2020","unstructured":"Yao Y, Liu Z, Cao Y, Guo H, Jiang B, Deng J, et al. Downregulation of TRIM27 suppresses gastric cancer cell proliferation via inhibition of the hippo-BIRC5 pathway. Pathol - Res Pract. 2020;216(9):153048. https:\/\/doi.org\/10.1016\/j.prp.2020.153048.","journal-title":"Pathol - Res Pract"},{"key":"8661_CR473","doi-asserted-by":"publisher","first-page":"101572","DOI":"10.1016\/j.bbrep.2023.101572","volume":"36","author":"J-Q Zheng","year":"2023","unstructured":"Zheng J-Q, Zhan Y, Huang W-J, Chen Z-Y, Wu W-H. N6-methyladenosine of TRIM27 enhances the stem cell-type phenotype of cisplatin-resistant colorectal cancer cells. Biochem Biophys Rep. 2023;36:101572. https:\/\/doi.org\/10.1016\/j.bbrep.2023.101572.","journal-title":"Biochem Biophys Rep"},{"key":"8661_CR474","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2147\/OTT.S235940","volume":"13","author":"X Su","year":"2020","unstructured":"Su X, Wang B, Wang Y, Wang B. <p>Inhibition of TRIM32 induced by miR-519d increases the sensitivity of colorectal cancer cells to cisplatin<\/p>. OTT. 2020, Volume, 13: 277\u201389. https:\/\/doi.org\/10.2147\/OTT.S235940.","journal-title":"OTT"},{"issue":"24","key":"8661_CR475","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.3390\/cancers14246218","volume":"14","author":"Y Guo","year":"2022","unstructured":"Guo Y, Hu G, Tian B, Ma M, Long F, Chen M. Circ_RNF13 regulates the Stemness and chemosensitivity of colorectal cancer by transcriptional regulation of DDX27 mediated by TRIM24 stabilization. Cancers. 2022;14(24):6218. https:\/\/doi.org\/10.3390\/cancers14246218.","journal-title":"Cancers"},{"key":"8661_CR476","doi-asserted-by":"publisher","unstructured":"Bian Z, Yang F, Xu P, Gao G, Yang C, Cao Y, et al. LINC01852 inhibits the tumorigenesis and chemoresistance in colorectal cancer by suppressing SRSF5-mediated alternative splicing of PKM. Mol Cancer. 2024;23(1). https:\/\/doi.org\/10.1186\/s12943-024-01939-7.","DOI":"10.1186\/s12943-024-01939-7"},{"issue":"4","key":"8661_CR477","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/1120009X.2024.2376422","volume":"37","author":"X Yao","year":"2025","unstructured":"Yao X, Yang Z, Hou G, Jiang J, Wang L, Jiang J. TRIM24\/ZFX affects the stemness and resistance to 5-FU of colorectal cancer cells. J Chemother. 2025;37(4):353\u201364. https:\/\/doi.org\/10.1080\/1120009X.2024.2376422.","journal-title":"J Chemother"},{"issue":"16","key":"8661_CR478","doi-asserted-by":"publisher","first-page":"12589","DOI":"10.3390\/ijms241612589","volume":"24","author":"W Xu","year":"2023","unstructured":"Xu W, Zhuang L, Zhu H, Mao A, Zhou J, Wang L. TRIM14 overexpression induces chemoresistance and malignant behaviors of hepatocellular carcinoma cells by activating the STAT3\/HIF-1\u03b1 pathway. IJMS. 2023;24(16):12589. https:\/\/doi.org\/10.3390\/ijms241612589.","journal-title":"IJMS"},{"issue":"3","key":"8661_CR479","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s10147-020-01832-5","volume":"26","author":"G Tan","year":"2021","unstructured":"Tan G, Xie B, Yu N, Huang J, Zhang B, Lin F, et al. TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway. Int J Clin Oncol. 2021;26(3):532\u201342. https:\/\/doi.org\/10.1007\/s10147-020-01832-5.","journal-title":"Int J Clin Oncol"},{"issue":"11","key":"8661_CR480","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1158\/0008-5472.CAN-23-2889","volume":"84","author":"S Wan","year":"2024","unstructured":"Wan S, He Q-Y, Yang Y, Liu F, Zhang X, Guo X, et al. SPARC stabilizes ApoE to induce cholesterol-dependent invasion and Sorafenib Resistance in hepatocellular carcinoma. Cancer Res. 2024;84(11):1872\u201388. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2889.","journal-title":"Cancer Res"},{"issue":"2","key":"8661_CR481","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jcmgh.2022.10.005","volume":"15","author":"J Yuan","year":"2023","unstructured":"Yuan J, Lv T, Yang J, Wu Z, Yan L, Yang J, et al. HDLBP promotes hepatocellular carcinoma proliferation and Sorafenib Resistance by suppressing Trim71-dependent RAF1 degradation. Cellular Mol Gastroenterol Hepatol. 2023;15(2):307\u201325. https:\/\/doi.org\/10.1016\/j.jcmgh.2022.10.005.","journal-title":"Cellular Mol Gastroenterol Hepatol"},{"issue":"3","key":"8661_CR482","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41416-020-01119-6","volume":"124","author":"C Schneeweis","year":"2021","unstructured":"Schneeweis C, Hassan Z, Schick M, Keller U, Schneider G. The SUMO pathway in pancreatic cancer: insights and inhibition. Br J Cancer. 2021;124(3):531\u201338. https:\/\/doi.org\/10.1038\/s41416-020-01119-6.","journal-title":"Br J Cancer"},{"issue":"2","key":"8661_CR483","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/jcmm.17109","volume":"26","author":"B Zhang","year":"2022","unstructured":"Zhang B, Yan Y, Gu Y-Q, Teng F, Lin X, Zhou X-L, et al. Inhibition of TRIM32 by ibr-7 treatment sensitizes pancreatic cancer cells to gemcitabine via mTOR\/p70S6K pathway. J Cellular Mol Medi. 2022;26(2):515\u201326. https:\/\/doi.org\/10.1111\/jcmm.17109.","journal-title":"J Cellular Mol Medi"},{"issue":"3","key":"8661_CR484","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ymthe.2025.01.047","volume":"33","author":"J Shi","year":"2025","unstructured":"Shi J, Zhang Z, Chen H-Y, Yao Y, Ke S, Yu K, et al. Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy. Mol Ther. 2025;33(3):1073\u201390. https:\/\/doi.org\/10.1016\/j.ymthe.2025.01.047.","journal-title":"Mol Ther"},{"issue":"1","key":"8661_CR485","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40364-025-00773-3","volume":"13","author":"T Fang","year":"2025","unstructured":"Fang T, Liu L, Sun H, Zhang X, Sun X, Yu Z, et al. A novel indirubin- 3-monoxime derivative I3MV- 8b exhibits remarkable cytotoxicity against multiple myeloma by targeting TRIM28. Biomark Res. 2025;13(1):57. https:\/\/doi.org\/10.1186\/s40364-025-00773-3.","journal-title":"Biomark Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08661-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08661-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08661-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T02:25:51Z","timestamp":1792722351000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08661-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":485,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8661"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08661-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"28 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1334"}}